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Summary
Tobacco use is the leading cause of preventable death worldwide. Each year the tobacco
epidemic accounts for 6 million deaths and costs hundreds of billions of dollars to the eco-
nomy. Cigarette smoking accounts for more deaths than AIDS, murder, legal and illegal
drugs, road accidents and suicide combined. Around 8590% of all lung cancer deaths
are estimated to be attributed to active or passive smoking. In Switzerland, lung cancer
is the first cause of cancer mortality in men and second in women (after breast cancer).
Gender-specific smoking patterns differ essentially in time as well as in space. In the 19th
and the beginning of the following century, smoking was restricted to the male population,
finding its peak in the 1970s in most European countries. In the past, the image of female
tobacco use experienced an essential turn. In the middle of the 20th century the smoking
prevalence among women increased due to the changes in gender roles and the subsequent
effect on female smoking reputation. Before, female smoking had not been socially ac-
cepted. After strong gender-related developments, female smoking was associated with
independence, emancipation and freedom. This movement was exploited to a great extent
by the tobacco industry by adjusting their marketing strategies regarding this new target
audience. In many developed countries the gap between gender and smoking prevalence is
closing since the last decades, as males are smoking less, while female tobacco smoking is
increasing steadily.
Information on spatial as well as temporal patterns and trends of a disease are essential
for health planning and intervention purposes. The Swiss Federal Office of Public Health
(FOPH) has launched the National Programme Tobacco 20082012 aiming to reduce the
proportion of smokers, targeting a decline of tobacco-related morbidity and mortality in the
country as a final result. Cancer mapping visualizes geographical and temporal patterns
and trends. Maps of estimated mortality serve as helpful tools to identify high risk areas
and therefore enable focused intervention planning at a higher geographical scale than the
national one.
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Disease maps of crude rates can be non-informative and might even lead to misinterpre-
tation, as rare diseases or small populations might dominate the map and result in large
variability in the estimated rates. Distinction between chance and real difference of the
obtained variability is challenging. Spatial modelling of the rates enables the assessment
of covariate effects to explain observed patterns and highlight them by obtaining smooth
maps. Bayesian methods are the state-of-the-art modelling approach for spatio-temporal
analysis. Model formulations improve the estimation of sparse, unstable rates by borrowing
strength from their neighbours. In addition, they allow risk factor analysis which takes into
account potential spatial correlation. Apart flexible modelling, Bayesian inference provides
computational advantages via the implementation of Markov chain Monte Carlo (MCMC)
simulation methods.
This thesis aimed (i) to assess geographical differences and trends of age- and gender-
specific lung and all tobacco-related cancer mortality in Switzerland; (ii) to project tobacco-
related cancer mortality in Switzerland at different geographical levels accounting for spa-
tial variation; (iii) to develop Bayesian age-period-cohort (APC) models for projecting
cancer mortality; (iv) to develop Bayesian back-calculation models to estimate age- and
gender-specific incidence from sparse mortality data; and (v) to develop models to indi-
rectly approximate gender-specific smoking patterns in space and time by unadjusted and
adjusted lung cancer mortality rates with non-smoking risk factors.
In Chapter 2 Bayesian spatio-temporal models were developed to estimate age- and gender-
specific lung and other tobacco-related cancer mortality in Switzerland from 1969 up to
2002. Age-standardized mortality ratios were estimated at municipality level, adjusted for
urbanization level and language region. Furthermore, models included random effects to
account for spatial variation. Nationwide smooth maps of lung as well as other tobacco-
related cancer mortality were produced, identifying high and low risk areas and illustrating
the temporal trend for each subgroup.
In Chapter 3 Bayesian APC models were applied to project Swiss gender-specific tobacco-
related cancer mortality at national level and for each language region in Switzerland, i. e.
German, French and Italian. The models were extended by including spatial random ef-
fects to predict cancer mortality due to tobacco use at cantonal level.
Moreover, nationwide projections were obtained for the age groups 5069 and ≥ 70 years.
Maps as well as future estimates of the disease-specific mortality are helpful tools in inter-
vention planning and identification of region-specific disparities.
In Chapter 4 a Bayesian APC model with power-link function was developed to overcome
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limitations of existing models such as estimation of extreme rates based on the log-link
function. The power parameter was considered to be random, estimated by the dataset.
Model performance was assessed by comparing observed age- and gender-specific lung can-
cer mortality rates with one-step ahead projections. The model was applied to project
lung cancer death counts in Switzerland up to 2018.
In Chapter 5 a back-calculation model was applied to estimate incidence from mortality.
Existing models were further developed to allow for estimation of rare cancer incidence.
Data from Eastern Switzerland were analysed to obtain age- and gender-specific survival
parameters. Incidence was estimated by linking subgroup-specific mortality with the corre-
sponding survival distribution. Countrywide maps of gender-specific lung cancer incidence
were produced, assuming a constant lung cancer survival across the cantons.
In Chapter 6 proxies of spatial patterns of smoking prevalence in Switzerland were devel-
oped. In particular, Bayesian spatial logistic regression models were applied to analyse
smoking data provided from the Swiss Health Survey (1992) and to study gender-specific
trends. Furthermore, lung cancer mortality data of 20082010 have been modelled using
negative binomial regressions with spatial random effects to obtain smoking proxies (i. e.
smooth mortality rates and spatial random effects). Validation was done (i) graphically,
by comparing maps of model-based smoking patterns and each proxy; (ii) numerically, by
estimating Kendall's τb coefficient and by applying logistic regression models to quantify
the magnitude of association. Results indicated that both, the spatial random effect as
well as the mortality rate approximated well the smoking patterns. Our approach provides
an indirect smoking approximation which in the absence of tobacco use survey data relies
on the availability of lung cancer mortality and non-smoking risk factors.
The main contributions of the research are (i) improved statistical models for projecting
cancer mortality. These models allow forecasting of sparse count data; (ii) improved sta-
tistical models for estimating tobacco-related incidence from mortality data. These models
enable estimation of incidence rates of the disease in the parts of the population, which
are not covered by cancer registries; (iii) smooth maps of gender-, age- and site-specific
patterns of lung and other tobacco-related cancer mortality over time. These maps identify
discrepancies of disease burden and assist implementation and evaluation of the National
Programme Tobacco; (iv) a better insight into the differences in tobacco-related cancer
mortality rates between linguistic regions and urbanisation by gender; (v) smooth maps
of gender-specific patterns of lung cancer incidence for a recent period; (vi) estimates of
the geographical patterns of tobacco-related cancer mortality for the next 10 years: this
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information is useful for planning purposes such as resource allocation and costing of med-
ical supplies for diagnosis and treatment; (vii) smooth maps of lung cancer mortality,
adjusted/unadjusted for non-smoking risk factors, which allow to find a good proxy of
smoking behaviour in order to study gender-specific geographical patterns of smoking in
Switzerland from limited smoking surveys.
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Zusammenfassung
Tabakkonsum ist die führende Ursache vermeidbarer Krankheiten weltweit. Jedes Jahr
sterben ca. 6 Millionen Menschen an den Folgen der Tabakepidemie und sie verursacht
Wirtschaftskosten in Höhe von hunderten Milliarden. Rauchen ist verantwortlich für mehr
Todesfälle als die Summe aus AIDS, Mord, legale und illegale Drogen, Verkehrsunfälle und
Suizid. Schätzungen zufolge sind rund 8590% aller Lungenkrebstodesfälle auf aktiven oder
passiven Tabakkonsum zurückzuführen. Männlicher Lungenkrebs ist für den größten Anteil
der gesamten Krebsmortalität in der Schweiz verantwortlich, wobei diese Position bei den
Frauen vom Brustkrebs, gefolgt von Lungenkrebs, eingenommen wird.
Geschlechtsspezifisches Rauchverhalten weist wesentliche Unterschiede in räumlichen und
zeitlichen Trends auf. Im 19. und Anfang des 20. Jahrhunderts war Rauchen ein Habi-
tus des männlichen Teils der Gesellschaft. In den meisten europäischen Ländern fand das
männliche Tabakkonsumverhalten seinen Höchstpunkt in den 1970ern. Im Gegenzug da-
zu erlebte das Gesellschaftsbild der rauchenden Frau in der Vergangenheit eine drastische
Kehrtwende. Infolge der Veränderungen der Geschlechterrollen und dem anschließenden
Wandel des Ansehens des rauchenden weiblichen Geschlechts stieg die Prävalenz Mitte des
20. Jahrhunderts an. Zuvor wurden rauchende Frauen als nicht gesellschaftsfähig angese-
hen. Nach starken Entwicklungen bezüglich der Geschlechterrollen wurde das Rauchen der
weiblichen Bevölkerung mit Unabhängigkeit, Emanzipation und Freiheit assoziiert. Diese
Bewegung wurde im großen Maße von der Tabakindustrie ausgenutzt, indem sie ihre Mar-
ketingstrategien an die neue Zielgruppe angepasst haben. In vielen Entwicklungsländern
hat sich die Lücke der geschlechtsspezifischen Raucherprävalenz in den letzten Jahrzehnten
verkleinert. Dies ist darauf zurückzuführen, dass der Tabakkonsum der Männer zurückge-
gangen ist und zeitgleich das weibliche Pendant einen steten und starken Anstieg erlebt
habt.
Wissen über räumliche als auch zeitliche Verhaltensmuster und Trends einer Krankheit
ist wesentlicher Bestandteil für die Gesundheits- und Interventionsplanung. In der Schweiz
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hat das Bundesamt für Gesundheit (BAG) das Nationale Programm Tabak 20082012 ins
Leben gerufen. Zielsetzung des Programms ist die Reduzierung des Raucheranteils und
längerfristig ein Rückgang der landesweiten tabakbedingten Morbidität als auch Mortali-
tät. Kartierung des Krebsvorkommens visualisiert geografische und zeitliche Muster und
Verläufe. Karten der geschätzten Mortalität dienen als nützliche Hilfsmittel um Gebiete
mit hohem Risiko zu identifizieren. Dadurch wird eine zielgerichtete Interventionsplanung
auf einem höheren geografischen Maßstab als der Landesebene ermöglicht.
Kartierung von Krankheiten mittels rohen Raten kann uninformativ sein und sogar zu
Fehlinterpretation führen, da seltene Krankheiten oder eine kleine Bevölkerungszahl die
Karte dominieren können und in großer Variabilität der geschätzten Raten resultieren.
Differenzierung zwischen Zufall und wirklichem Unterschied der beobachteten Variabilität
ist problematisch. Räumliche Modellierung von Raten ermöglicht die Abschätzung von Ef-
fekten der Kovariaten, um beobachtete Muster zu erklären und hebt diese durch geglättete
(smooth) Karten hervor. Bayes'sche Methoden sind der neueste Stand der raum-zeitlichen
Analysen. Sie ermöglichen flexible Modellierung und Schlussfolgerung und bieten rechne-
rische Vorteile durch die Implementierung von Markov chain Monte Carlo (MCMC). Mo-
dellformulierungen verbessern die Schätzungen von instabilen Raten, indem diese durch
deren Nachbarn stabilisiert werden. Dadurch heben die resultierenden geschätzten geglät-
teten Raten Muster hervor und erlauben die Einschätzung der Signifikanz der einzelnen
Risikofaktoren unter Berücksichtigung der geografischen Korrelation.
Das Ziel dieser Dissertation war es (i) Bayes'sche raum-zeitliche Modelle für die Analyse
der Schweizer tabakbedingten Krebsmortalitätsdaten zu entwickeln und landesweite ge-
glättete Karten der alters-, geschlechts- und standortspezifischen Verhaltensmuster dieser
Krebsarten seit 1969 zu erstellen; (ii) tabakbedingte Krebsmortalität in der Schweiz für un-
terschiedliche geografische Einheiten bis zum Jahre 2018 unter Berücksichtigung der geogra-
fischen Korrelation vorherzusagen; (iii) Modelle zur Vorhersage von geschlechtsspezifischen
tabakbedingter Krebsmortalität zu entwickeln; (iv) Bayes'sche Rückrechnungsmodelle zu
entwickeln, um mittels Mortalität Inzidenz nach Alter und Geschlecht zu schätzen; und (v)
Modelle zu entwickeln, welche das geschlechtsspezifische Rauchverhalten in der Schweiz in-
direkt approximieren, um mittels angepasster Lungenkrebsmortalität landesweite Trends
der Raucherprävalenz zu schätzen.
In Kapitel 2 wurden Bayes'sche raum-zeitliche Modelle zur Schätzung von alters- und
geschlechtsspezifischen Lungenkrebs- und sämtlicher tabakbedingten Krebsmortalität in
der Schweiz von 1969 bis 2002 entwickelt. Altersstandardisierte Mortalitätsraten wurden
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auf Gemeindeebene geschätzt und hinsichtlich des Grads der Urbanisierung und der loka-
len Sprache angepasst. Des Weiteren wurde räumliche Variation mittels random effects auf
Gemeindeebene berücksichtigt. Es wurden landesweite geglättete Karten der Lungenkrebs-
als auch sämtlicher tabakbedingter Krebsmortalität erstellt, welche Gebiete mit hohem als
auch niedrigem Risiko identifizieren und zeitliche Trends der jeweiligen Untergruppen il-
lustrieren.
In Kapitel 3 wurde mittels Bayes'sche Alter-Periode-Kohorte (APC) Modelle geschlechts-
spezifische tabakbedingte Krebsmortalität auf kantonaler und nationaler Ebene sowie für
die Sprachregionen Deutsch, Französisch und Italienisch prognostiziert. Eine Erweiterung
des Modells für die Schätzung kantonaler Krebsmortalität bedingt durch Tabakkonsum
beinhaltete räumliche random effects. Zusätzlich wurden landesweite Projektionen für die
Altersgruppen 5069 und ≥ 70 bestimmt. Sowohl Karten als auch Schätzungen zukünftiger
krankheitsspezifischer Mortalität sind unterstützende Hilfsmittel hinsichtlich der Interven-
tionsplanung und der Identifizierung regionaler Unterschiede.
In Kapitel 4 wurde ein Bayes'sches Power Model zur Projektion von Krebsmortalität und
-inzidenz entwickelt. Schätzungen basierten auf einer Power Link-Funktion zwischen der
Mortalitätsrate und den Effekten von Alter, Periode und Kohorte, indem ein fixer Power-
Parameter mit dem Wert fünf angenommen wurde. Als eine Erweiterung dessen wurde ein
Model entwickelt, welches einen nicht-fixen Power-Parameter annimmt, um dessen Grad
durch die Daten schätzen zu können. Modellvalidierung wurde anhand Vorhersage bekann-
ter Schweizer alters- und geschlechtsspezifischer Lungenkrebsmortalität durchgeführt. Jene
Modelle, welche die beste prädiktive Leistung aufwiesen, wurden angewandt, um Lungen-
krebstodesfälle bis 2018 zu prognostizieren. Die entwickelten Modelle adressieren Kritik,
welche gegen das etablierte Power- als auch das Bayes'sche APC Modell geäußert wurden,
indem deren jeweiligen Stärken kombiniert wurden.
In Kapitel 5 wurde das Rückrechnungsmodell angewandt, welches die Schätzung der Inzi-
denz auf Basis von Mortalität ermöglicht. Das Modell wurde weiterentwickelt, um verläss-
liche Schätzungen auch für seltene Krebsarten zu ermöglichen. Die Analyse der Inzidenzda-
ten der Ostschweiz umfassten Follow-up-Zeit und -Status und ermöglichten die Schätzung
der alters- und geschlechtsspezifischen Überlebensdauer in der Region. Schätzungen der
Inzidenz wurden durch Verbindung untergruppenspezifischer Mortalität mit der entspre-
chenden geschätzten Überlebensdauer ermittelt.
In Kapitel 6 wurden indirekte Schätzer für geschlechtsspezifisches Rauchverhalten in der
Schweiz entwickelt. Vorerst wurden logistische Modelle angepasst, um Daten der Schweizer
xv
Gesundheitsbefragung bzgl. der Raucherprävalenz zu analysieren. Des Weiteren wurden
räumliche Negativ-Binomiale Regressionsmodelle eingesetzt, welche hinsichtlich der Nicht-
raucherrisikofaktoren angepasst und auf Daten der Lungenkrebsmortalität in 20082010
angewandt wurden. Umweltrisikofaktoren beinhalteten Exposition zu Radon und Luftver-
schmutzung. Resultierende räumliche random effects als auch Mortalitätsraten basierend
auf unangepassten Regressionsmodellen wurden als Schätzer des Rauchverhaltens genutzt.
Validierung erfolgte (i) grafisch durch Vergleich der räumlichen Verteilung des modellier-
ten Rauchverhaltens und den indirekten Schätzern; (ii) numerisch, durch Schätzung des
Kendall's τb Koeffizienten und Verwendung von logistischen Regressionsanalysen. Ergeb-
nisse zeigten, dass sowohl die Mortalitätsraten als auch die räumlichen random effects die
Raucherprävalenz gut approximierten. Unsere Methodik ermöglicht es die Verteilung von
Raucherprävalenz indirekt abzuschätzen und benötigt Daten über Risikofaktoren und Lun-
genkrebsmortalität.
Die wichtigsten Beiträge dieser Dissertation sind (i) entwickelte statistische Modelle zur
Vorhersage von Krebsmortalität; (ii) erweiterte Modelle zur Rückberechnung von Krebs-
inzidenz anhand gegebener Krebsmortalitätsdaten; (iii) die Erstellung landesweiter geglät-
teter Karten über die alters- und geschlechtsspezifische Lungen- und sämtliche tabak-
bedingte Krebsmortalität in der Schweiz von 19692002. Hierfür wurden raum-zeitliche
Bayes'sche Negativ-Binomiale Regressionsmodelle verwendet; (iv) einen besseren Einblick
in tabakbedingte Krebsmortalität nach Sprachgebiet und Urbanisierungsniveau; (v) ge-
glättete Karten über aktuelle Lungenkrebsinzidenz; (vi) die Schätzung der zukünftigen
alters- und geschlechtsspezifischen Lungen- und sämtlicher tabakbedingten Krebsmortali-
tät in der Schweiz bis zum Jahre 2018; und (vii) die Entwicklung von Bayes'schen Modellen
zur indirekten Annäherung an das Rauchverhalten, welche die Schätzung von landesweiten
Tabakkonsumverhalten für jedes Geschlecht ermöglicht, indem die Modelle hinsichtlich der
Nichtraucherrisikofaktoren angepasst wurden.
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2 Chapter 1. Introduction
1.1 Tobacco  a global epidemic
Every day more than 15 billion cigarettes are smoked worldwide. Manufactured cigarettes
are the predominant form of tobacco-consumption. Several other types of tobacco use
exist as for example pipes and cigars. China is the leading cigarette manufacturer  its
production increased by 600% from 1960 to 1995 (MacKay and Eriksen, 2004). On a global
scale, each year over five trillion cigarettes are produced. Over time, the composition of a
manufactured cigarette has changed to a great extent. In the middle of the 20th century
strong health concerns on smoking caused first efforts to reduce the harm of cigarettes
by reducing its tar and nicotine yields. First attempts introduced filtered cigarettes which
were followed by light cigarettes. However, till today no clear evidence for a reduced health
risk is given for these tobacco products. Overall, former attempts to lower the harm of
smoking made cigarettes more addicting by adding chemicals or the use of flavours.
1.1.1 Gender- and age-specific tobacco use
Up to the beginning of the 20th century smoking was only socially accepted for males.
After the First World War the tobacco industry targeted female smoking. While before
that time, smoking by women was judged as misbehaviour, the tobacco companies created
a new image of female smoking by their advertising strategy. This new image suggested
a changing, more independent role of women. Philip Morris even offered lessons on how
to smoke for women in London. Media played a fundamental role on the way to tobacco
addiction. Figure 1.1 shows an advertisement of Philip Morris in the middle of the 20th
century. It clearly targets women by suggesting smoking as a sign of emancipation and
freedom.
While female smoking is declining in some developed countries as Australia, the USA,
Canada and the UK, the number of women smoking remains stable or still increases in many
European countries. More than 10% of women are smoking during pregnancy. In addition,
they are exposed to many sources of second-hand smoke as public places, at work or even
in the private environment at home. Youth smoking is a big challenge. The majority of
overall smokers start to consume tobacco before they reach the age of adulthood. About
25% of them smoked their first cigarette before having their 10th birthday (MacKay and
Eriksen, 2004). Tobacco industry advertisement is the major risk of youth smoking. As the
industry applied their strategy to boost female smoking by emphasizing on emancipation
and gender equality, it is also applied to younger males and females. While cigarette
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Figure 1.1: Philip Morris Tobacco Company advertisement in 1951 (source: tobacco-
standford.edu).
smoking is associated with coolness among teenagers and children, it plays an important
role in the socializing process. Peer pressure, allegiance, stress management, suppress
appetite and self-confidence are all aspects which have a great impact during youth and
are also directly linked with tobacco use.
`It is important to know as much as possible about teenage smoking patterns
and attitudes. Today's teenager is tomorrow's potential regular customer, and
the overwhelming majority of smokers first begin to smoke while still in their
teens... The smoking patterns of teenagers are particularly important to Philip
Morris.'(Philip Morris Companies Inc. 1981)
Studies have shown that even candy cigarettes (Fig. 1.2) double the risk of smoking in
older age. In many countries, i. e. Canada, Great Britain, Norway and Australia, candy
cigarettes are not allowed to be sold anymore. However, in Switzerland, and also many
other countries, they are still available in shops. Lopez et al. (1994) have developed a
model to describe the cigarette epidemic in developed countries. The authors used lung
cancer death rates as an index of total smoking-attributable mortality. They point out
three sources of information which can be used to describe the transition through the four
stages of their model: (i) How many adults smoke regularly? (ii) How much does an adult
smoke in a given period? (iii) How many people die from smoking (by age, sex and cause
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Figure 1.2: Candy cigarette advertisement (source: tobacco-standford.edu).
of death)?
The first stage of the model describes the origin of the smoking epidemic, characterized
by low male smoking prevalence. Driven by social conventions, tobacco use among women
is rarely seen. The health risks of smoking are not even recognized and lung cancer cases
among smokers are not yet inflated. The subsequent stage is influenced by a rapid increase
of male smoking prevalence, finding its peak around 5080%. Furthermore, smoking preva-
lence among women is rising as well, but lags behind by 1020 years.
Stage III is driven by a decline in male smoking prevalence, as many middle-aged and older
men stopped smoking. In addition, an initial decrease of female prevalence occurs by the
end of this phase, which lasts for around three decades. The essential development during
this stage is the rapid increase in smoking-attributable mortality. Anti-tobacco campaigns
are established and smoking undergoes another change in social acceptance to be rather
seen as socially aberrant.
The final stage (IV) describes a continuing, but slow decrease in overall smoking prevalence.
Death due to smoking is expected to fall below 30% for males. On the contrary, female
smoking-attributable mortality is increasing sharply, finding its peak at around 2025% of
all deaths after 30 years. Furthermore, protection against passive smoking at an individ-
ual level is discussed and policies also need to focus on the problem of failing attempts
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of smoking cessation by smokers who are addicted to nicotine. Figure 1.3 illustrates the
process of the epidemic as defined by Lopez et al.
Figure 1.3: Cigarette epidemic model (source: (Lopez et al., 1994)).
1.1.2 Passive smoking
In the last decades, after assessing the significant relation between smoking cancer and
lung cancer, several studies are focused on assessing the impact of passive smoking, so-
called Environmental Tobacco Smoke (ETS) on health. Association of ETS exposure with
several risks has been reported, i. e. increased risk of lower respiratory tract infections
(such as bronchitis and pneumonia) and asthma in children as well as lung cancer in adults
(United States Environmental Protection Agency, 1992). A frequently studied source of
exposure to ETS are non-smoking spouses of smokers. A meta-analysis reported a pooled
risk ratio of 1.27 (95% CI 1.171.37) for never-smoking women to passive smoking from
spouses. However, this risk might be confounded by other factors (Taylor et al., 2007).
For European countries, strong correlation between strength of tobacco control policies
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and concern about passive smoking has been reported (Willemsen et al., 2012). Therefore,
public information and education on the harmful health consequences from passive smoking
are essential.
1.2 Tobacco use in Switzerland
While in the beginning of the last century female smoking was socially not accepted, its
prevalence increased constantly with each following birth cohort. In the 19501959 cohort,
smoking prevalence among both sexes was nearly balanced (37% and 41% for females
and males, respectively) (La Vecchia et al., 1988). Another trend of female smoking is
the earlier age of starting smoking for younger ones, which in addition is characterized
by heavier tobacco consumption. Furthermore, it has been stated, that older men are
more likely to quit smoking compared to older women. Since the early 1970s cigarette
sales increased steadily with a strong rise, which levelled off around 3 000 cigarettes per
adult/year on average (La Vecchia et al., 1988). Gmel (2000) reported increasing trends in
current smoking in 19931997 for both genders. Costanza et al. (2006) analysed gender-
specific habits in tobacco use and concluded a stable smoking prevalence for males and
females based on a surveillance study in Geneva during 19932003. In 2010, the smoking
population was around 30% for males and 24% for females. Almost half of them (48%)
intented to quit smoking, while this willingness is highest in the French-speaking part of
the country (Keller et al., 2011).
1.2.1 Tobacco-related policies
Lack of knowledge regarding the harms of tobacco use has been observed among smokers
as well as non-smokers. Many people are unaware of the range of risks implied and diseases
caused by tobacco-smoking (WHO, 2008).
Light cigarettes are one example of a wrong perception, as they are seen to be less adverse
compared to regular ones. Cigarettes labelled as light are often used as a pre-step before
quitting. Studies showed that there is a positive association of switching to light cigarettes
and the attempt to quit smoking. However, so far there is no evidence that changing to
light-tar cigarettes increases the chance to stop smoking (Weinstein, 2001).
Different strategies exist to prevent and control the burden of tobacco use and related
diseases. In Switzerland, the National Programme Tobacco 20082012 has been launched
by the Federal Office of Public Health (FOPH) with the long-term goal to reduce the
number of tobacco-related morbidity and mortality. In 2012, it was extended till the end
1.2 Tobacco use in Switzerland 7
of 2016 and determines the national strategy regarding tobacco-prevention.
As the country is splitted into 26 cantons, each being independent and relying on a local
government and decision making processes, no strict national agreement or law exists.
In 2007, the majority (64%) of the Swiss population (aged 1465) favoured a smoking
ban in restaurants, cafés and bars (Krebs et al., 2008). The acceptance was highest in
the Italian-speaking region, followed by the French- (74%) and German-speaking (61%)
part of the country. In 2010, the Federal law to protect against passive smoking was
conducted. The smoking ban regulation aimed to achieve smoke-free interiors, covering
public or working places as restaurants, bars, schools, hospitals etc. As a refinement of
this minimal protection, further details have been defined independently at cantonal level.
While some cantons allowed service in rooms labelled as smoke-rooms, some prohibit any
service in rooms where smoking is allowed. This regulation, not offering any service in
smoke-rooms, protects the waiting staff, which is no longer exposed to the smoke of the
guests and being therefore passive-smokers.
In 2012, the Swiss population had to vote regarding an initiative for stricter smoking ban
regulations to protect against passive-smoking. This policy would have implied no service in
smoke-rooms for the whole country. With a turnout of 42.3% the initiative failed. Around
34.0% voted for the new initiative, while the lowest number of proponents was observed
in the German-speaking part (31.5%), followed by the French-speaking area (39.7%) and
almost half of the population living in the Italian-speaking region (48.8%). Geneva was
the only canton that voted for the initiative (51%).
Other federal smoking regulations include health warning labels on cigarette packs. Labels
either show statements of the health consequences of smoking or illustrate them, as a
metastatic lung.
In 2011, the FOPH launched a rather contrary campaign called SmokeFree, focusing on
advantages from non-smoking instead of highlighting disadvantages and risks from smoking.
The initiative attempts to emphasize on the coolness of non-smoking and the positive
implications.
1.2.2 The tobacco lobby
Worldwide, the tobacco industry influences tobacco-related interventions and public health
efforts. In Switzerland, the tobacco market is mainly driven by two tobacco companies:
Philip Morris and British American Tobacco, controlling the market of cigarette sales of
4550% each. It has been stated that Switzerland is a paradise for the tobacco industry,
being influenced by the tobacco lobby to a greater extent than anywhere else.
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`We have now a clear view of the tobacco industry's strategies in Switzerland as
a result of lawsuits in the United States which have made millions of pages of
previously secret tobacco industry documents public. These documents reveal
that [...] the tobacco industry made a large, and largely invisible, effort in
Switzerland to prevent implementation of meaningful tobacco control legislation
and policies in Switzerland.'(Lee and Glantz, 2001)
In addition, the lowest tobacco excise tax in Western Europe can be found in Switzerland.
One essential component of an effective intervention strategy planning is to discuss in
public and finally aim to eliminate the counter movement by the tobacco industry. In
Switzerland, this factor has been identified as a major obstacle of tobacco prevention.
However, interventions in the past have rather ignored this influence (Lee and Glantz,
2001).
1.3 Tobacco-related cancer
Tobacco use is the single most preventable cause of death in the world today. It is estimated
to reduce normal life expectancy by 2025 years (United States Department of Health and
Human Services, 2010). In the 20th century around 0.1 billion deaths are due to tobacco
use. This number is estimated to be ten times higher for the 21st century (MacKay and
Eriksen, 2004). Smoking is a risk factor of cardiovascular disease (CVD). It accounts
for more than 10% of all death cases from CVD in 2000 (Ezzati et al., 2005). Around
25% of ischaemic heart disease cases and 75% of chronic bronchitis and emphysema are
attributable to smoking. Furthermore, tobacco use is the predominant risk factor for
cancer  worldwide, it accounts for 22% of overall cancer mortality. It causes a range
of cancer sites, as cancer of the lung, larynx, oral cavity, pharynx, esophagus, pancreas,
bladder, kidney, cervix, stomach and acute myeloid leukaemia. Furthermore, a causal
relation between tobacco smoking and liver and colorectal cancer was suggested (United
States Department of Health and Human Services, 2004). However, no official definition of
tobacco-related cancer exists. According to Doll et al. (1976), the following cancer sites are
defined as related to tobacco: lung (C33C34), oesophagus (C15), rectum (C20), pancreas
(C25), bladder (C67) and cancer of other respiratory sites (C00C14) including cancer of
the lip, tongue, mouth, larynx, trachea and pharynx (excluding nasopharynx). Numbers in
brackets refer to the 10th revision of the International Classification of Disease (ICD-10).
It has been shown, that quitting smoking at various ages reduces the lifetime risk. The risk
for tobacco-related diseases remains for smokers quitting after 44 years of age. However,
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several conditions have to be considered regarding this threshold of age, i. e. age of starting
and the intensity of smoking.
Lung cancer
Smoking is the main risk factor of lung cancer. It accounts for 90% of lung cancer morbidity
and around 71% of all lung cancer deaths. Passive smoking increases the risk of lung
cancer by 2030%. Figure 1.4 shows estimated male lung cancer mortality for the year
2008. Highest rates are observed for Central-Eastern, Southern Europe, Northern America
and Eastern Asia. For females, lung cancer mortality rates at a global scale are highest
in Northern America (see Fig. 1.5). Lowest lung cancer mortality for both genders is
given in Africa, in particular Middle Africa. It should be mentioned that both maps are
characterized by different scales.
Figure 1.4: Estimated male lung cancer mortality rate per 100 000 (source: GLOBOCAN
2008 (IARC)).
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Figure 1.5: Estimated female lung cancer mortality rate per 100 000. (source: GLOBOCAN
2008 (IARC)).
Diagnosis in early lung cancer stage is crucial regarding treatment and survival. While
in earlier decades, chest X-rays were applied for screening, nowadays computed tomogra-
phy (CT) is in the focus as a tool for early lung cancer detection (Keshamouni et al., 2009).
Lung cancer can be described by two main types  small-cell lung carcinoma (SCLC) and
non-small-cell lung carcinoma (NSCLC). The types differ regarding the size of the lung
cancer cells. SCLC is the more aggressive type and grows very fast and often metasta-
sized. Around 8085% of all lung cancer cases are NSCLC, which is less aggressive than
the SCLC (Krebsliga Schweiz, 2012). Early detection is essential for the treatment. How-
ever, as the symptoms of lung carcinoma in the beginning are not conspicuous, detection in
early stages is challenging. Steps before diagnosis cover anamnesis, medical and laboratory
examinations, x-ray of the thorax, electrocardiogram and pulmonary function tests. De-
pending on the results, subsequent examinations, as bronchoscopy, follow for confirmation.
Different treatments of lung cancer exist, depending on several factors, i. e. age of the pa-
tient or stage of the cancer. The main therapeutic methods are surgery, drug treatment as
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chemotherapy and radiotherapy.
At the point of diagnosis, around 75% of all lung cancers are already in an advanced stage
or the tumour has metastasized by then. Consequently, survival rates for both genders are
very low and there was no significant change in lung cancer survival over the last decades
(Keshamouni et al., 2009). In Europe, the lowest survival has been reported for cancer
of the lung (beside cancers of the pancreas, oesophagus, brain and liver) (Coleman et al.,
2003), where an average 5-year survival of 20% was estimated.
Other risk factors are known  radon is the main risk factor of lung cancer in non-smokers
and has been classified as human carcinogen (group 1) by the International Agency for
Research on Cancer (IARC) (International Agency for Research on Cancer, 1988). It is
a radioactive gas, resulting as an intermediate product of the decay chain of an element
in the Earth's crust. Subsequently, radon finds its way through soil and rocks into the
houses, where people are exposed to it. In general, its concentration is low and highest
concentrations can be found in underground mines (Darby et al., 2001).
1.4 Tobacco-related cancer morbidity and mortality in Switzer-
land
In Switzerland, smoking causes the largest number of preventable deaths. In 2007, more
than 9 000 (6 427 men and 2 774 women) deaths were due to tobacco use, which is 14% of
all deaths. Respiratory diseases accounted for 1 669 of those cases, while 3 800 died from
cardiovascular diseases. Cancer was responsible for 3 729 smoking-attributable deaths,
while 2 485 of them were lung cancer cases (Federal Statistical Office, 2009). Lung cancer
is the most common cancer cause of death among men and the second frequent one for
women (after breast cancer). Its main risk factor is tobacco smoking, accounting for 85
90% (including passive smoking) (Hirrle, I/2005). Nowadays, around 2 000 males and 900
females die from this cancer every year. About 10% of the cases among males are younger
than 55, while the median age is 71. For women the corresponding numbers are 52 and
a median of 69 years of age. Since the last three decades, female lung cancer mortality is
growing steadily. While in the '80s, the disease-specific standardized rate was 5 per 100 000
inhabitants, it increased more than threefold up to 16 cases (in 2004). On the other hand,
male lung cancer mortality peaked in the '80s and decreased since then from 70 to 45 cases
per 100 000 in 2004 (Berrut and Junker, 2008).
The country is distinguished into three main languages  German, French and Italian.
Assuming that regions defined by the language spoken represent a corresponding cultural
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behaviour, this linguistic partition transforms Switzerland into a multicultural unit.
In Switzerland, cancer incidence data are available from the 11 cancer registries, which
cover 15 cantons. The largest gap can be found in the German-speaking part of the
country, where only 45.2% of its population was covered by cancer registries in 20052009
(Federal Statistical Office, 2013a). On the other hand, data on death cases are available
at the Federal Statistical Office. The cause of death statistics provide reliable information
on the age, gender, civil status, occupation, commune of residence, nationality and cause
of death (ICD-10 code) of the reported case. The statistics cover the whole country and
lack only by 3% missing cause of death.
Analysis of data at a high geographical resolution allows to assess the significance of risk
factors, to produce smooth maps to understand the temporal and spatial distribution of
the disease and to identify endemic areas. However, Swiss cancer morbidity and mortality
data have not yet been analysed to such extend.
1.5 Bayesian spatio-temporal modelling of cancer data
Spatial data can be broadly classified into three categories viz areal unit data, geostatistical
data and point processes (Bailey and Gatrell, 1995). The latter defines data observed at
random locations and thus the outcome of interest is the location itself. Areal data arise
when the outcome of interest is observed over an area, e. g. mortality rates within admin-
istrative regions. In this case the entire study area is partitioned into a finite number of
mutually exclusive and exhaustive regions each having a positive area with a measurement
attached to it. Geostatistical data arise when the outcome is observed at a finite number
of geocoded locations, e. g. village level surveys. Geographical dependency violates the
independence assumption of standard statistical models resulting in biased estimates of
the parameters if it is not taken into account (Ver Hoef et al., 2001).
Disease maps based on crude rates can be non-informative or misleading when the sizes of
the population for some of the areas are small, resulting in large variability in the estimated
rates, and making it difficult to distinguish chance variability from real differences.
Bayesian methods have been applied extensively in recent years for modelling spatial data
because they allow flexible modelling and inference and provide computational advantages
via the implementation of Markov chain Monte Carlo (MCMC) methods (Gelfand and
Smith, 1990). The spatial structure is commonly introduced in a hierarchical fashion via
the prior distribution of area- or location-specific random effects, although spatial depen-
dence can be built directly on Gaussian response data. The choice of prior distributions
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or spatial models depends on the type of data.
In areal data, simultaneously autoregressive (SAR) models (Whittle, 1954), conditional
autoregressive (CAR) models (Clayton and Kaldor, 1987; Bernardinelli and Montomoli,
1992; Gelfand and Vounatsou, 2003; Best et al., 2005) and modifications (Besag et al.,
1991; Marshall, 1991; Sun et al., 2000) have been suggested as prior specifications.
The models smooth or improve the estimate of an unstable rate by borrowing strength
from its neighbours. They enable smoothing of the rates to highlight patterns but also
assess the significance of risk factors taking into account the geographical correlation. In
addition, these models are able to show spatial patterns after adjusting for geographical
differences in certain risk factors. By adding a time dimension, Bayesian spatio-temporal
models indicate changes of geographical patterns over time and determine how the disease
evolves over time in different regions and groups of the population (age or gender-related
groups).
1.5.1 Cancer mapping
Graphical presentation of the distribution a disease or so-called disease mapping is essential
in spatial epidemiology. It allows to assess the spatial as well as temporal distribution of a
disease under consideration and identifies high/low risk areas. Cancer mapping has been
applied frequently in the last decades for different cancer sites, countries and geographical
units.
Several measures exist to express disease-specific incidence or mortality. Most commonly
used quantities are the Age Standardized Rate (ASR) and the Age Standardized Incidence
(SIR) or Mortality Ratio (SMR). Both are differing in the way of standardization, which
can be distinguished as direct and indirect. In the case of direct standardization, com-
mon reference populations are the Segi world population (Segi, 1960) or the European
(Scandinavian) one (Doll and Cook, 1967). The approach is to weight observed age group
specific mortality rates by the age distribution of the reference population. In the case
of indirect standardization, the overall area under consideration is used as the reference
group. Observed sub-regional age group-specific mortality rates are then related to the one
expected based on the overall scale, i. e. countrywide. While direct standardization allows
for comparison between several countries, the indirect approach gives a clear idea of the
distribution within a country in an absolute sense.
Geographical information systems (GIS) software has been used frequently for handling
and illustrating geographically referenced information in public health and epidemiology.
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Since the last decades numerous investigations have been done on cancer mapping studies
applying Bayesian hierarchical spatio-temporal models. First analyses include work by
Xia et al. (1997), mapping lung cancer mortality rates in Ohio based on Bayesian spatial
models. As a follow-up, these models were developed further by Waller et al. (1997) and
Sun et al. (2000) to assess space-time patterns of lung cancer rates.
Knorr-Held and Best (2001) introduced a shared component model in 2001, which allows
for identification of similar geographical patterns in multiple cancer sites in a joint spatial
analysis. These models aim to distinguish between the unobserved shared component for
all cancers (e. g. smoking) and the component related to the disease.
Richardson et al. (2006) jointly mapped lung cancer rates for males and females to extract
common risk factors. The authors assessed the temporal evolution of the gender-specific
risk factors and studied weather there is evidence of a differential risk between males and
females beyond that expected from tobacco use. Another joint model approach was pre-
sented by Downing et al. (2008), mapping lung, oesophagus, stomach, pancreas, bladder
and kidney cancer incidence rates in England. Numerous other applications of Bayesian
space-time modelling on mapping cancer related outcomes are available.
Comprehensive data on Swiss cancer mortality are available from death certificates, which
have been collected and coded by the Federal Office of Statistics since the end of the 19th
century, but they are available in electronic form (indispensable for analysis) since 1969.
They are geo-referenced and cover the whole country. Studies have been conducted to
obtain crude cancer incidence and mortality estimates including lung cancer and other
tobacco-related cancers by region and selected years during 19862005 (Luthi et al., 2005;
Pury et al., 2007a,b). Few studies have explored temporal trends in lung cancer mortality
(La Vecchia et al., 1988; Levi et al., 2006). Detailed analyses to assess spatio-temporal
patterns of site-specific cancers and their associated risk factors are scarce. The only map
of cancer mortality rates including lung and other tobacco-related cancers is that of Schüler
and Bopp (1997) depicting geographical variation in mortality during 19701990 in a rather
descriptive way.
So far, no covariate-adjusted and smooth nationwide maps of tobacco-related cancer mor-
tality and incidence rates, determining the changes over time in Switzerland, exist. The
wealth of information provided in these databases has not been fully explored to assess
space-time patterns and trends of lung and tobacco-related cancer at different administra-
tive levels in Switzerland.
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1.5.2 Projection of cancer mortality
Cancer projections aim to assess past trends of a disease-specific incidence or mortality
and to predict them into the future. Projections might be done for short- (≤ 5 years) or
long-term, both requiring different analyses and modelling approaches.
The most commonly used approach for cancer projections are age-period-cohort (APC)
models. Within this method, the dataset is stratified into age, indicating the age group,
period, indicating in which time period the death occurred and cohort, giving information
on the birth cohort of the person died. The relationship of the three components age
- period = cohort results in the well-known identification problem (Bray, 2002). Many
solutions to deal with this problem have been proposed. However, they are often based
on strong assumptions. Projected mortality rates are not influenced by this identification
problem.
Two main approaches have been well-established  the power model implemented in the
Nordpred software package developed by the cancer registry in Norway (Møller et al., 2003)
and on the other side the Bayesian APC model, mainly driven by the work of Bray et al.
(Bray, 2002; Baker and Bray, 2005). Both methods are based on the classical APC ap-
proach, assessing and extrapolating the effects of age, period and cohort. Main differences
are the statistical inference framework the models are built in and, as a more method-
ological difference, the link-function applied for regressing the effects on the outcome of
interest.
1.5.3 Back-calculation of cancer incidence
Data on mortality are available from Statistical Offices, which often compile information
from death certificates at national level. Reliable data on incidence can be obtained from
cancer registries, which often do not cover the whole country. In Switzerland, local cancer
registries exist at cantonal level, however, they only cover half of the Swiss population.
Registration of cancer cases is incomplete mainly for the German-speaking cantons in the
middle of the country. Furthermore, the cancer registries have been established at different
time points and therefore may only cover short time periods.
Different approaches have been developed to estimate incidence from mortality data in re-
gions without registries. A Bayesian back-calculation model has been proposed (Mezzetti
and Robertson, 1999), linking mortality data with survival probabilities to estimate inci-
dence in the past. The model considers a fixed one-year survival, followed by an exponen-
tially distributed survival up to five years. The incidence-mortality ratio is an alternative
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approach (Colonna et al., 1999) to estimate incidence based on observed mortality.
1.5.4 Indirect approximation of smoking patterns in space
Information on gender-specific smoking prevalence is rather sparse. Frequently, survey data
are not sufficient to assess space-time patterns of smoking, which is essential to estimate
the burden of tobacco use. In Switzerland, smoking data are provided from the Swiss
Health Survey (SHS), which was initiated in 1992 and conducted every five years. Another
source is the Tobacco Monitoring Switzerland, a survey on tobacco consumption among
those aged 1465, which was originated in 2001. Both sources have their limitations as they
do not cover the whole country and do not provide data from the past to assess longterm
trends and effects.
Lung cancer rates have been used as an indicator of tobacco use (Peto et al., 1992; Chellini
et al., 2006). This approach only depends on the availability of information about lung
cancer mortality, which is often provided by death certificates.
1.6 Objectives of the thesis
The overall objective of this research was to identify spatio-temporal patterns in tobacco-
related cancer in Switzerland and forecast future trends in cancer mortality in the country.
1.6.1 Specific objectives
The specific objectives of this thesis were:
(i) Assess geographical differences and trends of age- and gender-specific lung and all
tobacco-related cancer mortality in Switzerland (Chapter 2);
(ii) Project tobacco-related cancer mortality in Switzerland at different geographical
levels accounting for spatial variation (Chapter 3);
(iii) Develop Bayesian APC-models for projecting cancer mortality data (Chapter 4);
(iv) Develop Bayesian back-calculation models to estimate age- and gender-specific
incidence from sparse mortality data (Chapter 5);
(v) Develop models to indirectly approximate gender-specific smoking patterns in space
and time by adjusting lung cancer mortality rates with non-smoking risk factors
(Chapter 6).
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Abstract
Tobacco smoking is a main cause of disease in Switzerland; lung cancer being the most common
cancer mortality in men and the second most common in women. Although disease-specific
mortality is decreasing in men, it is steadily increasing in women. The four language regions in
this country might play a role in this context as they are influenced in different ways by the cultural
and social behaviour of neighbouring countries. Bayesian hierarchical spatio-temporal, negative
binomial models were fitted on subgroup-specific death rates indirectly standardized by national
references to explore age- and gender-specific spatio-temporal patterns of mortality due to lung
cancer and other tobacco-related cancers in Switzerland for the time period 19692002. Differences
influenced by linguistic region and life in rural or urban areas were also accounted for. Male lung
cancer mortality was found to be rather homogeneous in space, whereas women were confirmed to
be more affected in urban regions. Compared to the German-speaking part, female mortality was
higher in the French-speaking part of the country, a result contradicting other reports of similar
comparisons between France and Germany. The spatio-temporal patterns of mortality were similar
for lung cancer and other tobacco-related cancers. The estimated mortality maps can support the
planning in health care services and evaluation of a national tobacco control programme. Better
understanding of spatial and temporal variation of cancer of the lung and other tobacco-related
cancers may help in allocating resources for more effective screening, diagnosis and therapy. The
methodology can be applied to similar studies in other settings.
Keywords: Bayesian inference; Conditional Autoregressive models; disease mapping; lung cancer
mortality; Markov chain Monte Carlo simulation; tobacco smoking; Switzerland
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2.1 Introduction
In Switzerland, lung cancer is the first cause of cancer mortality in men and the second in women
(after breast cancer), accounting for 2 900 deaths per year (Berrut and Junker, 2008). In 1970,
the mortality rate per 100 000 inhabitants was around 60 cases for males, whereas it was only
five for females but, by 2004, it had decreased to 45 for males and increased to 16 for females
(Berrut and Junker, 2008). Also, the geographical distribution of the disease differs remarkably
by gender with female lung cancer showing high concentrations in the cities, whereas male lung
cancer is clustered in the central, more rural and industrialized part of the country (Schüler and
Bopp, 1997). Tobacco smoking is the main cause (Tyczynski et al., 2003), but can also result in
cancers of the larynx, oral cavity, pharynx and oesophagus (International Agency for Research on
Cancer, 2004). Even passive exposure to tobacco smoke raises the risk of disease (Subramanian
and Govindan, 2007). The Swiss Federal Office of Public Health (FOPH) launched a tobacco
prevention programme for the period 20012008, later extended to also cover the following years
(20092012). The main objective of this programme is to reduce the number of tobacco-related
deaths and diseases in Switzerland. To achieve appropriate public health decisions, differences
in regions influenced by certain factors, e. g. gender and whether people live in urban or rural
neighbourhoods, have to be identified. Maps of the spatial patterns and trends of lung cancer
and other tobacco-related cancers can assist the national tobacco programme by identifying high-
priority areas for particularly intensive anti-tobacco campaigns.
Over the last 15 years, Bayesian hierarchical spatio-temporal models have been widely used for
disease mapping (Sue Bell and Broemeling, 2000; Xia et al., 1997; Johnson, 2004). This methodol-
ogy enables the estimation of covariate-adjusted smooth maps highlighting patterns of the disease
and exploring covariate effects. In Switzerland, only a few studies exploring the temporal dif-
ferences and trends in lung cancer mortality have been published (La Vecchia et al., 1988; Levi
et al., 2006). Available estimations of geographical disparities are limited to raw rates at the
regional level and cover only selected years (Luthi et al., 2005; Pury et al., 2007a,b; Bouchardy
et al., 2011). Mapping the raw rates of the disease mortality can be non-informative and even
misleading by overestimating the mortality in small populations (Clayton and Kaldor, 1987).
The aim of this paper was to explore age- and gender-specific spatio-temporal patterns of lung
cancer and other tobacco-related cancer mortality rates in Switzerland using Bayesian hierarchical
spatio-temporal models. We also wanted to use this approach to determine differences between
rural or urban living and, as Switzerland is a multilingual country, extend the investigation into
age- and gender-specific mortality by linguistic region.
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2.2 Material and methods
2.2.1 Data sources
Mortality data were provided by the Federal Statistical Office (FSO). The data covered yearly
death records during 19692008 at the individual level. Information about year of birth, age at
death, sex, municipality of residence, nationality and cause of death was available. During the
period covered in this study, there was a transition from the 8th revision of international classifi-
cation of diseases (ICD-8) to ICD-10 in the period 1994/1995. We therefore chose to standardize
the whole database according to ICD-10.
Our analysis was separated into two parts. On the one hand we focused exclusively on lung cancer
mortality as its smoking-attributable fraction is very high and therefore reflects trends in smoking
behaviour. On the other hand we analysed mortality of all tobacco-related cancers, including
lung cancer. Following the definition of Doll et al. (1976), the following cancers were considered
as tobacco-related: lung (C33-C34), oesophagus (C15), rectum (C20), pancreas (C25), bladder
(C67) and cancer of other respiratory sites (C00C14), including cancer of the lip, tongue, mouth,
larynx, trachea and pharynx (excluding nasopharynx).
Population size by age, sex and municipality was obtained from the Swiss census. The munici-
pality was identified by name and the given FSO municipality number. During the study period,
a census was carried out every 10 years starting in 1970. Due to the missing population data for
the interim years, we divided the study into four periods, each covering the four years closest to
the census year, i. e. 19691972, 19791982, 19891992 and 19992002. The population size was
assumed to be constant within each period. The four main language regions of Switzerland (Ger-
man, French, Italian and Romansh  see Fig. 2.1) were taken into account because the language
can be used as proxy for culture and behaviour. Language information at the municipality level
was obtained from the FSO.
Digital information on the structure of the municipality boarders of Switzerland in 2009, given
by geospatial data in shapefile format, was extracted from the FSO website (Federal Statistical
Office, 2012b). Municipalities were considered as rural if the population density was less than 150
people per km2 and otherwise as urban, following the definition of the Organisation for Economic
Co-operation and Development (OECD) (Schrader, 1997). Information on the geographical size
of each municipality was extracted from the shapefile offered by the FSO. The current number
of Swiss municipalities amounts to about 2 700, more than 1 500 of which have less than 1 000
inhabitants. The number of municipalities with population size greater than 10 000 is less than
120 (census of 2000). There have been numerous fusions and partitions of municipalities over the
time of the study.
The death records of the mortality dataset were updated by the FSO to fit the municipality struc-
ture of October 2009. To align the data spatially, we converted the population data of the last
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Figure 2.1: Language regions of Switzerland in the year 2000 (source: (Federal Statistical
Office, 2012a)).
four censuses into this municipality structure. Municipalities without population were identified
and merged with one of their immediate neighbours. The shapefiles were modified in R (R De-
velopment Core Team, 2011) to restructure the municipality boarders.
2.2.2 Statistical Analysis
Spatio-temporal models for all tobacco-related cancer mortality rates were fitted separately for
each gender and age group. Age was grouped in two categories: middle aged (3559 years old)
and elderly (≥ 60 years old) according to Peto et al. (1992). Mortality before age 35 years was
excluded. Time trends were modelled as a categorical covariate with four levels corresponding to
the periods: 19691972, 19791982, 19891992 and 19992002.
Multivariate negative binomial regression models were used to 1) assess the patterns of age- and
gender-specific lung mortality due to cancer and other tobacco-related cancers in space and time;
and 2) determine differences by language and type of dwelling (urban or rural). Spatial correlation
was considered by introducing random effects at the municipality level. Models were formulated
following a Bayesian inferential framework, considering age- and gender-specific interactions of
time periods with language region and type of dwelling.
Mortality rates are often standardized to compare observed and expected rates with reference
to a standard population (Oberaigner and Vittadello, 2010). Standardisation may be direct or
indirect (Breslow and Day, 1987), the latter usually done by calculating the standardized mortality
ratios (SMRs) (Johnson, 2004). This is recommended if the mortality variation within-country
is of primary interest (Estève et al., 1994; PAHO, 2002). In this case, age- and gender-specific
SMRs were used to measure mortality. Standardisation over the entire study population was
not appropriate because of large absolute differences in disease occurrence. Therefore, indirect
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standardisation was done using the subgroup-specific national death rate averaged across the
whole study period from 1969 to 2002. However, this meant that the estimates of the temporal
trend for each period had to be interpreted in relation to the remaining periods for the specific
age group and gender. Since the resulting subgroup maps cannot be compared directly because
of the specific standardisation for each subgroup, a separate analysis was carried out for the
subset of mortality data during the 19992002 period, standardizing only over the corresponding
time. To take into account disparities in age distributions among municipalities, all SMRs were
additionally standardized by 5-year age groups, starting with age group 3539 years (Sturtz and
Ickstadt, 2007). An SMR of 1.0 implies that there is no difference between the mortality rate of
the municipality under consideration and the national rate for the specific subgroup. An SMR
that is lower or higher than 1.0 stands for a mortality rate that is lower or higher than the national
average.
We assumed the observed age- and gender-specific counts of lung and all tobacco-related cancer
deaths Yijlt in municipality i (i = 1, . . . , N), gender j (j = 1, 2) and age group l (l = 1, 2) in
period t to follow a negative binomial distribution Yijlt ∼ NegBin(pijlt, r) with parameters pijlt
and r, where pijlt relates to average number of cases via the formula pijlt = r/(r + µijlt). Age-
and gender-specific spatial random effects as well as possible non-linear trends were modelled on
the log of the mean age SMR following model formulations according to (Xia et al., 1997):
log(µijlt) = log(Eijlt) + α+X
T
isβs + φijl (2.1)
where Eijlt is the age- and gender-specific expected number of deaths, Xis the vector of covariates
s related to municipality i and βs the coefficients of associated covariates.
Spatial correlation was introduced by age- (l) and gender-specific (j) random effects φijl at mu-
nicipality level (i), modelled via a Conditional Autoregressive (CAR) process (Besag et al., 1991;
Bernardinelli and Montomoli, 1992). Spatial dependency among the municipalities was introduced
by the conditional prior distribution of the age- and gender-specific φi with
φi | φ−i ∼ N (
γ
N∑
q=1
q 6=i
ciqφq
wi
,
σ2
wi
) (2.2)
where φ−i = (φ1, . . . , φi−1, φi+1, . . . , φN ) and ciq indicates the degree of spatial influence of munic-
ipality i to the remaining municipalities, taking the value 1 if they are adjacent and 0 otherwise,
and γ quantifying the overall spatial dependence, assumed to be 1 following Besag et al. (1991),
and wi being the number of neighbours of municipality i. As the Bayesian formulation requires,
specification of prior distributions for the model parameters were specified. The variance parame-
ter r, controlling overdispersion, was assumed to follow a gamma prior distribution. We assumed
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Year Rate* Male Female
1970 68 1 568 (90%) 175 (10%)
1980 77 2 111 (87%) 311 (13%)
1990 76 2 245 (82%) 491 (18%)
2000 69 2 044 (72%) 781 (28%)
Table 2.1: Lung cancer mortality in Switzerland: death counts and proportion of males and
females. (*Per 100 000 inhabitants)
a flat prior for the intercept α and uniform prior distributions U(−∞,∞) for the regression coef-
ficients βs.
After a burn-in of 1 000 iterations the model was run for another 100 000 iterations achieving
convergence, which was assessed by graphical inspection of the Markov chain output. Finally
another 10 000 iterations were run to save a sample of 1 000 with thinning 10 to obtain summaries
of the posterior distribution of the parameters.
Preliminary analyses fitting negative binomial models were carried out in Stata/IC (Stata Corpo-
ration; College Station, USA). Bayesian models were fitted using OpenBUGS (Imperial College
and MRC, London, UK). The resulting maps of all tobacco-related cancer mortality rates and
results of the interaction analysis are given in the Apppendix (Figs. 2.82.13 and Tables 2.52.6).
The Kulldorff's spatial scan statistic implemented in the DCluster package within the R soft-
ware was used to detect significant mortality clusters in the most recent period (Kulldorff and
Nagarwalla, 1995; Gómez-Rubio et al., 2005).
2.3 Results
2.3.1 Lung cancer mortality
Males
Table 2.1 reports a decline of lung cancer deaths in males between 1990 and 2000. Table 2.2 shows
the results of the spatial negative binomial regression analysis carried out on the mortality data
over the whole study period. Lung cancer SMR in younger men (3559 years old) decreased by
40% during 19992002 in comparison to 19691972. This trend is illustrated in Figure 2.2. A
similar result has not been confirmed for older men (≥ 60 years). On the contrary, SMR increased
by around 25% in the 1980s and 1990s and was not significantly different in 19992002, compared
to the 1970s. Also, results indicate no significant differences in lung cancer mortality between the
language regions (Table 2.2, Figs. 2.22.3).
The SMR was 7% higher for older men in urban areas. Models including interaction terms
(Table 2.5) indicate that the mortality in younger men had decreased everywhere in Switzerland
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Figure 2.2: Geographical distribution of lung cancer mortality risks from 19691972 to
19992002 in Switzerland for males aged 3559 years.
Figure 2.3: Geographical distribution of lung cancer mortality risks from 19691972 to
19992002 in Switzerland for males aged 60 years and above.
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Male Female
Age group (years) 3559 ≥ 60 3559 ≥ 60
SMR Ratio (95% BCI*)
Period
19691972 1.00 1.00 1.00 1.00
19791982 1.07 (1.00; 1.15) 1.26 (1.20; 1.31) 1.64 (1.31; 2.05) 1.32 (1.16; 1.50)
19891992 0.81 (0.75; 0.88) 1.23 (1.18; 1.29) 2.48 (2.03; 3.04) 1.78 (1.58; 2.01)
19992002 0.60 (0.55; 0.64) 0.96 (0.92; 1.01) 3.50 (2.87; 4.28) 2.52 (2.25; 2.86)
Language
German 1.00 1.00 1.00 1.00
French 1.16 (0.99; 1.35) 1.07 (0.94; 1.17) 1.36 (0.98; 1.74) 1.30 (1.07; 1.59)
Italian 1.25 (0.93; 1.66) 1.15 (0.82; 1.41) 0.93 (0.58; 1.39) 1.23 (0.71; 2.06)
Romansh 0.95 (0.58; 1.44) 0.94 (0.72; 1.25) 0.76 (0.23; 1.87) 0.54 (0.25; 1.01)
Dwelling
Rural 1.00 1.00 1.00 1.00
Urban 0.97 (0.91; 1.03) 1.07 (1.03; 1.12) 1.20 (1.04; 1.36) 1.28 (1.18; 1.40)
Spatial variation 0.31 (0.26; 0.37) 0.31 (0.27; 0.35) 0.39 (0.28; 0.49) 0.35 (0.29; 0.42)
Table 2.2: Spatio-temporal model estimates of age- and gender-specific lung cancer mortality
in Switzerland from 19691972 to 19992002. (*Bayesian credible interval)
by the year 2000, with the exception of the Romansh-speaking and urban French-speaking regions.
Older males showed an increasing trend in the rural parts but the urban areas showed no difference
in SMR except for the German ones, where SMRs decreased between the 1970s and 2000. Figure
2.4 illustrates the most recent period (19992002) revealing a lower lung cancer mortality in the
alpine regions. While the highest mortality rate for young men was concentrated in the rural
French-speaking region, high mortality in older men was more common in the generally rural
German-speaking and Italian-speaking parts.
Females
Raw data (Table 2.1) indicate that female mortality increased between 1970 and 2000. Also,
Bayesian spatial models suggest an increasing trend during the last 30 years. In particular, the
SMR of younger females was 3.5 times higher in 2000 than in the 1970s. The SMR for older
women was 2.5 times higher in 19992002 compared to 19691972 (Table 2.2). The SMR in urban
regions was more than 20% higher than in the rural areas (Fig. 2.5, 2.6). In the French-speaking
part, older females had significantly higher mortality compared to the German one (SMR ratio
of 1.30). The lowest mortality was estimated in the Romansh part although the difference seen is
not statistically significant, probably due to the small number of deaths (0.13% out of the total
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(a) Male, age 3559 years (b) Male, age ≥ 60 years
(c) Female, age 3559 years (d) Female, age ≥ 60 years
Figure 2.4: Geographical distribution of age- and gender-specific lung cancer mortality risks
in Switzerland in the period 19992002.
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Figure 2.5: Geographical distribution of smooth lung cancer mortality in Switzerland from
19691972 to 19992002 for females aged 3559.
Figure 2.6: Geographical distribution of lung cancer mortality risks from 19691972 to
19992002 in Switzerland for females aged 60 years and above.
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(a) Male, age 3559 years (b) Male, age ≥ 60 years
(c) Female, age 3559 years (d) Female, age ≥ 60 years
Figure 2.7: Clusters of age- and gender-specific lung cancer mortality risks in Switzerland
in the period 19992002 (according to Kulldorff's statistic; red colour = highly significant
clustering; yellow colour = significant at lower level).
number for females in the year 2000). While the SMR increased from the 1970s to 2000 in all
remaining regions, it was not significantly different in 2000 in the rural Italian region. However,
this result was not seen in older women. Lung cancer mortality increased in the French-speaking
and urban German-speaking regions for the older age group during the 1990s and in the remainder
of regions during 2000. Figure 2.4 shows higher mortality in the French-speaking area in 2000,
whereas younger females showed the highest mortality in the rural part of this region.
Figures 2.22.3 and 2.52.6 and 2.82.11 show the spatial pattern of lung and all tobacco-related
cancer mortality separately for each age and gender group over the four time periods investigated.
The maps presented in Figure 2.4 and 2.12 show the distribution of lung cancer and all tobacco-
related cancer mortality for each subgroup in 19992002. The estimates have to be interpreted
independently for each subgroup. Figures 2.7 and 2.13 show the most (red) to the least (yellow)
significant clusters of modelled lung and all tobacco-related cancer mortality in 19992002 detected
by Kulldorff's spatial scan statistic.
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Year Rate* Male Female
1970 130 2 947 (79%) 790 (21%)
1980 152 3 747 (78%) 1 050 (22%)
1990 150 3 924 (73%) 1 440 (27%)
2000 130 3 571 (67%) 1 781 (33%)
Table 2.3: Tobacco-related cancer mortality in Switzerland: death counts and proportion of
males and females. (*Per 100 000 inhabitants)
2.3.2 Tobacco-related cancer mortality
Males
The estimates of the Bayesian spatial models regarding all tobacco-related cancer mortality (in-
cluding lung cancer) indicate a decrease of 33% for those 3559 years old and 20% for those aged
60 and above. For younger males a 21% significantly higher SMR was observed for the French-
speaking region in comparison to the baseline German (Table 2.4 and Fig. 2.8). The SMR in older
men did not differ between the language regions. Models including interaction terms showed an
overall decrease for younger men in 2000 with exception of the urban French part. For the older
age group an overall decrease was estimated, except for the rural, French-speaking and Italian-
speaking areas.
Females
Mortality increased steadily over the last 30 years. The SMR nearly doubled for the 3559 age
group and increased by 15% for the older women from 19691972 to 19992002. There were
no significant differences between the language regions over the entire study period (Table 2.4).
In comparison to the rural areas, mortality in the urban regions was significantly higher both
for younger and older women  14% and 11%, respectively (Figs. S3S4). In the 1990s, the
group aged 3559 years showed a significantly higher mortality in the German-speaking and rural
French-speaking areas. In 19992002 an overall increase was observed, except in the rural Italian-
speaking areas. In the older age group, there was no significant interaction between time period
and language or urban groups observed.
2.4 Discussion
This study explores the spatio-temporal patterns of lung and tobacco-related cancer mortality
in Switzerland, for the first time based on state-of-the-art Bayesian conditional autoregressive
models. Subgroups defined by age and gender were studied separately. The results show the steep
and constant rise, especially in urban regions, of mortality in women due to lung cancer and other
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Male Female
Age group (years) 3559 ≥ 60 3559 ≥ 60
SMR Ratio (95% BCI)
Period
19691972 1.00 1.00 1.00 1.00
19791982 1.08 (1.01; 1.14) 1.10 (1.06; 1.13) 1.26 (1.12; 1.42) 1.07 (1.00; 1.13)
19891992 0.89 (0.84; 0.95) 1.05 (1.01; 1.08) 1.57 (1.39; 1.76) 1.12 (1.06; 1.19)
19992002 0.67 (0.63; 0.71) 0.80 (0.77; 0.83) 1.95 (1.74; 2.19) 1.15 (1.09; 1.22)
Language
German 1.00 1.00 1.00 1.00
French 1.21 (1.03; 1.43) 1.12 (0.96; 1.23) 1.14 (0.95; 1.36) 1.04 (0.95; 1.20)
Italian 1.23 (0.87; 1.60) 1.12 (0.96; 1.43) 1.25 (0.92; 1.73) 1.10 (0.76; 1.51)
Romansh 0.86 (0.55; 1.20) 0.87 (0.72; 1.06) 1.15 (0.58; 2.11) 1.10 (0.79; 1.46)
Dwelling
Rural 1.00 1.00 1.00 1.00
Urban 0.97 (0.92; 1.02) 1.04 (1.01; 1.07) 1.14 (1.04; 1.25) 1.11 (1.05; 1.16)
Spatial variation 0.30 (0.26; 0.36) 0.25 (0.22; 0.28) 0.32 (0.27; 0.40) 0.26 (0.23; 0.32)
Table 2.4: Spatio-temporal model estimates of age- and gender-specific tobacco-related can-
cer mortality in Switzerland from 19691972 to 19992002.
tobacco-related cancers. The lung cancer mortality in women was found to be highest in the
French-speaking parts of the country, while the language region was not significantly associated
with lung cancer mortality in men. The rates of male lung cancer, and all tobacco-related cancer
mortality, were higher than those for women but with a decreasing temporal trend. A peak of
tobacco-related mortality for males was observed in the 1980s followed by a constant decrease as
also seen in other European countries (Levi et al., 2004). Results for lung cancer, and all other
forms of tobacco-related cancer mortality, were similar but the temporal trend was particularly
striking for lung cancer mortality. In general, around 85% of the lung cancer cases in Switzer-
land are attributed to the consumption of tobacco (Federal Office of Public Health, 2012a). The
temporal trends observed in lung cancer mortality can be explained by gender-specific changes
in smoking habits. These facts and the patterns observed reflect how ubiquitous the habit of
smoking is.
Several recent reviews of lung cancer in people who never smoked have highlighted the importance
of other risk factors such as genetic predisposition and various forms of exposure, e. g. environ-
mental tobacco smoke, outdoor air pollution, ionizing radiation as well as occupational exposures
to carcinogens (Couraud et al., 2012; Samet et al., 2009; Torok et al., 2011). The second most
important cause of lung cancer in Switzerland (but far behind that of tobacco) is exposure to
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radon especially in alpine regions and in the Jura. Radon is believed to be responsible for 200
lung cancer deaths per year (Federal Office of Public Health, 2012b). Due to a strong combined
effect of smoking and radon, most of the radon-induced lung cancers occur among smokers, but
radon is the primary cause of lung cancer among people who never smoked (WHO, 2009). Radon
exposure is assumed to be stable in time, while the temporal and gender-specific trends observed
change and are not related to radon exposure.
Schopper and Obrist (Schopper and Obrist, 2005) report that the highest incidence of male lung
cancer is found in Western and Southern Switzerland, an outcome which agrees with our findings.
Like our results indicate, these authors also found the highest female lung cancer incidence in
the western, French-speaking part. Apart from this, Schüler and Bopp (1997) described a cluster
of lung cancer in the central part of the German-speaking part of Switzerland, which is a rural
but still a highly industrialized region. Socio-economic or environmental factors related to high
industrialization might explain this cluster (Fano et al., 2004), which is confirmed by our analysis
for older males (Fig. 2.3).
High female mortality in the urban areas is likely to be due to the change in female smoking
behaviour of the middle of the twentieth century that took place earlier and was more pronounced
in the cities (Curtin et al., 1997). Similar trends have been observed in other populations of the
Western World (Graham, 1996). Exposure to environmental risks, such as air pollution and peer-
to-peer tobacco smoke (especially in urban areas), may have accentuated the trend (Subramanian
and Govindan, 2007). A similar observation has been reported in Germany, where lung cancer
mortality rates in women doubled from 1960 to 1996 and increased by 155% in the 4554 age
group (Lienert et al., 2000).
Faeh et al. (2009) describe differences in cause-specific mortality between Swiss regions main-
taining that patterns follow disparities among European populations suggesting an important,
cultural factor. Others beg to differ, e. g. Tyczynski et al. (2003) who compared lung cancer
mortality among European countries and report that female lung cancer mortality rates are high-
est in Northern Europe followed by the western part of the continent. Interestingly, while they
found lung cancer mortality in women to be lower in France compared to Germany, we found the
French-speaking parts of Switzerland having a higher mortality rates than the German-speaking
regions, similar to the results of Faeh et al. (2009).
Lopez et al. (1994) describe a model of smoking epidemic defined by different stages. The most
crucial component of this model is the lag of three to four decades between the rise in smoking
prevalence and the increase in smoking-attributable mortality. According to them, female smok-
ing highest prevalence typically lags males by 1020 years. In males, lung cancer mortality has
declined since the 1980s, so that if the predictions of Lopez et al. would take place in Switzerland,
a reduction in female smoking-related mortality can be expected to start soon. Indeed, a recent
decline of female lung cancer incidence and mortality from 20032007 has been reported from
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the United States of America (USA) (Kohler et al., 2011). This trend is expected to continue
for at least two more decades. Unfortunately, there is a dearth of data on smoking behaviour in
Switzerland for the past few decades. One of the first national surveys was not until 1997. Since
then a decrease in the number of smokers for both genders has been reported (Marques-Vidal
et al., 2011).
What sets this study apart is the methodological approach using Bayesian CAR models on a
small spatial unit (the municipality) allowing the identification of areas with high incidence of
lung cancer and other tobacco-related cancer mortality. We updated the boundaries, in many
places changed during the 40-year period covered, and defined the urbanization level and lan-
guage on the basis of the most recent structure, i. e. that of October 2009. This may have wrongly
classified those that had been restructured. However, less than 1% of the municipalities underwent
re-classification and this low percentage should not affect the general results of the study. Fur-
thermore, the Bayesian approach introducing spatial correlation at the municipality level should
have reduced the impact of any potential re-classification.
Several approaches for disease mapping exist, e. g. count regression models accounting for spatial
correlation by the CAR process are widely used. (Besag et al., 1991) proposed the inclusion of
unstructured random effects into the model to account for heterogeneity in the data. Identifiabil-
ity issues may arise when there is no prior information about the contribution of the spatial and
non-spatial variation to the total one (Eberly and Carlin, 2000). Frequently Poisson regression
models are used to map mortality rates but they are based on the assumption of the equality of
mean and variance, which is not always valid. Negative binomial models account for unobserved
variation by including an additional parameter. We did not consider an unstructured random ef-
fect, as we assume that additional variation is captured by the variance parameter of the negative
binomial distribution.
Before the change of coding system from ICD-8 to ICD-10 in 1995, a priority rule was used by
which cancer was rated high-priority and assigned as cause of death when multiple causes were
documented on the death certificate. Especially in older people with several morbidities, this pri-
ority rule may have led to inflated cancer rates. However, because the rule was applied centrally
and to all death certificates similarly, it cannot have affected the spatial patterns. Moreover it is
unlikely that this rule could have had much influence on mortality of persons aged ≥ 60 years. A
re-analysis taking into account the correction factor of 0.96 for lung cancer (Berrut and Junker,
2008) that was provided by the FSO did not change the results of the lung cancer-related mortal-
ity.
A limitation of the present study is the lack of more recent trends, which is due to the miss-
ing population data at the municipality level for the more recent years. As soon as data are
available we will carry out further analyses to explore the trends for the years after 2002 and to
address potential declining trends in female tobacco-related cancer mortality as seen in USA. We
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are currently developing models to estimate inter-censual population data to make use of the full
mortality dataset. However, in this study we aggregated the years around censuses, excluding
the inter-censual years. Although proportional mortality rate estimates do not rely on popula-
tion size (Sitas et al., 1989), we compared the results of this study using both standardized and
proportional mortality rates. The conclusions by both approaches were similar suggesting that
ignoring inter-censual years does not bias the results. The results also suggest a cohort effect for
both genders, which is known for lung cancer mortality (Lee et al., 1990). Most of these findings
can be explained by the gender-specific tobacco epidemics. Including information about the birth
cohorts in this analysis might improve the estimation of the temporal trends.
Our results and newer trends would be useful as basis for projections and estimates of lung and
all tobacco-related cancer mortality in the future. The insights of spatial differences in mortality
as well as visualization of time and regional differences in tobacco-related cancer derived from
this study will hopefully give new impetus to tobacco control activities and help evaluate the
effectiveness of the national control programme.
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Figure 2.8: Geographical distribution of tobacco-related cancer mortality risks from 1969
1972 to 19992002 in Switzerland for males aged 3559 years.
Figure 2.9: Geographical distribution of tobacco-related cancer mortality risks from 1969
1972 to 19992002 in Switzerland for males aged 60 years and above.
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Figure 2.10: Geographical distribution of tobacco-related cancer mortality risks from 1969
1972 to 19992002 in Switzerland for females aged 3559 years.
Figure 2.11: Geographical distribution of tobacco-related cancer mortality risks from 1969
1972 to 19992002 in Switzerland for females aged 60 years and above.
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(a) Male, age 3559 years (b) Male, age ≥ 60 years
(c) Female, age 3559 years (d) Female, age ≥ 60 years
Figure 2.12: Geographical distribution of age- and gender-specific tobacco-related cancer
mortality risks in Switzerland in the period 19992002.
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(a) Male, age 3559 years (b) Male, age ≥ 60 years
(c) Female, age 3559 years (d) Female, age ≥ 60 years
Figure 2.13: Clusters of age- and gender-specific tobacco-related cancer mortality risks in
Switzerland in the period 19992002 (according to Kulldorff's statistic; red colour = highly
significant clustering; yellow colour = significant at lower level).
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Factor 1 Factor 2 19791982 19891992 19992002
Dwelling Language Male, age 3559 years
Urban German 1.04 (0.80; 1.36) 0.98 (0.71; 1.32) 0.60 (0.45; 0.80)
Urban French 1.26 (0.80; 1.93) 0.98 (0.61; 1.59) 0.78 (0.49; 1.23)
Urban Italian 0.90 (0.48; 1.64) 0.86 (0.47; 1.62) 0.48 (0.42; 0.62)
Urban Romansh 1.07 (0.19; 5.73) /1 1.09 (0.19; 5.59)
Rural German 1.02 (0.91; 1.15) 0.75 (0.65; 0.85) 0.49 (0.43; 0.56)
Rural French 1.23 (0.92; 1.63) 0.98 (0.71; 1.32) 0.63 (0.46; 0.85)
Rural Italian 0.88 (0.55; 1.38) 0.86 (0.55; 1.34) 0.46 (0.28; 0.75)
Rural Romansh 1.04 (0.22; 4.84) 3.42 (1.01; 13.07) 0.89 (0.18; 3.86)
Dwelling Language Male, age 60 years and above
Urban German 1.13 (0.96; 1.34) 1.57 (1.32; 1.89) 0.79 (0.66; 0.93)
Urban French 1.32 (1.00; 1.76) 1.19 (0.91; 1.58) 0.92 (0.70; 1.23)
Urban Italian 1.45 (0.99; 2.12) 1.36 (0.93; 2.01) 0.99 (0.97; 1.05)
Urban Romansh 1.06 (0.45; 2.57) 1.48 (0.67; 3.51) 1.24 (0.56; 2.99)
Rural German 1.26 (1.17; 1.35) 1.35 (1.26; 1.46) 1.09 (1.01; 1.18)
Rural French 1.47 (1.22; 1.77) 1.57 (1.32; 1.89) 1.28 (1.06; 1.55)
Rural Italian 1.61 (1.20; 2.14) 1.80 (1.36; 2.41) 1.48 (1.10; 1.97)
Rural Romansh 1.19 (0.55; 2.59) 1.96 (0.97; 4.21) 1.73 (0.86; 3.77)
Dwelling Language Female, age 3559 years
Urban German 1.62 (0.68; 3.83) 2.81 (1.17; 6.14) 3.44 (1.52; 7.10)
Urban French 2.09 (0.53; 8.03) 2.59 (0.70; 8.36) 3.86 (1.08; 11.91)
Urban Italian 1.35 (0.22; 8.15) 3.47 (0.73; 16.03) 3.58 (3.71; 6.06)
Urban Romansh / 4.27 (1.47; 24.19) /
Rural German 1.40 (0.89; 1.99) 2.47 (1.67; 3.39) 3.55 (2.37; 4.89)
Rural French 1.81 (0.69; 4.16) 2.81 (1.17; 6.14) 3.98 (1.69; 8.20)
Rural Italian 1.17 (0.28; 4.22) 3.77 (1.20; 11.78) 2.68 (0.87; 8.68)
Rural Romansh / / /
Dwelling Language Female, age 60 years and above
Urban German 1.44 (0.86; 2.39) 1.71 (1.05; 2.70) 2.54 (1.66; 3.80)
Urban French 1.66 (0.75; 3.64) 2.51 (1.19; 5.07) 3.08 (1.58; 5.96)
Urban Italian 1.81 (0.62; 5.17) 2.47 (0.92; 6.32) 2.22 (1.69; 3.48)
Urban Romansh / / /
Rural German 0.95 (0.73; 1.18) 1.25 (0.98; 1.53) 2.08 (1.68; 2.50)
Rural French 1.09 (0.63; 1.80) 1.71 (1.05; 2.70) 2.52 (1.60; 3.92)
Rural Italian 1.19 (0.52; 2.56) 1.67 (0.82; 3.37) 2.87 (1.47; 5.51)
Rural Romansh / / /
Table 2.5: Interpretation of the results of the spatial negative binomial regression analysis
with interaction terms for age- and gender-specific lung cancer mortality in Switzerland.
1Due to very small counts, the estimates are not meaningful.
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Factor 1 Factor 2 19791982 19891992 19992002
Dwelling Language Male, age 3559 years
Urban German 0.98 (0.79; 1.24) 1.05 (0.83; 1.36) 0.63 (0.49; 0.80)
Urban French 1.16 (0.81; 1.68) 0.98 (0.68; 1.42) 0.77 (0.52; 1.12)
Urban Italian 1.01 (0.61; 1.63) 0.93 (0.58; 1.51) 0.63 (0.57; 0.73)
Urban Romansh 1.01 (0.27; 3.62) 2.14 (0.77; 6.99) 0.85 (0.23; 3.27)
Rural German 1.08 (0.97; 1.19) 0.87 (0.79; 0.98) 0.63 (0.56; 0.70)
Rural French 1.27 (1.01; 1.62) 1.05 (0.83; 1.36) 0.78 (0.60; 0.98)
Rural Italian 1.10 (0.75; 1.57) 1.00 (0.71; 1.45) 0.68 (0.47; 0.99)
Rural Romansh 1.10 (0.34; 3.48) 2.31 (0.95; 6.69) 0.85 (0.26; 2.87)
Dwelling Language Male, age 60 years and above
Urban German 1.03 (0.91; 1.17) 1.22 (1.07; 1.40) 0.71 (0.63; 0.80)
Urban French 1.11 (0.90; 1.37) 1.02 (0.83; 1.25) 0.79 (0.64; 0.97)
Urban Italian 1.08 (0.82; 1.43) 1.04 (0.77; 1.35) 0.83 (0.80; 0.87)
Urban Romansh 1.37 (0.74; 2.51) 1.40 (0.76; 2.57) 1.22 (0.68; 2.21)
Rural German 1.11 (1.05; 1.17) 1.11 (1.06; 1.18) 0.85 (0.80; 0.90)
Rural French 1.20 (1.05; 1.37) 1.22 (1.07; 1.40) 0.94 (0.82; 1.08)
Rural Italian 1.16 (0.95; 1.44) 1.21 (0.99; 1.51) 0.98 (0.80; 1.20)
Rural Romansh 1.48 (0.86; 2.52) 1.67 (0.98; 2.87) 1.46 (0.87; 2.46)
Dwelling Language Female, age 3559 years
Urban German 1.19 (0.68; 2.08) 1.82 (1.05; 3.18) 1.84 (1.12; 3.02)
Urban French 1.65 (0.69; 3.93) 1.84 (0.79; 4.32) 2.37 (1.07; 5.11)
Urban Italian 1.15 (0.38; 3.67) 2.06 (0.69; 6.25) 1.88 (1.71; 2.74)
Urban Romansh / / /
Rural German 1.15 (0.89; 1.51) 1.45 (1.13; 1.87) 1.88 (1.50; 2.36)
Rural French 1.59 (0.90; 2.85) 1.82 (1.05; 3.18) 2.42 (1.44; 3.99)
Rural Italian 1.12 (0.50; 2.66) 2.05 (0.92; 4.60) 1.54 (0.97; 4.35)
Rural Romansh / / /
Dwelling Language Female, age 60 years and above
Urban German 1.09 (0.87; 1.35) 1.15 (0.90; 1.47) 1.16 (0.95; 1.41)
Urban French 1.10 (0.76; 1.58) 1.32 (0.92; 1.90) 1.25 (0.89; 1.75)
Urban Italian 1.03 (0.64; 1.68) 1.35 (0.86; 2.09) 1.08 (0.98; 1.26)
Urban Romansh 1.67 (0.62; 4.66) 0.96 (0.33; 2.77) 1.38 (0.55; 3.47)
Rural German 1.03 (0.94; 1.15) 0.99 (0.89; 1.09) 1.07 (0.97; 1.17)
Rural French 1.04 (0.82; 1.35) 1.15 (0.90; 1.47) 1.16 (0.91; 1.45)
Rural Italian 0.98 (0.69; 1.43) 1.18 (0.84; 1.62) 1.26 (0.91; 1.76)
Rural Romansh 1.58 (0.67; 3.97) 0.84 (0.33; 2.13) 1.27 (0.57; 2.87)
Table 2.6: Interpretation of the results of the spatial negative binomial regression anal-
ysis with interaction terms for age- and gender-specific tobacco-related cancer mortality in
Switzerland.
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Abstract
Switzerland is divided into 26 cantons of variable population size and cultural characteristics.
Although a federal law to protect against passive smoking and a national tobacco control program
exist, details of tobacco-related policies are canton-specific. This study aimed to project gender-
specific tobacco-related cancer mortality in Switzerland at different geographical levels for the
periods 20092013 and 20142018.
In this analysis data on Swiss tobacco-related cancer mortality from 1984 until 2008 have been
used. Bayesian age-period-cohort models were formulated to assess past trends of gender-specific
tobacco-related cancer mortality and to project them up to 2018 at cantonal and language region
level. Furthermore, estimates are provided at national scale by age categories 5069 and ≥ 70.
Model-based estimates at cantonal level identified regions with low and high tobacco-related cancer
mortality rates for observed and projected periods. Our analysis based on language regions showed
the lowest mortality in the German-speaking part. Projections at national level, between younger
(age 5069) and older (age ≥ 70) males, indicated an ongoing decreasing trend for males but an
upward trend for females. The gap of tobacco-related cancer mortality rates between younger and
older males seems to be shrinking. In females, a stronger rise was obtained for the younger age
group.
Our findings indicate region-, sex- and age-related differences in tobacco-related cancer mortality
in Switzerland and this could be useful for health care planning and for evaluating the impact of
canton-specific tobacco-related policies and interventions.
Keywords: Bayesian inference; age-period-cohort models; tobacco-related cancer mortality; pro-
jections
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3.1 Introduction
Tobacco-smoking is a major cause of premature mortality. In 1990, around three quarters of a mil-
lion deaths in the age group 3569 were attributable to tobacco smoking in Europe (Boyle, 1997).
In fact, it accounts for more deaths than traffic-accidents, AIDS, alcohol, cocaine, homicide, sui-
cide and fires together (Chaturvedi, 2004). Smoking cessation reduces the hazard substantially in
younger age (Doll et al., 2004). Smoking behaviour changed over the last decades. In Switzerland,
smoking prevalence decreased during 1992 and 2007 in both genders (Marques-Vidal et al., 2011).
Several factors may have contributed to this trend including prevention programs and greater
sensitivity to mortality from tobacco-related illness in males (Flandorfer et al., 2010). Smoking
can be supposedly used to balance stress and especially younger women use smoking to control or
even suppress appetite. On average, the weight of smokers is 34 kg lower than for non-smokers
(Heishman, 1999).
Reports of the International Agency for Research on Cancer showed that in 2008 21.9% of all male
cancer deaths in Switzerland were related to the lung, whereas the proportion was 12.7% for Swiss
women. Smoking is the major risk factor for the development of lung cancer, but it also causes
cancers at other sites. Smoking may have an effect on cancers of the larynx and the pharynx (Lee
et al., 2008). Parental smoking may induce childhood cancer, however studies showing evidence of
definite association are still missing. In addition, there is strong evidence of a causal association
between passive smoking and lung cancer (Taylor et al., 2007). Doll et al. (1976) considered the
following cancer sites to be related to tobacco: lung (C33C34), oesophagus (C15), rectum (C20),
pancreas (C25), bladder (C67) and cancer of other respiratory sites (C00C14) including cancer
of the lip, tongue, mouth, larynx, trachea and pharynx (excluding nasopharynx).
Switzerland is divided into 26 cantons, which vary in population size and cultural characteristics.
Regulations, e. g. in health systems, are canton-specific, covering domains which are not controlled
by the federal constitution. In 2010 a federal law to protect against passive-smoking was enacted,
aiming at smoke-free interiors in enclosed spaces that are publicly accessible, i. e. restaurants, bars,
schools, hospitals etc., and workplaces with two or more people. However, smoking-rooms still ex-
ist under certain conditions in many cantons as federal law just provides the minimum provisions
for protection against passive smoking and stricter smoking-related laws are canton-dependent.
Figure 3.1 shows the Swiss cantons according to their smoking ban regulations in restaurants in
May 2012. All cantons applied the national law which can be seen as a minimal protection against
passive-smoking, whereas some defined further regulations. These refinements either allow service
only in those rooms indicated for smoking (smoke-rooms) or prohibit any service in smoke-rooms.
Information about the trend of tobacco-related cancer mortality over time as well as the spatial
distribution of the disease are essential for health care planning related to smoking behaviour.
They can identify areas with high tobacco-specific cancer mortality. Projections of mortality
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Figure 3.1: Canton-specific smoking ban regulations indicating application of the federal law
(Bundesgesetz zum Schutz vor Passivrauchen) (in grey), further regulations covering service
in smoke-rooms (in yellow) and no service in smoke-rooms (in green).
rates are helpful tools for assessing the future burden of a disease and as a basis for evaluating
the impact of interventions carried out. Model-based estimates can then be compared to observed
data for the projection periods.
Age-period-cohort (APC) models are commonly used to project cancer mortality and incidence.
Within this approach the dataset is stratified into three components separating the age, the period
when the event occurred and the birth cohort of the person. Typically, projections based on APC-
models are done at country level (Clèries et al., 2006; Eilstein et al., 2008), however estimates at
subunits may be useful (Knorr-Held and Rainer, 2001) especially when health care planning is
decentralized as in the case of Switzerland.
This study aims to project gender-specific tobacco-related cancer mortality Switzerland at different
geographical levels for the periods 20092013 and 20142018. Projected estimates at cantonal
level may identify high- or low risk areas and help evaluating canton-specific smoking-related
policies in the future. In addition, mortality data are aggregated over the three language regions
(i. e. German, French and Italian) to assess trends among the regions which can be compared
with trends in same language neighbouring countries  Germany, France and Italy. Furthermore,
countrywide projections are estimated by specific age groups to determine the burden of tobacco-
related cancer in the future on a larger scale and possibly identify age-specific differences.
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3.2 Methods
3.2.1 Data sources and management
Mortality data at individual level were provided by the Federal Statistical Office (FSO). Can-
cer death counts related to tobacco, following the definition by Doll et al. (1976) were used for
the analysis. Tobacco-related cancer rarely occurs in persons younger than 50. Therefore, we
excluded death counts of those aged below. In 1995 priority given to certain causes of deaths
was removed from rules related to coding death certificate. This change affected cause-specific
reported deaths, however FSO provides disease-related correction factors to adjust for the years
before 1995 (Berrut and Junker, 2008). Estimated rates were (age-) standardized directly, using
Segi World population (Segi, 1960).
Subgroup-specific population data at cantonal level were obtained from the webpage of the FSO,
covering the periods 19841988, . . . , 20042008, as well as 20092013 and 20142018. The data
for the latter time periods were estimated by the FSO considering a mid-way scenario, based on
past population trends and assuming no extreme changes (e. g. migration). Age and period were
aggregated to five-year groups.
Cantons with small number of cases, which did not allow for reliable estimates, were merged with
their neighbours. These included canton Uri, Obwalden and Nidwalden, as well as Appenzell
Ausserrhoden and Appenzell Innerrhoden. A map of Switzerland (Fig. 3.8) as well as cantonal
abbreviations are provided in the Appendix. ArcGIS, a geographic information system, has been
used to create maps illustrating the results. The required shapefile describing the spatial config-
uration of the cantons was obtained from the FSO and modified.
3.2.2 Statistical analysis
Bayesian Poisson and Negative Binomial APC regression models were formulated and fitted in
WinBUGS (Imperial College and MRC, London, UK) using Markov chain Monte Carlo (MCMC)
simulations. The mean of the age- and period-specific death counts µijk was regressed on the
effects of age, period and cohort. The general model applied for projecting at cantonal level reads
as follows:
log(µijk) = log(nijk) + αik + βjk + γj−i,k + φk (3.1)
where nijk is the population for the age group (i), period (j) and region (k), α, β and γ
account for the effect of age, period and cohort, respectively. Canton-specific random effects φk
modeled via conditional autoregressive (CAR) specifications (Bernardinelli and Montomoli, 1992)
were included to allow for spatial correlation.
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Figure 3.2: Overall lung and all tobacco-related cancer deaths observed during 19842008
at country level for males and females.
Bayesian APC-models were applied to project age- and gender-specific tobacco-related cancer
mortality for the periods 20092013 and 20142018 (i) at national level (ii) for the three language
regions and (iii) at cantonal level. The models for countrywide and language-specific analyses
did not consider spatial random effects. Results are presented for each gender and sub-region. In
addition, countrywide estimates are given for the age categories 5069 and ≥ 70. The predictive
performance of the models was assessed by comparing model-based and observed data using the
sum of squared residuals. In particular, models were fitted during 19841998 and predictions were
obtained for the remaining period of 19992008. Implementation details and model evaluation
can be found in the Appendix.
3.3 Results
Preliminary analysis suggested similar trends between lung and tobacco-related cancer mortality
in Switzerland during 1984 to 2008 (see Fig. 3.2). Death counts for males were stable while for
females increased steadily.
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(a) (b)
Figure 3.3: Age-specific and overall age-standardized tobacco-related cancer mortality rates
(per 100 000), observed (during 19842008) and predicted (posterior median during 20092013
and 20142018) at country level for males (a) and females (b). The vertical line indicates the
start of the prediction period.
3.3.1 Age- and gender-specific projections at national level
Figure 3.3 shows observed and predicted tobacco-related cancer mortality rates during 19842008
and 20092018, respectively, for each gender and age category. For both, males and females,
higher rates were observed for the younger age group.
For males, a decreasing trend was obtained which is less pronounced from 19941998 onwards.
On the other hand, projected absolute death counts increased during 20092013 and 20142018
(see Table 3.1), reflecting the demographic aging of the population (see Fig. 3.4).
The difference in mortality rates between younger and older males narrowed during the study
periods. Overall, the mortality rate in males decreased by approximately 30%.
Tobacco-related cancer mortality for Swiss women steadily increased during the study period. In
contrast to males, model-based estimates indicated that the difference of mortality rates between
younger and older females increased. The projected rates in 20142018 indicate that the female
tobacco-related cancer mortality rates rise by more than 60% during the whole study period.
3.3.2 Gender-specific projections for the language regions
Figure 3.5 shows the trends for gender-specific tobacco-related cancer mortality rates by language
regions. For males, the lowest rates were observed for the German-speaking region. No signif-
icant differences were observed for the rates in the French- and Italian-speaking part for either
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20042008 20092013 20142018
Males
Overall 17 656 18 340 (17 300, 19 820) 19 270 (17 260, 22 100)
5069 7 703 8 030 (7 522, 8 690) 8 023 (7 085, 9 333)
≥ 70 9 953 10 310 (9 713, 11 130) 11 260 (10 080, 12 910)
Females
Overall 9 349 11 080 (10 510, 11 620) 13 270 (11 960, 14 570)
5069 3 453 4 255 (4 005, 4 534) 5 010 (4 416, 5 643)
≥ 70 5 896 6 824 (6 456, 7 148) 8 261 (7 453, 9 026)
Table 3.1: Raw age- and gender-specific tobacco-related cancer death counts observed (dur-
ing 20042008) and projected (posterior median during 20092013 and 20142018) at country
level. The numbers in the brackets correspond to 95% Bayesian credible intervals.
Figure 3.4: Relative change in population (in % based on preceding year) for males (red)
and females (blue) and age groups 5069 (dashed) and ≥ 70.
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(a) (b)
Figure 3.5: Language regions-specific age-standardized tobacco-related cancer mortality
rates (per 100 000), observed (during 19842008) and predicted (posterior median during
20092013 and 20142018) for males (a) and females (b). The vertical line indicates the start
of the prediction period.
sex. Considering cause-specific mortality rates for females, the gap between the lowest (German-
speaking) and the highest (French-speaking) region-specific rates clearly decreased during the 30
study years. While the German-speaking region did show significantly lower rates up to 2008,
estimates for the projected periods indicate no significant difference between the two regions. In
19841988 the rates for the Italian-speaking area were not significantly different from those in
the German-speaking one. Subsequently, however, a significantly higher tobacco-related cancer
mortality rate for females was observed in the Italian-speaking part. Again, this can not be said
for the projected periods.
3.3.3 Gender-specific projections at cantonal level
Figures 3.6 and 3.7 show the observed gender-specific (male and female, respectively) tobacco-
related cancer mortality (age ≥ 50) observed for period 5 (20042008) and the model-based pro-
jections for period 6 (20092013) and 7 (20142018) at cantonal level. Cantonal boundaries
correspond to the updated structure including merged cantons. For males, an overall decreasing
trend was observed, whereas rates in the French-speaking cantons still remained the highest, with
the highest rates in cantons Valais and Neuchaˆtel.
Lowest tobacco-related cancer mortality rates were observed in the region covering the two cantons
Appenzell Ausserrhoden and Appenzell Innerrhoden in Eastern Switzerland. Figure 3.9 shows less
precise estimates for these regions. However, maps of the observed rates (Fig. 3.6(a), Fig. 3.7(a))
50 Chapter 3. Tobacco-related cancer mortality projections
(a)
(b) (c)
Figure 3.6: Age-standardized tobacco-related cancer mortality rates (per 100 000) for males
age ≥ 50, (a) observed during 20042008 and predicted posterior median (b) during 20092013
and (c) 20142018.
confirm low rates.
For males, the highest decrease was observed for the two cantons Zurich and Luzern  a steady
reduction of around 1216% per period. Regarding females, tobacco-related cancer morality was
projected to remain stable in the cantons Geneva and Graubünden. Furthermore, an increase
of approximately 50% from 20042008 to 20142018 was estimated for the cantons Schaffhausen,
Zug and Schwyz.
3.4 Discussion
This is the first study in Switzerland to project age- and gender-specific tobacco-related cancer
mortality at different geographical levels during 20092013 and 20142018. Gender-specific esti-
mates of age-standardized rates are presented for each canton and language region. In addition,
projections are also made at national scale by the two age categories 5069 and ≥ 70.
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(a)
(b) (c)
Figure 3.7: Age-standardized tobacco-related cancer mortality rates (per 100 000) for fe-
males age ≥ 50, (a) observed during 20042008 and predicted posterior median (b) during
20092013 and (c) 20142018.
Random effects at cantonal level have been considered to account for spatial correlation in
mortality which arises from similar exposures (e. g. environmental factors , cultural characteristics,
health policies) at neighbouring areas. The models have been formulated within the Bayesian
framework of inference adopting CAR priors for the random effects. The Bayesian approach
enables computation via the use of MCMC and smooths the rates so that estimates from areas
with small populations do not dominate (Clayton and Kaldor, 1987).
Overall, tobacco-related cancer mortality rates in males are decreasing, whereas female mortality
is increasing. Estimates at the national level show that mortality rates for younger (age 50
69) females increased more than those for older (age ≥ 70) ones. On the other hand, a steeper
downward trend was obtained for young males compared to older ones. The less pronounced trend
for males observed from 1994 onwards might be due to the change in the death certificate coding
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introduced in 1995. Early Swiss cancer mortality projections at national scale estimated a plateau
of male lung cancer mortality and a rising trend for females for the end of the last century (Negri
et al., 1990).
Maps of the projected rates can greatly help in identifying cantons with high or low mortality
rates. However, the accuracy of estimates needs to be considered carefully. In this study some
cantons were merged to allow for more precise estimates. Figure 3.9 shows, that estimates for
these regions have the lowest accuracy however, they seem reasonable compared to the trends of
preceding periods and neighbouring cantons.
Important differences in cancer-related mortality were estimated among the language regions for
the observed, but not the projected periods. The latter may be explained by the wide credible
intervals of the estimates. Results for language regions could be compared with projections in
Germany, France and Italy to assess the hypothesis that Swiss language regions reflect the situation
in the respective neighbouring countries.
Comparing Figure 3.1 with Figures 3.6 and 3.7 it is interesting to note that the high rates occurred
in the French-speaking part, which applied the strictest smoking ban regulations. Regarding males'
tobacco-related cancer mortality rates in 20142018 (Fig. 3.6(c)), cantons with the lowest rates
in the middle of the country resemble those only applying minimal smoking-ban regulations, i. e.
the federal law. However, this finding may have arisen by,chance because it does not take into
account the time lag of 2030 years between smoking (exposure) and the disease/death. In this
study, cancer deaths below the age of 50 were excluded, as lung cancer in this age group is rarely
due to tobacco smoking.
A decreasing prevalence of smoking in Switzerland has been reported for 19922007 (Marques-
Vidal et al., 2011). The authors reported a stronger trend, corresponding with stage 4 of the
smoking epidemic model proposed by Lopez et al. (1994). This model describes different stages
indicating changes in prevalence of smoking, tobacco consumption as well as mortality due to
smoking. Stage 4 is characterized by an overall declining trend in smoking prevalence and a
peak in male smoking-related mortality. As a consequence of rapid changes in female smoking
behaviour during the mid-twentieth century, mortality for women has increased. However, a peak
of female tobacco-related cancer mortality has not yet been observed. These findings confirm
European trends in gender-specific lung cancer mortality. Based on observations in 2007, rates in
Europe were estimated to decrease for males and increase for females in 2012, which is consistent
with our results (Malvezzi et al., 2012). However studies in the United States showed a declining
trend in female lung cancer mortality rates (Kohler et al., 2011).
It should be noted that we only account for cancer mortality and did not capture overall mortality
due to smoking. Furthermore, we did not account for smoking behaviour and related changes over
time. Model predictions could be optimized using additional information. For example, Knorr-
Held and Rainer (2001) introduced in their analysis information on tobacco consumption estimated
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from numbers of cigarette packages sold to project lung cancer mortality in Western Germany
based on the effects of age and cohort. In Switzerland, obtaining temporal as well as spatial
information on smoking patterns remains a challenge, especially for earlier years.
The current analysis cannot take into account the impact of recent interventions, such as the
Swiss federal law which was introduced in 2010, because there are no mortality data to estimate
the intervention effect. This may be considered as a limitation; however our analysis will allow
assessing the impact of smoking ban by comparing our projections with the observed rates in the
future.
Demographic changes have an impact on incidence and mortality, especially for diseases mainly
occurring in elderly people, as the fraction of older people in the population is rising. Among
others, improved health care is one reason for the increasing longevity.
Stable rates may be estimated despite that the absolute number of deaths is increasing because
the older population is increasing. In this study, a downward trend was observed for male cause-
specific cancer mortality, although raw death counts increased for these periods.
Maps of observed and projected tobacco-related cancer mortality highlight cantons with low or
high rates. Estimates for language regions show lowest mortality in the German-speaking part
of country but appear to become less pronounced over time especially for women. Countrywide
projections indicate an ongoing declining trend for males, while for females a continuing rise is
predicted, which is more pronounced in the younger age group.
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Figure 3.8: Swiss cantons labeled by their abbreviations.
3.5 Appendix
3.5.1 Details on cantons
Zurich (ZH), Bern (BE), Lucerne (LU), Uri (UR), Schwyz (SZ), Obwalden (OW), Nidwalden
(NW), Glarus (GL), Zug (ZG), Fribourg (FR), Solothurn (SO), Basel-Stadt (BS), Basel-Landschaft
(BL), Schaffhausen (SH), Appenzell Ausserrhoden (AR), Appenzell Innerrhoden (AI), St. Gallen
(SG), Graubünden (GR), Aargau (AG), Thurgau (TG), Ticino (TI). Vaud (VD), Valais (VS),
Neuchâtel (NE), Geneva (GE), Jura (JU).
3.5.2 Details on results
Accuracy of estimates
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20042008 20092013 20142018
Males
German 45.6 42.0 (39.9, 45.3) 38.8 (35.1, 45.3)
French 55.4 50.4 (46.7, 55.0) 45.7 (38.9, 54.4)
Italian 52.8 49.2 (44.7, 53.8) 45.8 (38.8, 53.8)
Females
German 19.3 21.5 (20.3, 22.7) 23.9 (21.3, 26.8)
French 21.4 23.1 (21.1, 24.9) 24.7 (21.3, 28.1)
Italian 20.9 23.5 (20.6, 26.6) 25.5 (20.7, 30.6)
Table 3.2: Age-standardized tobacco-related cancer mortality rates (per 100 000), observed
(during 20042008) and predicted (posterior median during 20092013 and 20142018) at
language region level for males and females. The numbers in the brackets correspond to 95%
credible intervals.
(a) (b)
(c) (d)
Figure 3.9: Maps showing the width of the 95% credible intervals relative (to the actual
tobacco-related cancer mortality rates (shown in Fig 67) for males in (a) period 6 (2009
2013); (b) period 7 (20142018) and females in (c) period 6; (d) period 7.
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3.5.3 Bayesian APC model formulations
Bayesian Poisson regression models were fitted for each gender and age category. Following the
APC approach, the canton-specific effects of age, period and cohort were used to model and predict
tobacco-related cancer deaths µijk, where population size nijk of each age group i and period j
was considered as the exposure. As the analysis covered 26 coherent regions, models were further
developed including gender- and canton-specific random effects φk (k = 1, . . . , 26) accounting for
spatial correlation.
log(µijk) = log(nijk) + αik + βjk + γj−i,k + φk (3.2)
In addition, we extended the model to consider under-/overdispersion assuming that mortality
counts follow a Negative Binomial. The Negative Binomial is an extension of the Poisson distri-
bution and it includes an additional parameter to account for the extra-variation.
To complete Bayesian model formulation, priors are specified for the unknown parameters. For
the first two groups of the time effects (i. e. age, period and cohort) a normal distribution was
considered with mean 0 and vague precision depending on the overall precision of the remaining
groups. For the remaining groups, a second-order autoregressive process was assigned allowing
for dependence and smoothing (Bray, 2002). For example, for the age effects the above prior is
formulated as follows:
α1 ∼ N (0, 1.0E-06τα) (3.3)
α2|α1 ∼ N (0, 1.0E-06τα) (3.4)
αi|α1,...,i−1 ∼ N (2αi−1 − αi−2, τα), for 3 ≤ i ≤ I (3.5)
where I is the total number of age groups. Uninformative priors were assigned to the precision
parameter of each effect. Spatial random effects were assumed to derive from a Conditional Au-
toregressive (CAR) process Besag et al. (1991); Bernardinelli and Montomoli (1992). Dependence
in space among the cantons was introduced by the conditional prior distribution of the φk with
φk | φ−k ∼ N (
N∑
q=1
q 6=k
ckqφq
wk
,
σ2
wk
) (3.6)
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Cantonal Language regions National
Males Females Males Females Males Females
Nordpred
Poisson 293 234 13.25 3.99 1.20 0.19
Power 5 311 214 12.80 3.55 1.13 0.17
Bayesian APC model
Poisson 113 104 3.57 1.98 0.71 0.08
Poisson spatial 109 101
Negative Binomial 145 106 2.73 2.15 0.28 0.09
Negative Binomial spatial 175 101
Table 3.4: Results of empirical projections of gender-specific tobacco-related cancer mortal-
ity given by the sum of squared residuals for the projected periods.
where φ−k = (φ1, . . . , φk−1, φk+1, . . . , φN ) and ckq indicates the degree of spatial influence of
canton k to the remaining ones, taking the value 1 if they are adjacent and 0 otherwise and wk
represents the number of neighbours of canton k.
3.5.4 Model validation
For validation purpose models were applied for empirical projection of age- and gender-specific
tobacco-related cancer mortality at cantonal, national and language region level in periods with
known mortality. Model performance was evaluated by comparing model-based projections with
observed data in 19992003 and 20042008 using the sum of squared residuals (SSR).
SSR =
∑
i,j,k
(Rijk − Rˆijk)2
Rijk
(3.7)
where Rijk and Rˆijk are the observed and estimated rates for canton k, age group i and period j,
respectively. Table 3.4 shows the SSR for the two periods of the empirical projection of gender-
specific tobacco-related cancer mortality. Regarding the projections at cantonal level the spatial
Poisson model performed best for males. The spatial models showed best predictive ability for
females, whereas the Negative Binomial ones gave more precise estimates. Therefore, spatial
Poisson and Negative Binomial models were applied to project cantonal age- and gender-specific
tobacco-related cancer mortality in Switzerland. For projections at country and language regions
Negative Binomial and Poisson models were applied for males and females, respectively.
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Abstract
Age-Period-Cohort (APC) models are the state of art in cancer projections, assessing past and
recent trends and extrapolating mortality or incidence data into the future. Nordpred is a well
established software, assuming a Poisson distribution for the counts and a log- or power-link
function with fixed power, however its predictive performance is poor for sparse data. Bayesian
models with log-link function have been applied but they can lead to extreme estimates. In this
paper, we address criticisms of the above models by providing Bayesian formulations based on a
power-link and develop a generalized APC power-link model (GPM), which assumes a random
rather than fixed power parameter. In addition, a power model with a fixed power parameter of
five was formulated in the Bayesian framework. The predictive performance of the new models was
evaluated on Swiss lung cancer mortality data using model-based estimates of observed periods.
Results indicated that the GPM provides best estimates for male and female lung cancer mortality.
The gender-specific models were further applied to project lung cancer mortality in Switzerland
during the periods 20092013 and 20142018.
Keywords: Bayesian inference; cancer projection; power model; Nordpred; lung cancer mortality
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4.1 Introduction
Cancer projections estimate the future burden of the disease. They provide important information
for health planning and evaluation of intervention effects, e. g. screening or changes in diagnostic
techniques.
The most common modelling approaches for projecting cancer rates are time series and Age-
Period-Cohort (APC) models (Lee et al., 2011; Qiu et al., 2010). Time series models have been
applied assuming a Poisson distribution for the disease counts. The models include autoregressive
error terms (Wingo et al., 1998) and/or time trends fitted by linear (Lee et al., 2011), polynomial
(Wingo et al., 1998), piecewise linear (Kim et al., 2000) or spline curves. APC models typically
include three components  age, corresponding to the age of death, period, representing the time
period that the death was recorded and cohort, giving the birth cohort of the person that died.
Usually these components are stratified into 5-year intervals which are identified by the relation
cohort = period - age. The dependence between the components is well-known as the identification
problem however it does not affect estimation of the projected rates. Intervals smaller than 5
years have been considered, however the smaller the interval the more likely to lead to sparse or
zero death counts. Age is assumed to have the highest effect on cancer mortality and incidence
rates, whereas period or cohort effects can be neglected in some settings. Short-term projections
(≤ 5 years) are mainly based on age-period models, and long-term ones are based on age-period-
cohort-models. However, depending on the dataset, cohort effects might also be important for
short-term projections. Preliminary analyses are carried out to assess the contribution of cohort
effects. Models may include a drift parameter to measure the average trend. The drift is often
considered constant throughout the periods or reduced by a fixed amount (i. e. 25%) (Møller et al.,
2002).
APC models are fitted within a generalized linear model framework. Different link functions
can be considered to relate the predictors with the mean (Mallick and Gelfand, 1994; Pregibon,
1980). Osmond (1985) used a Poisson regression model with a log-link function to estimate age-
and period-specific rates. Møller (2004) proposed the power model, using a power rather than a
log-link function with a fixed power equal to 5 derived by empirical estimation. Both, the Poisson
power- and log-link models are implemented in the R (R Development Core Team, 2011) software
package Nordpred developed by the Cancer Registry of Norway. A Bayesian formulation of the
Poisson APC model with log-link was suggested by Bray (2002), assigning autoregressive priors
to the effect of age, period and cohort. Second-order autoregressive processes were appropriate
in several settings. Bayesian APC models have been applied frequently to model for example
lung cancer mortality in West Germany (Knorr-Held and Rainer, 2001), in France (Eilstein et al.,
2008) or breast cancer mortality in Spain (Clèries et al., 2006).
Several reviews compared different models for cancer projections (Qiu et al., 2010) showing that
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the Poisson power-link and Bayesian Poisson log-link model outperformed other approaches (Lee
et al., 2011; Cancer Projections Network (C-Projections), 2010). The latter model assumes an
exponential growth of the predictions. It has been criticized that it might give extreme predictions
(Qiu et al., 2010; Bray and Møller, 2006; Møller et al., 2005). The power-link overcomes this
problem however it may inaccurately estimate low or even zero counts. The Bayesian model
formulation smooths age, period and cohort effects obtaining valid estimates for sparse rates or
even zero counts (Qiu et al., 2010; Baker and Bray, 2005). In addition it can provide uncertainty
estimates of rates and assess model performance taking into account the estimation error. To our
knowledge a Bayesian formulation of the Poisson power-link model has not been developed yet.
Furthermore, it is unclear whether all applications of the power-link model support a fixed power
parameter equal to 5.
In this paper, we formulated the power model within the Bayesian framework and developed a
generalized model considering a random rather than fixed power parameter. The above models
were compared with the ones using the log-link function. All models were applied on gender-
specific lung cancer mortality data from Switzerland and compared with the fixed power- and
log-link model fitted in Nordpred using maximum likelihood. The sum of squared residuals (SSR)
of the projected rates was calculated for all models, while the logarithmic score (LS) (Ntzoufras,
2009) and Deviance Information Criterion (DIC) was applied to the Bayesian models to assess
their predictive performance. The gender-specific model with the best accuracy was employed to
project lung cancer mortality rates for the periods 20092013 and 20142018.
4.2 Methodology
4.2.1 Model formulations
In this study, we developed Bayesian APC models assuming that the observed age- and period-
specific death counts Nij follow a Poisson Nij ∼ Pois(µij) distribution and using a model-specific
link-function g.
The mean of the age- and period-specific death counts µij was regressed on the effects of age,
period and cohort, using the corresponding population as the offset. In particular, let αi, βj and
γk (k = I − i + j) be the effects of age, period and cohort and Nij and Mij be the age- and
period-specific death counts and population, respectively.
g
(
µij
Mij
)
= αi + βj + γk (4.1)
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Under a log-link as well as power-link function the regression model relating the mortality rate to
the time effects reads as follows:
Log-link model: log(µij) = log(Mij) + αi + βj + γk
Power-link model: µ
1
5
ij =M
1
5
ij (αi + βj + γk)
(4.2)
In the above model the power is assumed to be fixed. We extended the model by considering
the power to be a parameter estimated by the data and called it generalized APC power model
(GPM). The power w was assumed to be random, as the degree of the growth of the rate might
change, depending on the given dataset. The model was formulated as follows:
GPM: µ
1
w
ij =M
1
w
ij (αi + βj + γk)
(4.3)
The above model overcomes estimation of extreme rates that may be obtained from the log-
link. Bayesian simulation-based estimation allows flexible prior specification which smooths time
effects.
4.2.2 Prior specifications
To complete Bayesian specification, prior distributions were assigned to the parameters. Following
Bray (2002), time effect-specific (i. e. age, period and cohort) smoothing prior formulations were
considered. The first two groups of each time effect were restricted to follow a normal distribution
with mean 0 and vague precision. The remaining groups were assumed to follow a second-order
autoregressive processes, depending each effect on its two predecessors, to allow for dependence
and smoothing (Bray, 2002). The above prior distributions are formulated as follows (illustrated
for the effect of age):
α1 ∼ N (0, 1.0E−06 ∗ τα) (4.4)
α2|α1 ∼ N (0, 1.0E−06 ∗ τα) (4.5)
αi|α1,...,i−1 ∼ N (2αi−1 − αi−2, τα), for 3 ≤ i ≤ I (4.6)
where I is the total number of age groups. Non-informative priors were assigned to the precision
parameters τα, τβ and τγ for the effect of age α, period β and cohort γ, respectively. For comparison
purposes we used the same prior distributions across models.
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(a) (b)
Figure 4.1: Observed crude lung cancer mortality rate (per 100 000 inhabitants) for males
(a) and females (b) from 19741978 to 20042008.
A discrete prior distribution was assigned on the power parameter w, assuming that w ∼ cat(p[]).
This prior formulation specifies a set of possible values w ∈ {1, . . . , n} with probabilites
p[w = i] = pi and
n∑
i=1
p[i] = 1. In our specification, we consider w could take any integer from 1
to 10, each with probability equal to 0.1.
4.3 Assessing model predictive performance
Empirical projections, estimating mortality for observed periods, have been done applying the
different models, i. e. Bayesian log-, power-link model and the GPM, the Nordpred log- and power-
link model. In addition, the performances of the log-linear model (excluding the cohort effect),
which is generally used for short-term projections (Hakulinen and Dyba, 1994), and the simple
averaging method (Qiu et al.) have been assessed. The latter has been recommended for the
projection of low count data and is based on the assumption that the population size will change
in the future, but the mortality rate remains the same as in the current period. Model-specific
results have been validated by the LS, DIC, SSR as well as graphical assessment of the projected
rates.
4.4 Application
In Switzerland the National Program Tobacco 20082012 (NPT 20082012) was launched to reduce
tobacco-related morbidity and mortality in the country. The initiative strategic goals were set
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until the end of 2012 to accomplish the mission. Projections of tobacco-related cancer mortality
based on past trends, not taking into account recent interventions as the NPT 20082012, may
increase awareness on the program. However, interpretation on the impact of the program based
on the projected rates should be done carefully as the difference between estimated and observed
might be due to several factors and interventions are only one possibility among others.
Count mortality data from death certificates and population size at national level were provided
from the Swiss Federal Statistical Office (FSO). The time range considered for both datasets, was
19742008 and was splitted into seven periods (19741978, . . . , 20042008). Age was classified in
five-year groups (2529,. . . , older than 85) and 19 ten-year overlapping cohorts were constructed
following the relation cohort = period - age. Gender-specific mortality rates were age-standardized
directly using Segi World population (Segi, 1960). In 1995 the rules related to coding death
certificates have been changed in Switzerland  priority of certain causes has been removed from
the regulations. Therefore, the number of these cause-specific deaths reported before and after
this changes differed and have to be adjusted. The FSO provides a disease-related correction
factor to adjust death reports before 1995 (Berrut and Junker, 2008).
Exploratory analysis of tobacco-related cancer mortality from 19742008 indicated different trends
for each gender (see Figure 4.1). Rates for men remain stable since the last decade, while female
lung cancer mortality increased steadily.
Empirical projections were carried out for the two last periods (19992003, 20042008) with known
mortality rates to validate the model performance. After validation, the model with the best fit
was applied to project gender-specific lung cancer mortality in Switzerland for the periods 2009
2013 and 20142018. In addition, predictive performance of the models was assessed for a shorter
period of observed mortality, i. e. 19841988, . . . , 20042008. Model formulation and fitting was
based on Markov chain Monte Carlo (MCMC) (Gilks et al., 1996) and was done in WinBUGS
(Imperial College and MRC, London, UK). Convergence was assessed by the Gelman and Rubin
diagnostic test within the R package coda.
4.4.1 Model predictive performance
Exploratory analysis assuming different drifts indicated no effect on the fitting and the estimates.
Therefore, the drift parameter was considered to be zero. Model predictive ability was evaluated
by different metrics. Results were compared with the Nordpred equivalent whenever possible (see
Table 4.1). Firstly, the SSR was calculated for all models and visual assessment was done by
comparing model-based estimates with the observed rates for the projected periods. As a next
step, Bayesian models were compared based on the LS and DIC.
The results of the empirical projections are shown in Table 4.1. SSR and visual assessment of the
projected rates (Fig. 4.2) indicated that Bayesian models performed better than the equivalent
implemented in Nordpred. For males, the power-link outperformed the log-link model. The latter
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Males Females
LS DIC SSR6,7 LS DIC SSR6,7
Bayesian
Log-link -207.7 589.2 40.1 -207.4 494.3 8.9
Power-link -206.5 590.3 30.9 -208.4 490.4 9.9
Log-linear -340.5 868.4 142.6 -259.5 516.6 13.1
GPM -205.7 597.3 21.9 -206.5 496.8 8.6
Nordpred
Log-link 53.1 13.7
Power-link 41.6 11.4
Simple averaging 60.1 86.4
Table 4.1: SSR of empirical projections of gender-specific lung cancer mortality rates, loga-
rithmic score (LS) and DIC for the Bayesian models.
provided extremely low estimates. For females, the log-link was better thatn the power-link,
however it overestimated mortality. The Bayesian log-linear model and the simple averaging
method performed worst. Best predictive ability for for both genders was given by the GPM, as
indicated by the SSR, LS as well as the plotted estimates of the empirical projection. The random
power parameter for males and females was estimated to be 3 and 7, respectively. For males, the
mortality rates level off during the projected period. Female mortality rates continue increasing
during 19992008 following a slightly steeper trend than during 19741998.
Empirical projections based on a shorter time period of observed mortality (19841988, . . . , 2004
2008) indicated best performance of the Bayesian log-link model for males. However, the predictive
performance of the GPM based on the longer observed period was better than the one based on
the shorter fitting period. For females, the GPM, indicated best predictive ability for the shorter
as well as for the longer fitting period, however, the latter provided better fit.
4.4.2 Projections
Gender-specific lung cancer mortality rates were projected for the periods 20092013 and 2014
2018, based on observed data from 19742008. Future rates were predicted for each gender by
using the GPM and the Bayesian log-link model for males and females, respectively. Based on
evaluation, different models were applied for gender-specific projections. To account for potential
age-specific trends, age was splitted into four age categories 2544, 4564, 6584 and above 85
years. Overall and age category-specific rates were age-standardized by Segi World population.
Observed lung cancer mortality rates by gender are illustrated in Figure 4.1. Figure 4.3 and Table
4.2 indicate a steadily declining trend for male lung cancer mortality since 19791983. This can be
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(a)
(b)
Figure 4.2: Observed and predicted Swiss lung cancer mortality rates for males (a) and
females (b).
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(a)
(b)
Figure 4.3: Observed (red), model-based estimates of fitted (19741978 to 20042008) and
projected (20092013, 20142018) Swiss age-standardized lung cancer mortality rate for males
(a) and females (b) (per 100 000 inhabitants) with 95% Credible Bounds (CB).
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seen for all groups, except the ones older than 85, which shows a rising trend until 1993, followed
by a decline (Fig. 4.4).
Female lung cancer mortality was estimated to be more than three times higher in 20142018
in comparison to 19741978. Age category-specific plots present a stable trend for females aged
4564 in 20042008.
Final projections for males estimated the random power parameter to be 3 and 7, respectively.
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(a)
(b)
Figure 4.4: Observed (red), model-based estimates of fitted (19741978 to 20042008) and
projected (20092013, 20142018) Swiss age-standardized lung cancer mortality rate for males
(a) and females (b) (per 100 000 inhabitants) by age category.
4.4 Application 71
F
it
te
d
ra
te
s
P
ro
je
ct
ed
ra
te
s
74
7
8
79
8
3
84
8
8
89
9
3
94
9
8
99
0
3
04
0
8
09
1
3
14
1
8
M
a
le
s
O
ve
r-
al
l
44
.3
5
(4
3.
52
;4
5.
21
)
44
.8
4
(4
4.
14
;4
5.
55
)
43
.3
2
(4
2.
62
;4
4.
01
)
40
.0
9
(3
9.
50
;4
0.
78
)
35
.3
8
(3
4.
75
;3
5.
94
)
31
.4
9
(3
0.
95
;3
2.
02
)
28
.4
1
(2
7.
87
;2
8.
98
)
26
.0
8
(2
3.
93
;2
8.
46
)
24
.2
8
(2
0.
17
;2
9.
55
)
25
4
4
1.
07
(0
.9
8;
1.
17
)
1.
00
(0
.9
3;
1.
09
)
0.
98
(0
.9
1;
1.
06
)
0.
88
(0
.8
2;
0.
95
)
0.
72
(0
.6
5;
0.
78
)
0.
62
(0
.5
6;
0.
68
)
0.
57
(0
.5
0;
0.
65
)
0.
57
(0
.4
1;
0.
80
)
0.
59
(0
.3
1;
1.
19
)
45
6
4
20
.6
4
(2
0.
11
;2
1.
16
)
19
.9
4
(1
9.
52
;2
0.
38
)
18
.4
0
(1
7.
99
;1
8.
80
)
16
.0
2
(1
5.
68
;1
6.
41
)
13
.5
5
(1
3.
20
;1
3.
86
)
12
.0
9
(1
1.
79
;1
2.
40
)
11
.2
0
(1
0.
89
;1
1.
53
)
10
.4
1
(9
.3
7;
11
.5
6)
9.
79
(7
.8
9;
12
.2
6)
65
8
4
21
.6
5
(2
1.
22
;2
2.
09
)
22
.7
1
(2
2.
33
;2
3.
10
)
22
.6
2
(2
2.
25
;2
2.
97
)
21
.7
5
(2
1.
40
;2
2.
11
)
19
.6
9
(1
9.
37
;2
0.
02
)
17
.4
6
(1
7.
16
;1
7.
75
)
15
.4
1
(1
5.
11
;1
5.
72
)
13
.9
2
(1
3.
00
;1
4.
95
)
12
.8
9
(1
1.
11
;1
5.
04
)
ol
de
r
85
1.
00
(0
.8
9;
1.
11
)
1.
18
(1
.1
2;
1.
26
)
1.
33
(1
.2
7;
1.
39
1.
44
(1
.3
8;
1.
50
)
1.
42
(1
.3
6;
1.
47
)
1.
32
(1
.2
6;
1.
37
)
1.
23
(1
.1
8;
1.
28
)
1.
15
(1
.0
6;
1.
24
)
1.
00
(0
.8
5;
1.
18
)
F
e
-
m
a
le
s
O
ve
r-
al
l
4.
21
(4
.0
7;
4.
36
)
5.
12
(4
.9
8;
5.
26
)
6.
22
(6
.0
8;
6.
36
)
7.
50
(7
.3
5;
7.
63
)
8.
94
(8
.7
8;
9.
09
)
10
.4
4
(1
0.
23
;1
0.
63
)
11
.8
7
(1
1.
59
;1
2.
17
)
13
.1
2
(1
2.
72
;1
3.
57
)
14
.0
3
(1
3.
42
;1
4.
64
)
25
4
4
0.
27
(0
.2
4;
0.
30
)
0.
35
(0
.3
2;
0.
39
)
0.
45
(0
.4
1;
0.
50
)
0.
52
(0
.4
8;
0.
57
)
0.
52
(0
.4
8;
0.
57
)
0.
47
(0
.4
2;
0.
51
)
0.
39
(0
.3
3;
0.
45
)
0.
34
(0
.2
6;
0.
44
)
0.
31
(0
.1
9;
0.
49
)
45
6
4
1.
96
(1
.8
7;
2.
06
)
2.
40
(2
.3
0;
2.
50
)
2.
97
(2
.8
5;
3.
08
)
3.
67
(3
.5
6;
3.
79
)
4.
46
(4
.3
2;
4.
58
)
5.
25
(5
.0
9;
5.
40
)
5.
92
(5
.7
1;
6.
14
)
6.
21
(5
.9
1;
6.
54
)
6.
01
(5
.6
0;
6.
44
)
65
8
4
1.
82
(1
.7
5;
1.
91
)
2.
20
(2
.1
3;
2.
28
)
2.
62
(2
.5
4;
2.
70
)
3.
11
(3
.0
3;
3.
19
)
3.
72
(3
.6
3;
3.
82
)
4.
42
(4
.3
1;
4.
55
)
5.
22
(5
.0
7;
5.
37
)
6.
17
(5
.9
6;
6.
40
)
7.
22
(6
.9
3;
7.
54
)
ol
de
r
85
0.
15
(0
.1
3;
0.
18
)
0.
16
(0
.1
5;
0.
18
)
0.
18
(0
.1
6;
0.
19
)
0.
20
(0
.1
8;
0.
22
)
0.
24
(0
.2
3;
0.
26
)
0.
30
(0
.2
8;
0.
32
)
0.
34
(0
.3
2;
0.
36
)
0.
40
(0
.3
8;
0.
43
)
0.
48
(0
.4
5;
0.
51
)
T
a
b
le
4
.2
:
M
o
d
el
-b
as
ed
es
ti
m
at
es
(G
P
M
)
of
fi
tt
ed
an
d
p
ro
je
ct
ed
ag
e-
st
an
d
ar
d
iz
ed
ge
n
d
er
-s
p
ec
ifi
c
lu
n
g
ca
n
ce
r
m
or
ta
li
ty
ra
te
(p
er
10
0
00
0
in
h
ab
it
an
ts
)
w
it
h
95
%
C
B
.
72 Chapter 4. Bayesian generalized age-period-cohort power model
4.5 Discussion
In this paper, we developed a Bayesian APC power model with fixed power of 5 and a generalized
APC power model for cancer mortality/incidence projections which overcomes limitations of well
established models. The commonly used power model was formulated within the Bayesian frame-
work and it was further extended to allow for a random power parameter instead of the fixed one
proposed by Møller (2004).
Model performance was compared to the frequently used Bayesian APC model with a log-link
function. We assumed that the counts arise from a Poisson distribution. The models were com-
pared to the commonly used ones implemented in the Nordpred software assuming the log- and
the power(5)-link. The predictive performance of the new models was evaluated on Swiss lung
cancer mortality data using model-based projections of observed periods. The model with the
best fit was applied to project age- and gender-specific lung cancer mortality rates in Switzerland
for the periods 20092013 and 20142018.
The GPM performed best for males and females. For both gender, the log-linear and simple aver-
aging method gave poorest fit. The latter assumes continuation of the trend observed in the recent
period and is sensitive to the projected population (Qiu et al.). For the empirical projection the
population was known, which suggests that the assumption of a continuing trend was violated.
Figure 4.2 illustrates the changing trend for both gender  a flattening decrease for males and a
steepening increasing trend for females.
The unsatisfactory performance of the log-linear model can be explained by the missing cohort
effect, which was found to be strongly related to lung cancer mortality rates (Lee et al., 1990).
This relation can be explained by the gender-specific tobacco epidemics.
Møller et al. (2003) compared several projection methods, e. g. APC models using a power- or a
log-link on several cancer incidence data from five Nordic countries. They also found that models
using a power instead of a log-link function have better predictive ability. The authors assessed
models with power parameters fixed to 5 and 2 and concluded that for short term predictions (≤ 5
years) the model based on the power of 2 outperformed the one with a power of 5. This result was
not seen for the long term projections and they pointed out that too small values may implicate
numerical problems.
The Canadian research group from the Alberta Health service evaluated long-term projections
of cancer mortality and incidence data based on Nordpred, Generalized Additive and Bayesian
Models (Qiu et al., 2010). The Bayesian specifications included the log-link assuming different
prior distributions for the effects of age, period and cohort. They concluded that the models in
Nordpred using power 5 and the Bayesian model using second-order autoregressive priors for the
age, period and cohort effects performed best, however the Bayesian one performed better con-
sidering mortality projections and the Nordpred achieved better results for incidence. Mortality
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is more sparse than incidence and therefore more challenging for the modelling. The latter is true
for cancer sites with high survival rates. Some authors (Qiu et al., 2010) argue against the use of
Bayesian APC models due to the complexity of the MCMC fitting, however over the last years
the number of scientific publications, using the Bayesian framework, is increasing steadily.
The analysis of the Swiss lung cancer mortality data indicated an ongoing decline for overall male
mortality from 1974 onwards. Age-specific mortality followed the overall trend with exception the
group of 6584 years old, whose decreasing trend started after 1979. Despite mortality rates are
decreasing, the number of projected deaths increased after 2009. Female mortality increases since
1974 for all age groups, however the group of 4564 years old reaches a plateau around 20042008.
In general, results of projections should be interpreted carefully, as they depend on different fac-
tors such as model choice. Clements et al. (2005) analysed lung cancer mortality for females in
five countries. They compared different approaches, which provided different trends for the future
rates. The authors pointed out that the dependence of the projections on the form of the model is
an important limitation. Furthermore, cancer projections are sensitive to population projections
since the proportion of elderly people influences mortality rates and crude deaths counts. In our
analyses, population data for 20092013 and 20142018 were provided by the Swiss Federal Office
of Statistics which extrapolates populations under different scenarios regarding migration, birth
and death rates. Our population estimates are based on non-extreme demographic changes.
Projections of lung cancer mortality are based on past trends, not taking into account recent
interventions. The National Program Tobacco 20082012 (NPT 20082012) was launched to re-
duce tobacco-related cancer morbidity and mortality in the country. The initiative strategic goals
were set until the end of 2012. Our findings could help to evaluate the program, as model-based
estimates can be compared with observed data in the future.
Several metrics exist to assess the predictive performance of a model (Czado et al., 2009). We
used the SSR (Baker and Bray, 2005) as well as the DIC and the LS (Ntzoufras, 2009) for the for
the Bayesian models. In addition, the estimates rates have been plotted and predictive ability has
been assessed graphically. For males and females, the different metrics gave the same conclusion.
In this paper, different functions have been applied to link the expected value of the mortality to
the predictor. Their choice depend on the dataset under consideration. While a log-link function
is more suitable to model a steep trend, a power-link function allows the specification of a cer-
tain degree of increase or decrease of the trend. In this study, gender-specific trends have been
observed. Males had a rather decreasing trend which flattened at the end of the study period.
For females an increasing trend was observed. Models based on the log-link function provided
the most extreme estimates, underestimating and overestimating the mortality rate for males and
females, respectively (Fig. 4.2). Estimates of the power-link models were less extreme and per-
formed better, while the GPM performed best in both settings. Visualization of the estimated
rates by the different link-functions clearly shows the under- and overestimation by the log-link
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and power-link models and indicates that a power parameter lower/greater than 5 would be more
appropriate to model Swiss male/female lung cancer mortality. This was confirmed by the esti-
mated power of 3 and 7 by the GPM for males and females, respectively.
The proposed models extend the list of APC-models and as already discussed above they had
better predictive performance in modelling the lung cancer data of our application. The models
have a number of strengths that make them especially suitable for modelling low counts as we
have shown in the analysis of female mortality data. Lee et al. (2011) and Qiu et al. suggested
that the average counts in the few years prior to projection may be a reasonable approach for
sparse or low count data. Our analysis showed that the simple average method performed worse
than any other approach in the case of female low count mortality data and that Bayesian for-
mulations outperform non-Bayesian approaches especially when modelling low counts. We are
currently assessing the models in projecting cause-specific mortality other than lung cancer.
The Bayesian model formulations we developed can be extended to account for extra Poisson
variation, present in sparse cancer data, by considering a Negative Binomial distribution which is
a mixture of a Poisson distribution with a Gamma mean parameter (Ntzoufras, 2009). However,
no over- or under-dispersion was present in the dataset under consideration. In fact, the Negative
Binomial model did not improve the predictive performance of the Poisson model. Choosing a
distribution other than the Poisson might be reasonable for the analysis of low count data, e. g. at
sub-regional level, which would allow the formulation of a subgroup-specific dispersion parameter.
Furthermore, potential heterogeneity can be captured by introducing random effects, however,
this specification will increase the number of parameters to be estimated.
Our analyses projected mortality rates at national level. Regional differences can be important for
health planning purposes. Model formulations can be easily extended to assess regional difference
and spatio-temporal pattern across the country (Lee et al., 2011).
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Abstract
Data on lung cancer incidence provide important information on the burden of the disease. In
Switzerland, incidence data are estimated by the cantonal cancer registries. However, only half
of the country is covered by cancer registries. On the other hand, mortality data are available at
municipality level obtained from death certificates. Back-calculation models allow for estimation
of incidence by linking subgroup-specific survival with mortality.
Mortality and incidence data from the Cancer Registry of St.Gallen-Appenzell (SGA) were used
to estimate lung cancer survival probabilities. Bayesian back-calculation models were developed
to estimate incidence from survival distributions and lung cancer deaths. The latter was extracted
from the national mortality database which is maintained by the Federal Statistical Office (FSO).
The proportion of miss-reported cause of death in the FSO data was calculated from the SGA
cancer registry data and considered in the analyses. Conditional autoregressive models were em-
ployed to provide gender-specific smooth maps of age standardized incidence ratios.
Validation comparing observed and estimated incidence for cantons with cancer registries indi-
cated good model performance. Smooth maps of lung cancer incidence for females showed higher
estimates in the urbanized regions, while for males a rather homogeneous distribution was ob-
served.
The proposed models improve earlier methodology and are important not only in mapping the
spatial distribution of the disease but also in assessing temporal trends of lung cancer incidence
in cantons without registries.
Keywords: Bayesian inference; lung cancer; incidence; survival
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5.1 Introduction
Cancer registries provide essential information to assess trends of cancer survival, incidence and
mortality in order to control and intervene. In Switzerland, 11 cancer registries cover 15 of the 26
cantons. Recently, attempts have been undertaken to establish cancer registries for the remaining
ones, however in 20052009 cancer registries covered 97.7% of Western Switzerland and Ticino,
while only 45.2% of the German-speaking part was covered (Federal Statistical Office, 2013a).
On the other hand, reliable information on cause-specific mortality at national level is given by
the death certificates provided by the Federal Statistical Offices. Therefore, the lack of availability
of cancer incidence data complicates the analysis space-time patterns of the cancer-specific bur-
den. The Federal Office of Statistics (FSO) extrapolated observed incidence to regions without
registration and provides gender-specific incidence estimates aggregated for two language-regions
(German-speaking Switzerland, French- and Italian-speaking Switzerland combined) (Federal Sta-
tistical Office, 2013b). This approach assumes homogeneity of the cancer incidence between those
regions covered and uncovered by cancer registries (Bouchardy et al., 2011).
Statistical approaches have been developed, which approximate incidence by observed mortality
data (Mitton et al., 2011; Ong and Soo, 2006). An established method is the back-calculation
model (Brookmeyer and Gail, 1988), which allows the estimation of incidence data by linking
survival functions and mortality data via the equation:
M(t) =
∫ t
0
I(t− i)f(t− i, i)di (5.1)
where M(t) is the death count at time point t, I(t − i) the incident case at time (t − i) and
f(t− i, i) the probability density of dying at time t when diagnosed at (t− i).
Model formulation requires an appropriate survival function to model the time to death since
diagnosis. Early diagnosis and treatment options after detection influence survival. Some can-
cers, like lung cancer, are difficult to be detected early and therefore it is less likely that there is
regional variation in patient survival. Other cancers, like breast cancer, can be diagnosed at an
early stage. Therefore screening policies have an impact on survival. For the latter, it is expected
to differ not only in individuals but also among the regions.
Lung cancer survival is rather low. In Switzerland, the 5-year survival for males is 10.0% and
13.4% for females in 19951999, while the majority dies within the first year (survival of 35.6%
and 36.8% for males and females, respectively) (Bordoni et al., 2012).
A number of studies have tried to estimate the survival distribution applying different functions,
either parametric or non-parametric (Collett, 1994). Mezzetti and Robertson (1999) modelled
lung cancer survival using a mixed distribution, considering a fixed probability for failure during
the first year after diagnosis. The survival for the years afterwards was assumed to follow an
exponential distribution, which assumes a constant hazard h(t) = λ over time t. De Angelis
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et al. (1999) analysed colon cancer survival in Finland, considering a Weibull density to model
failure time, which assumes the hazard to increase in time. Furthermore, a logistic function was
considered to account for the proportion of cured cases. Recently, Armero et al. (2012) used a
multi-state Bayesian analysis to examine lung cancer survival time and the progress of the disease.
Sánchez et al. (2010) estimated cancer incidence in Spain, modelling incidence as a polynomial
function of age, period and cohort and back-calculating its model parameters by the means of a
maximum likelihood regression based on the observed death counts using the software MIAMOD
(mortality-incidence analysis model) (Angelis et al., 1994). Mezzetti and Robertson (1999) esti-
mated lung cancer incidence in France by developing Bayesian back-calculation models. Survival
probabilities were considered to be known, based on preliminary analysis. The authors assumed
the observed mortality counts to follow a weighted linear regression with a Normal distribution.
The assumption of normality is not always justifiable, especially if the mean count is low. Further-
more, they smooth incidence over time by adopting an autoregressive normal prior distribution
for the mean incidence parameter. This assumption might also be violated, especially in the case
of analysis at a lower geographical level or a sparse disease, where the number of cases is low and
a rather skewed distribution is expected.
In this study, we extend existing Bayesian back-calculation models by using a count distribution
instead of a normal one to model observed mortality counts. Furthermore, we adopt a gamma
autoregressive process for the incidence parameter. Models were applied to assess space-time pat-
terns of lung cancer incidence from 19812009 in Switzerland. The incidence data from the SGA
cancer registry have been used to estimate age- and gender-specific lung cancer survival rates.
Model goodness of fit was assessed by comparing observed and model-based incidence of the SGA
region. Furthermore, smooth maps of age standardized lung cancer incidence ratio (SIR) for both
genders in 20052009 are presented at sub-district level.
5.2 Materials and methods
5.2.1 Data
Information on age- and gender-specific lung cancer incidence was provided from the cancer reg-
istry St.Gallen-Appenzell (SGA). The dataset was stratified by the year of incidence, municipality
of residence as well as days to event and status at end of follow-up (dead, alive or lost to follow-
up). Data covered the period from 1980 up to 2010. Some incidence records were reported with a
follow-up time of zero days. These are captured via the death certificates and are known as death
certificates only (DCO) (Parkin and Hakulinen, 1991). Our dataset covered 6% of DCO cases for
males and 5% for females. These counts were excluded from the survival analysis, but used as
death counts for the back-calculation model.
Mortality data for the SGA region were aggregated by year of death, age and gender. Countrywide
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analysis at cantonal level considered lung cancer mortality provided from the FSO.
Population data from the Swiss censuses were used for spatial modelling SIR during the period
20052009. The unit of analysis was ms-region (ms = mobilité spatiale). Switzerland is divided
in 106 such regions which are often used for scientific analyses (Federal Statistical Office, 2013c).
Digital information files (shapefiles) at municipality level for the year 2009 have been obtained
from the FSO and modified within the software ArcGIS to map the results at ms-region level.
5.2.2 Methods
Subgroup-specific differences in survival were assessed in the preliminary analysis. Age was cat-
egorized in two groups (4564, 6584) and the study period was separated in 5-year periods
(19801984, 19851989, 19901994, 19951999, 20002004 and 20052010). Bayesian gender-
specific survival models were adjusted for the two age categories and the time periods. Models
were fitted in WinBUGS (Imperial College and MRC, London, UK) for each gender separately.
We considered different survival distribution, such as exponential, Weibull and mixed following
Mezzetti and Robertson (1999), to account for high lung cancer mortality in the first year, which
was up to 70% in the SGA region. Based on model performance, a mixed distribution was con-
sidered assuming to be fixed for the first year and was modelled based on a Weibull distribution
for the years 25.
A single model was used for the estimation of survival distributions and back-calculation formu-
lations. Observed age- and gender-specific death counts xt in year t were assumed to follow a
Poisson or negative binomial distribution with parameter µx,t.
xt ∼ Pois(µx,t) or xt ∼ NegBin(px,t, rx) (5.2)
where px,t = rx/(rx + µ˜x,t). Mortality was linked to survival probabilities βi via the following
relation:
µx,t =
5∑
i=1
βiµI,t−i (5.3)
The survival function βi for year i is estimated by the difference of the failure probability in year
i and i− 1 as follows:
βi = exp(−λ(i− 1)a)− exp(−λia) (5.4)
where λ and a are the scale and shape parameters of the Weibull distribution defined by the
survival function as follows:
S(i) = exp(−λia) (5.5)
A gamma prior distribution was considered for the shape parameter with shape parameter equal
to zero and a scale parameter equal to 0.0001.
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The autoregressive prior formulation of the incidence allows the estimation of a smooth curve
over time. In addition, unstructured random effects were included in the regression formulation
to capture temporal variation.
µI,t = µI,t−1 ∗ t (5.6)
A gamma process was assumed for the random effects, to ensure estimation of positive incidence
and to allow for skewness.
As lung cancer survival is known to be very low, the maximal time of survival was restricted to
be 5 years following Mezzetti and Robertson (1999).
The model goodness of fit was assessed by comparing model-based estimates and observed in-
cidence of the SGA region using the mean square errors. The model subsequently was used to
obtain age- and gender-specific incidence estimates at cantonal level from mortality data extracted
from the FSO database, assuming the same survival among all cantons.
Difference in cancer death records from certificates and those reported from cancer registries have
been discussed in literature (Burnett and Dosemeci, 1994; Freedman et al., 2006). Miss- reported
cause-of death on the death certificates sent to FSO are the main sources of this discrepancy.
We calculated the proportion of under-reporting by comparing mortality data by FSO with those
from SGA cancer registry. We then applied the back-calculation to relate lung cancer survival
distributions with FSO mortality data, adjusted for the proportion of under-reporting.
The above model was employed to produce country-wide smooth maps of lung cancer SIR at the
level of ms-region for the period 20052009. In particular, conditional autoregressive (CAR) mod-
els (Besag et al., 1991; Bernardinelli and Montomoli, 1992) were applied on incidence estimated
from the back-calculation model using population data of 2010 to convert to SIR. This quantity
relates the estimated incidence rate in a region to the one expected based on the national average.
An SIR of 1.0 indicates same incidence as observed for the whole country. CAR models took
into account spatial variation by introducing a random effect φj at ms-region level j, which was
assumed to follow a conditional autoregressive prior distribution.
φj | φ−j ∼ N (
N∑
q=1
q 6=j
cjqφq
wj
,
σ2
wj
) (5.7)
where φ−j = (φ1, . . . , φj−1, φj+1, . . . , φN ) and cjq is the degree of spatial influence of ms-region j
to the remaining ones. cjq is equal to 1 if they are adjacent and 0 otherwise. The wj indicates
the number of neighbours of ms-region j. Final estimated rates were mapped within the software
ArcGIS.
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Figure 5.1: Observed and fitted age- and gender-specific survival in the SGA region in
19801985.
5.3 Results
Exploratory analysis using the log-rank test indicated significant differences between groups de-
fined by age category, gender and period. Fitted and observed curves suggest a good fitting based
on the mixed Weibull distribution for all periods (results shown only for the first period). Figure
5.1 indicates lower lung cancer survival of the older age group for both genders. The curves are
dominated by the very low 1- and 2-year survival.
Figure 5.2 displays yearly observed and model-based gender-specific incidence for the SGA region
during 19802010. Estimated incidence resembles the observed trends and indicates good model
predictive performance. Lung cancer incidence for males remains stable within the range around
120180 cases per year. Female lung cancer incidence data increased from around 20 cases per
year in 1980 up to more than 80 counts in 2009.
Table 5.1 shows our model-based and reported (FSO) incidence estimates aggregated to German-
and French/Italian-speaking region for the period 20052009. Estimates from the FSO are based
on extrapolation of observed incidence to those cantons that are not covered by cancer registries.
Incidence estimates based on mortality non-adjusted for the proportion of miss-specified cause
of death are around 1020% lower than the incidence reported by the FSO by language region.
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Figure 5.2: Observed and estimated incidence (with 95% Bayesian credible interval (BCI),
dotted lines) for males (left) and females (right) in the SGA region from 19802010.
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FSO Model-based Model-based adjusted
German
M 1666 1 503 (1 461;1 543) 1 648 (1 606;1 691)
F 937 758 (725;790) 838 (802;873)
French/Italian
M 794 690 (663;720) 756 (723;783)
F 443 372 (351;398) 413 (390;438)
Table 5.1: Lung cancer incidence estimates based on extrapolation reported by the FSO
and our model-based median (with 95% BCI in brackets) for males (M) and females (F) in
the German- and French/Italian-speaking in 20052009.
Estimates based on adjusted mortality indicated good predictive performance, with exception
the estimates for females for the German-speaking part, which was estimated to be around 10%
lower than the reported one based on extrapolation by the FSO. Evaluation of the model-based
incidence estimates at cantonal level is limited due to missing data. Estimates published by the
National Institute for Cancer Epidemiology and Registration (NICER) are compared with esti-
mated incidence. Table 5.2 shows published lung cancer incidence and our model-based estimates
(based on adjusted mortality) for each gender by canton.
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Results confirm a good model predictive performance capturing well the temporal trends. The
only exceptions however were estimates for Fribourg during 20052009 and Ticino during 1994
1998 which were higher than the actual number of reported cases.
Tables 5.3 and 5.4 show model-based incidence at cantonal level for the periods 19901994, 1995
1999, 20002004 and 20052009. Age group-specific estimates are presented in the Appendix.
1Estimates were retrieved from the corresponding publication of Statistics of Cancer Incidence from
NICER (National Institute for Cancer Epidemiology and Registration & Federal Statistical Office, 2012;
National Institute for Cancer Epidemiology and Registration, 2011a; Foundation National Institute for
Cancer Epidemiology and Registration, 2012; Ceschi et al., 2009; Observatoire valaisan de la santé, 2005;
National Institute for Cancer Epidemiology and Registration, 2011b,c,d)
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(a) (b)
Figure 5.3: Model-based estimates of age standardized incidence ratio for males (a) and
females (b) in Switzerland during 20052009.
Figure 5.3 shows estimated lung cancer SIR for both gender at ms-region level during the
period 20052009. For males, a rather homogenous distribution was obtained. Highest incidence
was shown in the French-(west) and Italian-(south) speaking part of Switzerland. Female lung
cancer incidence estimates were higher in urbanized regions, i. e. Basel and Zurich.
5.4 Discussion
In this study, Bayesian back-calculation models were developed to estimate age- and gender-
specific lung cancer incidence at different geographical levels. Observed mortality data was linked
with estimated survival functions to approximate the incidence counts. Model goodness of fit was
assessed by comparing observed with estimated incidence for the SGA region, an area admin-
istrated by a cancer registry covering the three cantons St.Gallen, Appenzell Innerrhoden and
Appenzell Ausserroden.
Back-calculation models were applied to estimate age- and gender-specific incidence for all cantons
from 19852009, assuming a constant survival across the country. Mortality data from the FSO
were adjusted according to the missed proportion of lung cancer deaths in the FSO mortality
database. Bayesian spatial count regression models were formulated on the incidence estimates
to create smooth maps of SIR covering the whole country at ms-region level.
Comparison of the observed with the estimated incidence counts for the SGA region indicated a
good predictive performance of the formulated back-calculation models. As shown in Figure 5.2,
5.4 Discussion 89
variation of observed incidence for both, males and females, for the SGA region was covered by
the estimated cases.
Preliminary analysis highlighted differences in survival by gender, age as well as calendar time.
This finding coincides with the report of Bordoni et al. (2012) who analysed Swiss lung cancer sur-
vival in 19951999 and 20052009. The authors reported nationwide period- and gender-specific
survival estimates, which correspond to our results. Therefore, assuming a constant survival for
the whole country based on those estimated in the SGA area appears to be valid.
Mezzetti and Robertson (1999) followed a similar methodology to obtain model-based nationwide
lung cancer incidence estimates in France. Data was aggregated by age at national level. They
did account for age-specific survival distributions, but did not assess gender-differences. Results
of our preliminary analysis indicated a significant difference in gender-specific lung cancer survival
in Switzerland. Furthermore, the authors reported constant survival over time, which was not
confirmed in our analysis. However, their analysis covered the period from 1950 up to 1990, while
our study time was 19802010. The authors pointed out that individual-based survival analysis
might improve the estimation and that uncertainty should be taken into account. In our study,
survival time was assessed at individual level and a single model formulation, covering estimation
of survival and incidence, allowed to taking into account the uncertainty driven by the estimation
of the survival function within the back-calculation process.
The model formulation of Mezzetti and Robertson (1999) considered i) the Normal approxima-
tion of the Poisson distribution to model mortality counts, ii) known survival probabilities in the
back-calculation estimated via maximum likelihood in a preliminary analysis and iii) positively
restricted Normal prior distribution on the incidence parameter. We were not able to apply the
above approach because our analysis was carried out at a lower geographical level, reporting small
numbers of deaths. In our setting, Normal prior distribution on the incidence parameters was not
appropriate because of the low number of incidence cases, resulting in a skewed distribution.
Colonna et al. (1999) considered the incidence-mortality ratio (IMR) to estimate incidence from
mortality.This approach assumes a constant IMR, estimated from regions with both sources of
data. In France, only 10% of the population is covered by cancer registries. The authors applied
the above method to study the geographical trend and variation of breast and colorectal cancer.
Validation of the estimates based on adjusted mortality data at national and cantonal level demon-
strated good model performance. However, a few discrepancies have been obtained as for example
for the canton Fribourg and Ticino during the last and first period, respectively.
Limitations of death certificates, such as incompleteness and lack of accuracy, are known and have
been discussed (Burnett and Dosemeci, 1994; Freedman et al., 2006). In 2009, Bedford (2009)
assessed the utility of death certificate data in predicting cancer incidence in Iowa. Lung cancer
was concluded to be useful for this approach, as 75% or more of the incidence cases recorded at
the cancer registry were captured by the underlying cause of death.
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Our analysis assumed that i) the proportion of miss-specified lung cancer deaths in the FSO mor-
tality database and ii) the survival distribution were the same for all cantons. Both have been
estimated using data from the SGA cancer registry. Data from other cantonal cancer registries
would allow us to assess the above assumptions and potentially improve the estimation of inci-
dence for cantons with limited data.
In conclusion, the proposed back-calculation models improved earlier methodology and provided
age- and gender-specific estimates of lung cancer incidence at cantonal level. Besides estimates for
cantons without cancer registries, our results cover years for which cancer registries did not exist.
In addition, smooth, gender-specific SIR maps highlight spatial patterns of the disease during
20052009.
Acknowledgements
This work was supported by Oncosuisse [grant number KLS-02393-02-2009] and the Swiss National
Science Foundation [grant number 32003B_135769]. We would like to thank the Swiss Federal
Statistical Office for providing the data.
5.5 Appendix 91
5.5 Appendix
Cantonal abbreviations
Zurich (ZH), Bern (BE), Lucerne (LU), Uri (UR), Schwyz (SZ), Obwalden (OW), Nidwalden
(NW), Glarus (GL), Zug (ZG), Fribourg (FR), Solothurn (SO), Basel-Stadt (BS), Basel-Landschaft
(BL), Schaffhausen (SH), Appenzell Ausserrhoden (AR), Appenzell Innerrhoden (AI), St. Gallen
(SG), Graubünden (GR), Aargau (AG), Thurgau (TG), Ticino (TI). Vaud (VD), Valais (VS),
Neuchaˆtel (NE), Geneva (GE), Jura (JU).
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Abstract
Background Smoking is the leading cause of lung cancer. Besides the consumption of tobacco,
other (non-smoking) factors, such as radon and air pollution, have been associated with lung
cancer mortality. Information on tobacco-use is sparse in Switzerland and existing survey data
are not sufficient to assess space-time patterns of smoking behaviour. Knowledge about the dis-
tribution of tobacco use and the attributable number of deaths is essential in order to estimate
its contribution to lung cancer burden.
The study aims to assess whether lung cancer mortality adjusted for non-smoking risk factors can
be used as a proxy of smoking patterns in Switzerland.
Bayesian conditional autoregressive (CAR) logistic regression models have been applied on smok-
ing data from a national survey of 1992 to estimate spatial patterns of gender-specific frequency of
smokers. Negative binomial regression models with CAR spatial random effects (SREs) have been
employed on lung cancer mortality data of 20082010 to obtain smoking proxies based on smooth
mortality rates and SREs adjusted for radon and air pollution exposures (PM10 and NO2). As-
sociation between the spatial patterns of smoking prevalence with the estimated smoking proxies
was assessed graphically as well as by quantifying the magnitude of association via the Kendall's
τb and logistic regression. Population attributable fractions due to smoking were estimated by age
and gender to assess the burden of tobacco-use on lung cancer mortality in Switzerland.
There is a moderate correlation between observed smoking prevalence with smoking proxies. The
correlation is stronger in females. This study showed that smooth lung cancer mortality rates,
unadjusted for non-smoking risk factors, is a better proxy than the adjusted SREs.
In the absence of sufficient smoking survey data, the proposed indirect proxy can be used to assess
spatio-temporal smoking patterns in Switzerland.
Keywords: Bayesian inference; smoking prevalence; lung cancer mortality; Switzerland
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6.1 Introduction
Smoking is a well-known predominant risk factor of lung cancer. In the middle of the 20th cen-
tury a causal relation was confirmed by the findings of case-control and cohort studies (Armero
et al., 2012). Several subsequent studies assessed the influence of tobacco-consumption on several
diseases such as various cancer sites, cardiovascular and heart diseases. In 1964, the Surgeon Gen-
eral's committee of the United States published its first report on the effects of smoking on health
(United States Public Health Service, 1964), giving definitive evidence about the risk caused by
smoking, followed by counterattacks from the tobacco industry. In the 20th century the number
of deaths due to tobacco use worldwide was estimated to be around 100 million and predicted
to increase up to 1 billion deaths during the following century (WHO, 2008). Besides direct
tobacco-consumption, passive smoking has been confirmed to be a risk factor of the disease. First
investigations on this relation have been considered in the early '80s (Trichopoulos et al., 1981).
The leading non-smoking, environmental lung cancer risk factor is exposure to radon (Federal Of-
fice of Public Health, 2012b), which is a radioactive gas, occurring in nature. In Europe, around
9% of lung cancer mortality and 2% of all cancer deaths are caused by radon exposure in the home.
The risk for smokers or recent ex-smokers has been estimated to be notably greater than for life-
time non-smokers (Darby et al., 2005). The spatial distribution of radon depends on the geology
of the country, as it can be mainly found in rocks and soil. The level of exposure is related to the
source of material, where the gas is released. The Swiss Federal Office of Public Health has carried
out a survey on indoor radon measurements over the last 20 years. The study covered more than
70 000 units and aimed to identify houses with high indoor radon concentrations. In Switzerland
the average indoor radon concentration is 78 Bq/m3. Based on these figures, Menzler et al. (2008)
determined the population attributable fraction (PAF) for lung cancer due to residential radon.
They reported a PAF of 8.3% for the Swiss population. One hundred and sixty-nine male and
62 female lung cancer deaths per year can be attributed to residential radon. Overall, more than
90% of these cases are in smokers. The authors emphasized the large spatial variation in the PAF,
determined by cantonal discrepancies of radon concentrations and population structure.
Another risk factor for lung cancer is air pollution. While in the United States evidence of positive
association of air pollution and lung cancer based on cohort studies has already been published
in 1993 (Dockery et al., 1993), results of European long-term exposure cohort studies have been
reported in 2000. The authors of a Dutch study concluded air pollution to be a potential risk
factor (Hoek et al., 2002). Results of a Norwegian study in 2003 indicated a significant increase
risk of lung cancer in NOx exposure (Nafstad et al., 2003).
Nevertheless, smoking is the main risk factor of cancer related to the lung. Identifying high risk
regions and analysing site-specific risk factors to improve intervention planning are the elementary
steps for the reduction of tobacco-related diseases.
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Data on smoking patterns in Switzerland are sparse. Only few surveys have been carried out to
collect data on smoking behaviour among the Swiss population. There is no study about trends
of tobacco-consumption covering the whole country. Smoking survey data are available for the
last two decades, but they cannot be used for a long-term analysis, due to the time lag between
consumption/exposure to tobacco and the outbreak of lung cancer which is 2030 years.
Tobacco Monitoring Switzerland, a survey of tobacco consumption among those aged 1465, was
initiated at the University of Zurich in 2001. These are telephone surveys, collecting smoking data
four times a year and covering around 2 500 participants each. The data however cannot provide
useful information for assessing the effect of smoking behaviour 2030 years ago on current lung
cancer mortality data. Another source is the Swiss Health Survey conducted every five years since
1992, providing different information on smoking, e. g. number of cigarettes per day, duration of
smoking in years and the number of smokers out of those surveyed.
Patterns of tobacco consumption, the leading cause of lung cancer mortality, are driven by numer-
ous indicators. One factor is the cultural behaviour of a population. In Switzerland, a possible
cultural classification is the language region. The country is splitted into four linguistic areas 
following the order of the cardinal directions starting in the northern part, one can describe the
partition as German, Romansh, Italian and French. However, the German and French parts cover
the main part of the Swiss population. Another characteristic is the level of urbanization of a
region, which is driven by the population density.
In this study, we studied spatial patterns of gender-specific frequency of smokers in Switzerland.
Moreover, we assessed whether lung cancer mortality unadjusted and adjusted for non-smoking
risk factors can be used as a proxy of smoking patterns in Switzerland. Population attributable
fractions due to smoking were estimated by age and gender to quantify the burden of tobacco-use
on lung cancer mortality in the country.
6.2 Materials and methods
6.2.1 Data
Mortality data at municipality level were acquired from the Swiss Federal Statistical Office (FSO).
Data were aggregated by ms-region (ms = mobilité spatiale) for the three most recent available
years (20082010). This geographical unit divides Switzerland into 106 regions which are often
used for scientific analyses (Federal Statistical Office, 2013c). Population data of the census 2010
were retrieved from the FSO. Digital maps of municipalities were provided by the FSO for the
year 2009. They were modified within the software ArcGIS to obtain the boarder structure of
the ms-regions. The population density of each ms-region was calculated and used to classify
6.3 Methods 101
it as urban or rural, following the definition of the OECD1 (Schrader, 1997), i. e. an ms-region
was classified as rural if the density was less than 150 people per square kilometre. Language
information at the ms-region level was obtained from the FSO.
Data on radon, categorising the exposure risk in four groups, were provided from the Swiss Federal
Office of Public Health. The data are available during 20002011, however data after 2008 were
ensured to be error-free and used for this analysis. Yearly gridded surfaces of Particulate Matter
of 10 (PM10) and Nitrogen Dioxide (NO2) at 200m by 200m spatial resolution were provided by
Meteotest and used as indicators of air pollution. The data are available since 1990 for NO2 and
1998 for PM10 and allow for a 2030 years time lag between the exposure and the disease. Data
on radon, PM10 and NO2 were aggregated at ms-region level by their mean exposure.
Data on smoking behaviour were provided from the Swiss Health Survey conducted in 1992. This
is a nationwide population-based telephone survey carried out by the FSO and covered 14 521
participants. Several information were recorded such as the frequency of smokers (number of
smokers and surveyed) and frequency of the number of cigarettes and years smoked (both by
categories and summarized by median). However, only the number of smokers and those surveyed
has been considered for this analysis based on preliminary analysis.
6.3 Methods
Estimating spatial patterns of smoking prevalence
Bayesian spatial logistic regression models were applied to analyse gender-specific smoking preva-
lence pi (i = 1, . . . ,m) in 1992, adjusted for the covariates Xi to assess differences of smoking
behaviour by language region and urbanization level.
logit(pi) = α+X
T
i β + φi (6.1)
where α is the intercept and β is the vector of the regression coefficients. Spatial random effects
(SREs) φi were included in the model to account for spatial correlation at ms-region level, which
were assumed to follow a Conditional Autoregressive Gaussian (CAR) distribution (Besag et al.,
1991; Bernardinelli and Montomoli, 1992) as follows:
φi | φ−i ∼ N (
N∑
q=1
q 6=i
ciqφq
wi
,
σ2
wi
) (6.2)
where φ−i = (φ1, . . . , φi−1, φi+1, . . . , φN ). The degree of spatial dependency of ms-region i to the
remaining ones is indicated by ciq, taking the value 1 if they are adjacent and 0 otherwise. wi
1Organisation for economic co-operation and development
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represents the number of neighbours of ms-region i. Following a Bayesian model specification,
prior distributions were assigned to the unknown parameters. Vague normal prior distributions
were considered for the coefficients.
Estimating proxies of spatial smoking patterns based on lung cancer mortality
Bayesian negative binomial regression models with spatial CAR random effects were fitted to
model gender-specific lung cancer mortality unadjusted and adjusted for non-smoking risk factors
(exposure to radon, PM10 and NO2). The spatial distribution of radon was assumed to be constant
over time and therefore data of 2008 were considered representative of radon exposure over the
last decades. This appears to be a valid assumption, as its occurrence is in rocks and soil where it
is stored for long periods. In addition, random effects φi were included in the model to account for
spatial correlation at ms-region level. Covariate effects (radon, PM10and NO2) β were modelled
on the log mean of lung cancer death counts µi, using the gender-specific population ni of the
corresponding ms-region i as the offset.
log(µi) = log(ni) + α+X
T
i β + φi (6.3)
We assessed whether lung cancer mortality unadjusted for non-smoking risk factors fit the ob-
served smoking behaviour data. Furthermore, we investigated the hypothesis that the SRE from
the adjusted regression model can serve as an indirect proxy for smoking patterns. The SRE
captures spatial patterns unexplained by the risk factors implemented as covariates in the regres-
sion model(Law and Ping, 2011), therefore, the spatial distribution of the SRE is expected to be
similar to the one of the smoking-related factors which were not included in the regression model.
Validating smoking proxies
The goodness of fit between the mortality rates and SREs adjusted for non-smoking risk factors
with the smoking prevalence was determined: (i) graphically, by comparing the smooth maps of
model-based estimates of smoking prevalence with estimates of adjusted lung cancer mortality
rates and SREs; (ii) by estimating Kendall's τb correlation coefficients and applying a logistic
regression model on the smoking data from the Swiss Health Survey to assess the magnitude of
association between the different proxies and the smoking prevalence.
Estimating PAF of tobacco use on lung cancer mortality
The number of lung cancer cases due to smoking was quantified following the approach of Parkin
(2011). The author estimated the tobacco-attributable cancer burden in the UK in 2010. Re-
garding lung cancer, estimation of incidence in never-smokers was based on the American Cancer
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Society's second Cancer Prevention Study (CPS II, (Thun et al., 2006)) and the attributable
fraction of lung cancer was given by
PAF = (O − E)/O (6.4)
where O is the number of overall lung cancer deaths and E is the expected number of lung cancer
deaths in never-smokers. This approach is referring to the method developed by Peto et al. (1992)
and assumes that the lung cancer deaths exceeding the number expected in never-smokers, is due
to smoking. Age- and gender-specific lung cancer rates in never-smokers were applied to the Swiss
population under consideration to calculate those lung cancer cases expected in a non-smoking
population. The number of lung cancer cases due to smoking was directly estimated by subtracting
the expected cases from those observed in Switzerland in 2010. High PAFs would support the
hypothesis that lung cancer mortality can be used as a proxy for smoking.
Preliminary analyses were carried out in Stata/IC 12 (Stata Corporation; College Station TX,
USA) and Bayesian models were fitted in using WinBUGS (Imperial College and MRC, London,
UK).
6.4 Results
Estimating spatial patterns of smoker frequency
Logistic regression estimates on gender-specific frequency of smokers are provided in Table 6.1.
The odds of smoking were significantly higher in the French-speaking region compared to the
German-speaking one for both genders (higher by 24% for males and 39% females). No significant
differences were observed in the odds of smoking between the Italian- and Romansh-speaking
compared to the German-speaking one. Results indicated a significant increase of 27% for fe-
male smoking odds in urbanized ms-regions. Figure 6.1 illustrates the spatial distribution of the
environmental covariates, i. e. radon risk, PM10 and NO2 (annual means). Higher risk of radon
exposure was found in the south-eastern and western part of the country, defined by the Alps
and the Jura Mountains. Spatial patterns of PM10 and NO2 are rather similar, characterized by
hotspots in the urbanized regions Basel, Zurich, Geneva and Lugano. In particular, the Swiss
midland is dominated by high levels of PM10, due to the main roads in this region, as road traffic
is one of the major sources of particulates.
Figure 6.2 shows model-based smooth gender-specific smoking prevalence in 1992 adjusted for
language region and urbanization level. The maps show higher male smoking prevalence in the
French- and Italian-speaking regions. For females, the map is dominated by high estimates in
the urban regions as well the French-speaking part. For both genders, the estimated smoking
prevalence did not exceed 42%.
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OR (95% BCI)
Males Females
Language
German 1.00 1.00
French 1.24 (1.05;1.47) 1.39 (1.17;1.65)
Italian 1.26 (0.97;1.67) 1.18 (0.88;1.57)
Romansh 1.12 (0.63;1.96) 1.35 (0.73;2.28)
Urbanization level
Rural 1.00 1.00
Urban 1.08 (0.92;1.27) 1.27 (1.08;1.49)
Table 6.1: Logistic regression parameter estimates for the gender-specific frequency of smok-
ers in Switzerland in 1992 (with 95% Bayesian credible interval (BCI)).
Figure 6.1: Spatial distribution of the environmental risk factors radon (in 2008), PM10 (in
1998) and NO2 (in 1990).
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(a) (b)
Figure 6.2: Model-based smooth smoking prevalence (%) for males (a) and females (b) in
Switzerland in 1992.
Validating smoking proxies
Gender-specific maps of unadjusted smooth mortality rates and SREs (derived from the adjusted
negative binomial regression) are given in Figures 6.3 and 6.4. For validation purposes, the spatial
patterns of gender-specific smoking prevalence are presented and estimates are standardized (by
subtracting the mean and dividing by the standard deviation) to achieve a common scale for all
maps.
Resulting maps for males indicate a good approximation of smoking prevalence by the SRE and
the unadjusted mortality rate (see Fig. 6.3). Clustered regions with high frequency of smokers
are captured by both proxies, however, the mortality rate overestimated smoking frequency in the
alpine region. On the other hand, maps of the SRE indicate an overestimation around Zurich and
underestimation in the south-western part of Switzerland. Logistic regression results provided
in Table 6.2 confirm a better association of the smoking prevalence with the unadjusted smooth
mortality rates than the SREs, however, estimated OR are important for both proxies. Kendall's
τb indicates a rather moderate association (0.43 and 0.55 for males and females, respectively).
Similarly to males, maps of indirect smoking proxies for females suggest that the unadjusted
smooth mortality rate is a better proxy (see Fig. 6.4). Logistic regression estimates provide
a higher OR for the mortality rates, compared to the SREs, while the Kendall's τb indicate a
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(a) Smoking prevalence
(b) Unadjusted mortality rate (c) Adjusted SRE
Figure 6.3: Model-based estimates of smoking prevalence, lung cancer mortality rates and
SREs for males.
moderate positive correlation for both proxies.
Estimating PAF of tobacco use on lung cancer mortality
Excess lung cancer mortality attributable to smoking by age group together with observed and
expected cases is presented in Table 6.3. For males, the highest PAF (88%) was observed for those
aged 5569, while a peak of 80% was obtained for females aged 5559. The overall PAF was 85%
and 69% for males and females, respectively. The estimates are based on the assumption that the
lung cancer mortality rates among non-smokers in Switzerland in 2010 are the same as those of
the US CPS II(Thun et al., 1997) in the '80s.
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(a) Smoking prevalence
(b) Unadjusted mortality rate (c) Adjusted SRE
Figure 6.4: Model-based estimates of smoking prevalence, lung cancer mortality rates and
SREs for females.
OR (95% BCI) DIC τb
Mortality rate (unadj) 2.8 (1.4;6.6) 16.6 (5.9;74.9) 1362.4 1248.5 0.43* 0.55*
SRE 2.1 (1.4;3.7) 2.8 (2.0;4.6) 1352.3 1248.1 0.45* 0.56*
Table 6.2: Logistic regression parameter estimates, DIC and Kendall's τb for adjusted fre-
quency of smokers in Switzerland in 1992 for males and females (grey).
∗p<0.001
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Observed Expected Excess PAF (%)
Age cases cases attributable
(years) cases
3539 13 7 13 17 0 0 0 0
4044 59 45 22 28 37 18 63 39
4549 140 102 34 40 105 63 75 61
5054 288 180 47 50 241 131 84 73
5559 496 314 62 63 434 251 88 80
6064 765 420 90 87 675 333 88 79
6569 1 017 460 118 110 899 350 88 76
7074 970 431 132 127 837 304 86 71
7579 1 031 469 163 163 868 307 84 65
8084 791 378 171 190 620 188 78 50
Total 5 564 2 812 854 872 4 716 1 943 85 69
Table 6.3: Age-specific observed/expected lung cancer deaths and its population attributable
cases/fraction due to smoking in 20082010 for males and females (grey).
6.5 Discussion
In this work, we aimed to assess whether lung cancer mortality rates unadjusted and adjusted for
environmental risk factors (i. e. radon and air pollution) can be used to indirectly approximate
gender-specific smoking patterns in space. Two proxies were estimated from negative binomial
models, a smooth mortality rate unadjusted for non-smoking risk factors and regression-adjusted
SREs. Moreover, we applied Bayesian spatial logistic regression models on survey data and pro-
vided nationwide model-based maps of smoking prevalence in 1992 for males and females. To
quantify the burden of tobacco use on lung cancer, population attributable fractions due to smok-
ing were estimated during the period 20082010.
Based on graphical and numerical validation of the two smoking proxies, we obtained moderate
association between smoking prevalence with mortality rate and SRE, which was stronger for
females. Mortality rates performed better in approximating smoking patterns than SREs. Resid-
uals of the gender-specific lung cancer adjusted mortality have been also estimated and tested
regarding their ability to approximate smoking prevalence patterns. Results indicated no associ-
ation (Kendall's τb of 0.16 and 0.15 for males and females, respectively).
Chellini et al. (2006) used female lung cancer mortality trends in central Italy from 19872002
as an indicator of female smoking trends. They reported higher female lung cancer mortality in
urbanized regions, which is consistent with findings in Switzerland. The authors estimated yearly
per cent change in overall age-standardized lung cancer mortality rates of 24.5% in the urban and
17.2% in the rural Italian areas. Their findings also suggested that female smoking prevalence
increased during the last decades.
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Frequency of smoking by language region and urbanization level coincides with findings of gender-
specific lung cancer mortality, which was found to be higher in urban regions for females. For
males a rather homogeneous distribution of the disease was seen.
The smoking data used in this study were provided from the Swiss Health Survey of 1992. These
data cover different information on smoking, e. g. number of cigarettes per day, duration of smok-
ing in years and the number of smokers out of those surveyed. Preliminary analysis of the data
indicated only association of the latter with lung cancer mortality, which was then used for the
analysis described in this work.
The geographical coverage of the Swiss Health Survey of 1992 is incomplete. This might explain
some associations, which were expected to be stronger, as for example the moderate correlation
between lung cancer mortality rate and smoking prevalence.
The estimation of the PAF is based on the assumption that the lung cancer mortality rates among
non-smokers in Switzerland in 2010 are the same as those of the US CPS II (Thun et al., 1997)
in the '80s. This assumption is based on previous studies showing that lung cancer mortality in
never smokers did not change over time (Thun et al., 2008; Samet et al., 2009) and that the fig-
ures observed within the US CPS II study are representative of those in other developed countries
(Peto et al., 1992).
Availability of smoking data in the country is rather limited. Data on non-smoking factors are also
sparse for early years. For radon, information of good quality was obtained for the year 2008. We
assumed that the spatial distribution and exposure to radon is constant over the last decades and
we related mortality in 20082010 with radon exposure in the same year. Countrywide surfaces for
air pollution indicators, such as NO2, are already available yearly from 1990 onwards. Therefore,
a time gap of around 20 years can be considered between mortality and exposure. However, lack
of data at high-resolution introduces limitation to the study. For example information on PM10
exists only since 1998.
Smoking ranks the first cause of lung cancer followed by radon exposure (Federal Office of Public
Health, 2012b). The lung cancer risk associated with radon exposure is higher for smokers than
for non-smokers (Federal Office of Public Health, 2011). However, preliminary analysis did not
indicate any interaction between radon and smoking prevalence, which might be due to the in-
completeness of the smoking data.
In this study, we developed and assessed different smoking proxies with high spatial and temporal
resolution. Our approach enables to indirectly estimate smoking patterns from observed lung
cancer mortality. These estimates allow studying gender- and age-specific geographical patterns
and time trends of smoking at a sub-regional scale. In addition, they can be used to assess the
contribution of smoking on the burden of other cancer types or diseases such as cardiovascular or
respiratory ones.
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This PhD thesis contributes to the field of tobacco-related cancer epidemiology with statistical
methodology and epidemiological knowledge on spatio-temporal patterns of cancer mortality and
incidence in Switzerland. The main contributions of the research are (i) improved statistical
models for projecting cancer mortality. These models allow forecasting of sparse count data; (ii)
improved statistical models for estimating tobacco-related incidence from mortality data. These
models enable estimation of incidence rates of the disease in the parts of the population which are
not covered by cancer registries; (iii) smooth maps of gender-, age- and site-specific patterns of
lung and other tobacco-related cancer mortality over time. These maps identify discrepancies of
disease burden and assist implementation and evaluation of the National Programme Tobacco; (iv)
a better insight into the differences in tobacco-related cancer mortality rates between linguistic
regions and urbanisation by gender; (v) smooth maps of gender-specific patterns of lung cancer
incidence for a recent period; (vi) estimates of the geographical patterns of tobacco-related cancer
mortality for the next 10 years: this information is useful for planning purposes such as resource
allocation and costing of medical supplies for diagnosis and treatment; (vii) smooth maps of lung
cancer mortality adjusted for non-smoking risk factors which allow to find a good proxy of smoking
behaviour in order to study gender-specific geographical patterns of smoking in Switzerland from
limited smoking surveys.
The methods, modelling approaches and results are discussed and presented in five manuscripts
included as chapters in this thesis. Each chapter of the thesis provides a detailed discussion. This
section gives an overview about the main findings of each piece of work, its limitations, impact
and an outlook covering open issues and potential future directions.
7.1 Significance
7.1.1 Spatio-temporal modelling of cancer data
Age-period-cohort (APC) analysis is an established method for predicting disease future burden.
The most commonly used models for cancer projections are the Power model (implemented within
the R software package Nordpred) (Møller et al., 2003) and the Bayesian APC-model which is
based on a log-link function (Bray, 2002). In Chapter 4 we address limitations of the above models
by developing the Bayesian power model. This is the first model applying a link-function other
than the log-link within the Bayesian framework and therefore expands the options for modelling
cancer data. The model overcomes extreme estimation of rates arising from the log-link function
and benefits from the Bayesian framework, which smooths among the subgroups of age, period
and cohort. Furthermore, our model allows the inclusion of covariates into the regression model
(e. g. information on tobacco-consumption), which can improve estimation of future cases of lung
cancer and incorporates random effects to take into account spatial variation. We further de-
veloped the Bayesian power model to a generalized analogue with a random power parameter
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estimated by the data under consideration. The improvement of our models over the existing
ones in forecasting cancer mortality rates are shown in Chapter 4, where the different modelling
approaches are compared on Swiss lung cancer mortality data.
The model developed in Chapter 5 contributes to the methodology of back-calculating cancer
incidence from observed mortality data. A single-model formulation estimates age-, gender-
and period-specific survival distributions and incidence by combining survival parameters with
observed subgroup-specific mortality via back-calculation. This combined approach allows the
uncertainty of the survival curve estimation to be taken into account in the back-calculation. Fur-
thermore, model formulations can be easily adjusted for risk factors by including covariates. Our
methodology overcomes limitations of the widely used MIAMOD (Mortality-Incidence Analysis
Model) software (Angelis et al., 1994), which models cancer incidence based on a maximum like-
lihood regression and cannot consider analysis-specific covariates. Moreover, the latter assumes
survival to be known input data.
Our back-calculation model assumes gamma prior distributions for the incidence parameters. This
is a more appropriate choice than the previously used normal distributions (Mezzetti and Robert-
son, 1999), as it allows for a skewed distribution of the incidence, which is common for rare cancer
sites or analyses at a subregional level.
7.1.2 Tobacco-related cancer spatial epidemiology in Switzerland
It is well known that tobacco accounts for the majority of global morbidity and mortality. Among
others, it is the main risk factor for several cancer sites, in particular for cancer of the lung.
Although consequences of smoking have been observed and defined since decades, yet a high
proportion of the population consumes tobacco. While in the first half of the last century its
consumers were mainly males, female smoking has developed in the second half, mainly as a side-
effect of the emancipation. A further trend arose when the tobacco industry targeted another
audience, which was teenagers.
During the last decade, cancer mapping has become the state-of-art in assessing spatial patterns
of the disease burden. A map, illustrating the spatial distribution of the cancer, gives a clear
overview of the disease and is rather intuitive, as endemic areas are highlighted and can be easily
identified, while numbers might not be that easily understood. Cancer maps of crude rates can
be misleading and non-informative since estimates from areas with small population may domi-
nate the map resulting in high variability. Estimates based on Bayesian spatial models highlight
spatial patterns by smoothing the rates, taking into account the neighbouring structure of the
areas. Furthermore, these models can adjust for risk factors and assess their contribution taking
into account geographical correlation. Consideration of the latter is crucial, as spatial association
might be present, violating the assumption of independence. Maps at high geographical resolution
are particularly useful, as they give insights into local spatial patterns. Maps of the residuals of
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spatial regressions can indicate geographical patterns that are not explained by the risk factors
considered in the model. Cancer maps over time illustrate potential temporal trends of the dis-
ease. Cancer atlases are available for several countries, e. g. U. S., United Kingdom or Germany,
providing a collection of cancer site-specific nationwide maps.
In Switzerland, data on cancer mortality and partially cancer incidence are available. However, no
countrywide model-based cancer maps, adjusted for risk factors, exist. Schüler and Bopp (1997)
published an atlas of cancer mortality for the period 19701990, based on maps of raw data and
unadjusted analysis. Recently, Oberaigner and Vittadello (2010) presented cancer maps in the
alpine regions from 20012005. However, the maps only cover the eastern part of the country and
do not provide analysis of cancer-specific risk factors.
In this thesis, first countrywide smooth estimates of age- and gender-specific tobacco-related can-
cer mortality are provided at a high geographical resolution, introducing spatial correlation via
Bayesian Conditional Autoregressive Models (CAR) (Besag et al., 1991; Bernardinelli and Mon-
tomoli, 1992). Maps of gender-specific model-based estimates showed a contradictory temporal
trend of tobacco-related cancer mortality, decreasing for males and increasing for females. Fur-
thermore, risk factor analysis presented significant differences in gender-specific tobacco-related
cancer mortality among the Swiss language regions and level of urbanization. The latter could
easily be identified by the smooth nationwide maps, as female mortality shows high estimates in
the cities, i. e. Zurich and Basel.
In addition to estimation of tobacco-related cancer mortality this thesis provides spatio-temporal
estimates of lung cancer mortality. However, both analyses showed similar patterns.
7.1.3 Intervention planning
In Switzerland, the National Programme Tobacco 20082012 (NPT 20082012) has been launched
by the Federal Office of Public Health. The programme has been extended up to 2016. The
overall aim of the NPT is to reduce the number of tobacco-related morbidity and mortality in
the country. Among others, one strategic goal of the programme is the ratification (practical
implementation) of the WHO Framework Convention on Tobacco Control, which was signed in
2004 and defines policies regarding tobacco control at a global scale (WHO, 2013a). Results of
our risk factor analyses and the estimated maps are important for implementation and evaluation
of the NPT, as they can be used to target and intensify anti-tobacco campaigns in high priority
areas. In particular, the maps can serve as baseline ones to assess the success of the programme
implementation in the future.
Furthermore, the NPT 20082012 aims to sensitize the population and specific target groups about
the consequences of smoking (Federal Office of Public Health, 2010). Smoothed nationwide maps
of tobacco-related cancer mortality can serve as powerful tools for supporting the above strategy
of the NPT 20082012. Maps illustrating the spatial as well as temporal distribution and extent of
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the disease might increase the awareness of its burden, which in turn can increase the acceptance
of tobacco interventions in the country. Furthermore, awareness of smoking consequences may be
raised at an individual level as maps allow people to identify the area of their residence and get
information of the disease mortality in their region.
Estimates on the future trends of gender-specific tobacco-related cancer mortality might also
increase the awareness of the population. Especially for a disease like lung cancer with a time
lag of 2030 years, future predictions might be linked to recent personal behaviour. In the case
of female lung cancer, strictly increasing mortality rates could sensitize women who are currently
smoking. Those estimates are presented at national, language-region and cantonal level in Chapter
3. In addition, the latter is illustrated via maps and might support the acceptance of tobacco
control planning, in particular at cantonal level.
7.1.4 Public health
The global burden due to tobacco has been estimated to be 4.9 million deaths (8.8% of total)
worldwide and 59.1 disability life years (DALYs) (4.1% of total) in 2000 (WHO, 2013b). Ac-
cording to WHO, a continuation of the current trend will lead to an expected increase up to 10
million deaths per year in the 2020s or early 2030s, while 70% of those deaths will be in developing
countries. Future trends of a disease are important to be able to project the burden.
In Chapter 3 and 4 we quantified the future trends of age- and gender-specific cancer mortality
due to tobacco use. Trends of all tobacco-related and lung cancer mortality are presented for
each gender at different regional scale  nationwide, language-regional and cantonal. The latter
is an important administrative level in Switzerland, as many laws are not decided by the federal
institutions and therefore can be refined at cantonal level, as for example smoking ban regulations.
Estimation of the burden of a disease requires consideration of different data sources. Beside the
knowledge of how many people die from a disease, it is essential to know how many people are
actually having the disease. Temporal trends of disease-specific survival distributions, derived by
incidence and mortality data, reflect developments in treatment. Overall incidence or mortality
provide a general picture, while gender- and age-specific trends allow for detailed assessment of
interventions. In Switzerland, cancer incidence data are recorded at cancer registries, which only
covered 60.7% of the country in 20052009, mainly due to cantons in the German-speaking part.
While those cantons are establishing new registries, data are not available in the past for long-term
analyses. In Chapter 5 we presented nationwide estimates of age- and gender-specific lung cancer
incidence at cantonal level. Our results do not only give information on lung cancer incidence for
those cantons without registries, but also contribute to the data completeness of all cantons as
they cover the time period starting in 1981. At that time less than 50% of the Swiss population
was covered by registries.
Smoking is a factor describing the public health situation of a country. In Switzerland, tobacco
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use accounts for more than 9 000 deaths, which is 14% of all deaths (in 2007). Information on
the smoking behaviour of the Swiss population is sparse. The Swiss Health Survey (SHS) has
been conducted in 1992, 1997, 2002 and 2007. Smoking data of those telephone-surveys have been
analysed regarding its temporal trend (Federal Office of Public Health, 2010). However, to our
knowledge, spatial and spatio-temporal analyses of smoking behaviour have not been conducted
so far. In Chapter 6 we studied gender-specific spatial smoking patterns in Switzerland based
on survey data in 1992. Analysis of the smoking data highlighted gender-specific differences by
language regions and urbanization level, resembling gender-specific patterns of lung cancer mor-
tality presented in Chapter 2. In addition, the age- and gender-specific proportional attributable
fraction of lung cancer due to smoking in 2010 has been estimated, which quantifies the propor-
tional reduction in lung cancer mortality if the risk factor smoking would be eliminated. These
estimates quantify the impact of smoking in Switzerland.
We identified the spatial pattern of those risk factors not considered in the analysis and assessed
the hypothesis that unadjusted lung cancer mortality rates are more appropriate to serve as a
proxy of smoking patterns in space than the adjusted spatial random effects.
The tobacco epidemic in Switzerland accounts for CHF510 billion every year. On the contrary, a
yearly amount of CHF100 million is spent by the tobacco industry to advertise smoking (Lee and
Glantz, 2001). Meanwhile, many European countries introduced a law against tobacco advertise-
ment, except Germany, Switzerland and Greece. Nowadays Philip Morris and British-American
Tobacco are the leading companies controlling the Swiss tobacco market. In Switzerland, the
tobacco lobby is influential and might control interventions. It has been criticized that smoking
interventions do not take into account the actions and influence of the local tobacco lobby (Lee
and Glantz, 2001). Future control planning should consider this important factor and research
should not be driven by the interests of the tobacco industry.
7.2 Limitations
Maps of age- and gender-specific tobacco-related cancer mortality at municipality level have been
obtained for the years around the censuses, i. e. 19691972, 19791982, 19891992 and 19992002.
We did not consider mortality for the intercensual years, as population data were only provided
for the census years. By assuming no big changes in the size of the population for the years close
to the census, we pooled those years. Analysis was done for subgroups at a high geographical
scale. As the country is separated into nearly 2 700 municipalities, this resulted in many zero
counts in municipalities characterized by the subgroups. Therefore, simple linear interpolation
between two censuses was inappropriate, as several factors should be taken into consideration to
achieve realistic estimates. For example, migration plays an important role for the estimation of
population development and differs depending on the location. Municipalities close to boarders
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and big cities as Zurich might be more affected than rural areas. However, Proportional Mortality
Ratios, relating cause-specific deaths to all-cause mortality, have been estimated over the whole
time period and confirmed that no trend was missed by our period-specific analysis.
Although mortality data were available for later years, we did not consider them, as the corre-
sponding population size was missing. Also, as the analysis was done before the publication of
the census in 2010, we did not consider recent years.
The APC-models developed and applied in this thesis do not take into account environmental
and behavioural factors, i. e. smoking habits. Lung cancer morbidity and mortality are strongly
influenced by smoking trends and further information included in the model would clearly improve
the estimation of future trends of the disease burden.
Information on tobacco-consumption is rather sparse in Switzerland. The SHS has been conducted
in 1992, 1997, 2002 and 2007, which partially requested information about the smoking pattern
of the person. This information is only given for a certain part of the country.
In Chapter 5 countrywide incidence estimates were obtained at cantonal level. However, these es-
timates are based on the assumption of a constant gender- and period-specific survival distribution
and a fixed proportion of misclassification in the FSO death certificate database across cantons.
Incidence from other cancer registries would allow us to investigate on these assumptions, further
analyse the spatial distribution of survival and improve incidence estimation.
Data availability of smoking behaviour in Switzerland was limited. Data used in Chapter 6 helped
identifying risk factors and highlighted spatial patterns, however, due to limited coverage an ana-
lysis at municipality level was not feasible.
7.3 Extension of the work
Our work cannot only be improved by addressing the above limitations, but also by a number of
potential extensions. An immediate next step will be to extend this work to other cancer types
with the aim of obtaining an up-to-date cancer atlas providing a complete overview of the burden
of all cancer sites in Switzerland indicated by nationwide maps, future predictions of the number
of cases and contribution of risk-factors. In fact, built on this work, methods are currently applied
within a new project at the Swiss Tropical and Public Health Institute looking at gender-specific
cancer in Switzerland. Furthermore, we plan to apply the developed models to other chronic
diseases in Switzerland in order to analyse spatio-temporal patterns and project disease future
trends.
To overcome the lack of intercensual population counts, Bayesian migration models will be de-
veloped to allow for estimation of the number of men and women at a certain age living in each
municipality. Among others, these models will take into account important factors as migration
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as well as demographic developments.
The nationwide lung cancer incidence maps are based on survival parameters estimated from data
from the St.Gallen-Appenzell cancer registry. Incidence estimates can be improved when data
from other cancer registries are used to take into account geographical variation in site-specific
cancer survival distributions as well as in the disagreement of cause-specific death classification
between cancer registries and the national mortality database built up on death certificates.
In this thesis, mortality due to cancer has been analysed. However, several other diseases, e. g. car-
diovascular diseases, exist, which might give further information to the health impact of smoking.
In particular those diseases, which are not characterized by a time lag of some decades between
exposure/smoking and the disease, might be helpful for assessing the impact of control interven-
tions and different smoking regulations. As discussed in Chapter 2, the spatial heterogeneity of
approaches regarding protection against passive smoking in Switzerland offers the possibility to
easily assess their impacts.
Bibliography
Angelis, GD, Angelis, RD, Frova, L, Verdecchia, A, 1994. MIAMOD: A computer package to
estimate chronic disease morbidity using mortality and survival data. Computer Methods and
Programs in Biomedicine, 44(2):99107.
Armero, C, Cabras, S, Castellanos, M, Perra, S, Quirós, A, Oruezábal, M, Sánchez-Rubio, J, 2012.
Bayesian analysis of a disability model for lung cancer survival. Statistical Methods in Medical
Research.
Bailey, T, Gatrell, A, 1995. Interactive spatial data analysis. Longman Scientific & Technical.
Baker, A, Bray, I, 2005. Bayesian projections: What are the effects of excluding data from younger
age groups? American Journal of Epidemiology, 162(8):798805.
Bedford, RL, 2009. Utility of death certificate data in predicting cancer incidence. University of
Iowa. PhD thesis.
Bernardinelli, L, Montomoli, C, 1992. Empirical Bayes versus fully Bayesian analysis of geograph-
ical variation in disease risk. Statistics in Medicine, 11(8):9831007.
Berrut, S, Junker, C, 2008. Von Generation zu Generation: Entwicklung der Todesursachen 1970
bis 2004, Bundesamt für Statistik, Neuchâtel, Schweiz.
Besag, J, York, J, Mollié, A, 1991. Bayesian image restoration, with two applications in spatial
statistics. Annals of the Institute of Statistical Mathematics, 43(1):120.
Best, N, Richardson, S, Thomson, A, 2005. A comparison of Bayesian spatial models for disease
mapping. Statistical Methods in Medical Research, 14(1):3559.
Bordoni, A, Lorez, M, Bouchardy, C, Camey, B, Betticher, D, Dehler, S, Gautschi, O, Konzel-
mann, I, Clough-Gorr, K, the NICER Working Group, 2012. Trends in lung cancer survival in
Switzerland. Schweizer Krebsbulletin, 2:107122.
Bouchardy, C, Lutz, JM, Kühni, C, 2011. Cancer in Switzerland. Situation and development from
1983 to 2007. Neuchâtel: Federal Statistical Office, National Institute for Cancer Epidemiology
and Registration, Swiss Childhood Cancer Registry.
120 BIBLIOGRAPHY
Boyle, P, 1997. Cancer, cigarette smoking and premature death in Europe: A review including
the recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996.
Lung Cancer, 17(1):160.
Bray, F, Møller, B, 2006. Predicting the future burden of cancer. Nature Reviews Cancer, 6(1):63
74.
Bray, I, 2002. Application of Markov chain Monte Carlo methods to projecting incidence and
mortality. Journal of the Royal Statistical Society: Series C (Applied Statistics), 51(2):151164.
Breslow, NE, Day, NE, 1987. Statistical methods in cancer research. Volume II  The design and
analysis of cohort studies. IARC Scientific Publications, 82:1406.
Brookmeyer, R, Gail, MH, 1988. A method for obtaining short-term projections and lower bounds
on the size of the AIDS epidemic. Journal of the American Statistical Association, 83(402):301
308.
Burnett, CA, Dosemeci, M, 1994. Using occupational mortality data for surveillance of work-
related diseases of women. Journal of Occupational Medicine, 36(11):11991203.
Cancer Projections Network (C-Projections), 2010. Comparison of short-term projection methods:
Proposing the hybrid approach and Bayesian models. Alberta Health Services.
Ceschi, M, Bopp, M, Dick, A, Probst-Hensch, N, 2009. Krebs im Kanton Zürich  Ein Bericht
des Krebsregisters. Institut für Sozial- und Präventivmedizin der Universität Zürich.
Chaturvedi, P, 2004. Tobacco is a "weapon of mass destruction". Should Western countries be
invaded for that? Postgraduate Medical Journal, 80(946):477.
Chellini, E, Gorini, G, Martini, A, Giovannetti, L, Costantini, AS, 2006. Lung cancer mortality
patterns in women resident in different urbanization areas in central Italy from 19872002.
Tumori, 92(4):271275.
Clayton, D, Kaldor, J, 1987. Empirical Bayes estimates of age-standardized relative risks for use
in disease mapping. Biometrics, 43(3):671681.
Clements, MS, Armstrong, BK, Moolgavkar, SH, 2005. Lung cancer rate predictions using gener-
alized additive models. Biostatistics, 6(4):576589.
Clèries, R, Ribes, J, Esteban, L, Martinez, JM, Borràs, JM, 2006. Time trends of breast cancer
mortality in Spain during the period 19772001 and Bayesian approach for projections during
20022016. Annals of Oncology, 17(12):17831791.
Coleman, MP, Gatta, G, Verdecchia, A, Estève, J, Sant, M, Storm, H, Allemani, C, Ciccolallo, L,
Santaquilani, M, Berrino, F, the EUROCAREWorking Group, 2003. EUROCARE-3 summary:
Cancer survival in Europe at the end of the 20th century. Annals of Oncology, 14(suppl 5):v128
v149.
BIBLIOGRAPHY 121
Collett, D, 1994. Modelling survival data in medical research. Texts in statistical science. Chapman
& Hall.
Colonna, M, Grosclaude, P, Faivre, J, Revzani, A, Arveux, P, Chaplain, G, Tretarre, B, Launoy, G,
Lesec'h, JM, Raverdy, N, Schaffer, P, Buémi, A, Ménéegoz, F, Black, RJ, 1999. Cancer registry
data based estimation of regional cancer incidence: Application to breast and colorectal cancer
in French administrative regions. Journal of Epidemiology & Community Health, 53(9):558564.
Costanza, MC, Salamun, J, Lopez, AD, Morabia, A, 2006. Gender differentials in the evolution of
cigarette smoking habits in a general European adult population from 19932003. BMC Public
Health, 6:130.
Couraud, S, Zalcman, G, Milleron, B, Morin, F, Souquet, P, 2012. Lung cancer in never smokers
 A review. European Journal of Cancer, 48(9):12991311.
Curtin, F, Morabia, A, Bernstein, M, 1997. Smoking behavior in a Swiss urban population: The
role of gender and education. Preventive Medicine, 26(5):658663.
Czado, C, Gneiting, T, Held, L, 2009. Predictive model assessment for count data. Biometrics,
65(4):12541261.
Darby, S, Hill, D, Doll, R, 2001. Radon: A likely carcinogen at all exposures. Annals of Oncology,
12(10):13411351.
Darby, S, Hill, D, Auvinen, A, Barros-Dios, JM, Baysson, H, Bochicchio, F, Deo, H, Falk, R,
Forastiere, F, Hakama, M, Heid, I, Kreienbrock, L, Kreuzer, M, Lagarde, F, Mäkeläinen, I,
Muirhead, C, Oberaigner, W, Pershagen, G, Ruano-Ravina, A, Ruosteenoja, E, Schaffrath
Rosario, A, Timarche, M, Tomáscaron, L, Whitley, E, Wichmann, HE, Doll, R, 2005. Radon
in homes and risk of lung cancer: Collaborative analysis of individual data from 13 European
case-control studies. BMJ, 330(7485):223.
De Angelis, R, Capocaccia, R, Hakulinen, T, Soderman, B, Verdecchia, A, 1999. Mixture models
for cancer survival analysis: Application to population-based data with covariates. Statistics
in Medicine, 18(4):441454.
Dockery, DW, Pope, CA, Xu, X, Spengler, JD, Ware, JH, Fay, ME, Ferris, Jr., BG, Speizer,
FE, 1993. An association between air pollution and mortality in six U.S. cities. New England
Journal of Medicine, 329(24):17531759. PMID: 8179653.
Doll, R, Cook, P, 1967. Summarizing indices for comparison of cancer incidence data. International
Journal of Cancer, 2(3):269279.
Doll, R, Peto, R, Doll, R, Peto, R, 1976. Mortality in relation to smoking: 20 years' observations
on male British doctors. The British Medical Journal, 2(6051):15251536.
Doll, R, Peto, R, Boreham, J, Sutherland, I, 2004. Mortality in relation to smoking: 50 years'
observations on male British doctors. BMJ, 328(7455):1519.
122 BIBLIOGRAPHY
Downing, A, Forman, D, Gilthorpe, MS, Edwards, KL, Manda, SOM, 2008. Joint disease map-
ping using six cancers in the Yorkshire region of England. International Journal of Health
Geographics, 7(1):41.
Eberly, LE, Carlin, BP, 2000. Identifiability and convergence issues for Markov chain Monte Carlo
fitting of spatial models. Statistics in Medicine, 19(17-18):22792294.
Eilstein, D, Zoé, U, Lim, TA, Bloch, J, 2008. Lung cancer mortality in France: Trend analysis and
projection between 1975 and 2012, using a Bayesian age-period-cohort model. Lung Cancer,
59(3):282290.
Estève, J, Benhamou, E, Raymond, L, 1994. Statistical methods in cancer research. Volume IV.
Descriptive epidemiology. IARC Scientific Publications, 128:1302.
Ezzati, M, Henley, SJ, Thun, MJ, Lopez, AD, 2005. Role of smoking in global and regional
cardiovascular mortality. Circulation, 112(4):489497.
Faeh, D, Minder, C, Gutzwiller, F, Bopp, M, 2009. Culture, risk factors and mortality: Can
Switzerland add missing pieces to European puzzle? Journal of Epidemiology & Community
Health, 63(8):639645.
Fano, V, Michelozzi, P, Ancona, C, Capon, A, Forastiere, F, Perucci, CA, 2004. Occupational
and environmental exposures and lung cancer in an industrialised area in Italy. Occupational
& Environmental Medicine, 61(9):757763.
Federal Office of Public Health, 2010. Nationales Programm Tabak. NPT 20082012.
Federal Office of Public Health, 2011. Nationaler Radonaktionsplan 20122020.
Federal Office of Public Health, 2012a. Rauchen verursacht tödlichen Lungenkrebs. http:
//www.bag.admin.ch/themen/drogen/00041/00612/03652/03659/index.html?lang=de. Ac-
cessed 29 May 2012.
Federal Office of Public Health, 2012b. Radon. http://www.bag.admin.ch/themen/strahlung/
00046/index.html?lang=de. Accessed 29 May 2012.
Federal Statistical Office, 2009. Smoking-attributable mortality in Switzerland. Estimation for
the years 1995 to 2007. neuchâtel.
Federal Statistical Office, 2012a. Sprachgebiete der Schweiz 2000. http://www.bfs.admin.ch/
bfs/portal/de/index/themen/01/05/blank/key/sprachen.html. Accessed 29 May 2012.
Federal Statistical Office, 2012b. Generalisierte Gemeindegrenzen. http://www.bfs.admin.ch/
bfs/portal/de/index/dienstleistungen/geostat/datenbeschreibung/generalisierte_
gemeindegrenzen.html. Accessed 29 May 2012.
Federal Statistical Office, 2013a. Surveys, sources  Cancer epidemiology. http:
//www.bfs.admin.ch/bfs/portal/en/index/infothek/erhebungen__quellen/blank/
blank/kbs/02.html. Accessed 29 January 2013.
BIBLIOGRAPHY 123
Federal Statistical Office, 2013b. Cancer  Data, indicators. http://www.bfs.admin.ch/bfs/
portal/de/index/themen/14/02/05/key/02/03.html. Accessed 31 January 2013.
Federal Statistical Office, 2013c. MS-Regionen, Arbeitsmarktregionen. http://www.bfs.
admin.ch/bfs/portal/de/index/regionen/11/geo/analyse_regionen/03.html. Accessed
14 March 2013.
Flandorfer, P, Wegner, C, Buber, I, 2010. Gender Roles and Smoking Behaviour (Working Papers).
Vienna Institute of Demographics.
Foundation National Institute for Cancer Epidemiology and Registration, 2012. Geneva Statistics
of Cancer Incidence 19852009.
Freedman, DM, Sigurdson, AJ, Doody, MM, Love-Schnur, S, Linet, MS, 2006. Comparison
between cancers identified by state cancer registry, self-report, and death certificate in a
prospective cohort study of US radiologic technologists. International Journal of Epidemiology,
35(2):495497.
Gelfand, A, Vounatsou, P, 2003. Proper multivariate conditional autoregressive models for spatial
data analysis. Biostatistics, 4(1):1125.
Gelfand, AE, Smith, AFM, 1990. Sampling-based approaches to calculating marginal densities.
Journal of the American Statistical Association, 85(410):398409.
Gilks, W, Richardson, S, Spiegelhalter, D, 1996. Markov Chain Monte Carlo in Practice. Chapman
and Hall/CRC Interdisciplinary Statistics Series. Chapman and Hall.
Gmel, G, 2000. Prevalence of tobacco use in Switzerland in the 1990's  Estimation of consumption
trends based on 2 methods. Sozial- und Präventivmedizin, 45(2):6472.
Gómez-Rubio, V, Ferrándiz-Ferragud, J, López-Quílez, A, 2005. Detecting clusters of disease with
R. Journal of Geographical Systems, 7(2):189206.
Graham, H, 1996. Smoking prevalence among women in the European community 19501990.
Social Science & Medicine, 43(2):243254.
Hakulinen, T, Dyba, T, 1994. Precision of incidence predictions based on Poisson distributed
observations. Statistics in Medicine, 13:15131523.
Heishman, SJ, 1999. Behavioral and cognitive effects of smoking: Relationship to nicotine addic-
tion. Nicotine & Tobacco Research, 1(Suppl 2):S143S147.
Hirrle, B, I/2005. Lungenkrebs bei Frauen  Tendenzen und Risikofaktoren. Onkologie.
Hoek, G, Brunekreef, B, Goldbohm, S, Fischer, P, van den Brandt, PA, 2002. Association between
mortality and indicators of traffic-related air pollution in the Netherlands: A cohort study. The
Lancet, 360(9341):12031209.
International Agency for Research on Cancer, 1988. IARC monographs on the evaluation of
carcinogenic risks to humans. Volume 43. Man-made mineral fibres and radon. Lyon.
124 BIBLIOGRAPHY
International Agency for Research on Cancer, 2004. IARC monographs on the evaluation of
carcinogenic risks to humans. Volume 83. Tobacco smoke and involuntary smoking. Lyon.
Johnson, GD, 2004. Small area mapping of prostate cancer incidence in New York State (USA) us-
ing fully Bayesian hierarchical modelling. International Journal of Health Geographics, 3(1):29.
Keller, R, Radtke, T, Krebs, H, Hornung, R, 2011. Der Tabakkonsum der Schweizer Wohn-
bevölkerung in den Jahren 2001 bis 2010  Tabakmonitoring  Schweizerische Umfrage zum
Tabakkonsum.
Keshamouni, VG, Arenberg, DA, Kalemkerian, GP (eds.), 2009. Lung cancer metastasis. Springer.
Kim, HJ, Fay, MP, Feuer, EJ, Midthune, DN, 2000. Permutation tests for joinpoint regression
with applications to cancer rates. Statistics in Medicine, 19(3):335351.
Knorr-Held, L, Best, NG, 2001. A shared component model for detecting joint and selective
clustering of two diseases. Journal of the Royal Statistical Society: Series A, 164(1):7385.
Knorr-Held, L, Rainer, E, 2001. Projections of lung cancer mortality in West Germany: A case
study in Bayesian prediction. Biostatistics, 2(1):109129.
Kohler, B, Ward, E, McCarthy, B, Schymura, M, Ries, L, Eheman, C, Jemal, A, Anderson,
R, Ajani, U, Edwards, B, 2011. Annual report to the nation on the status of cancer, 1975
2007, featuring tumors of the brain and other nervous system. Journal of the National Cancer
Institute, 103(9):714736.
Krebs, H, Keller, R, Radtke, T, Hornung, R, 2008. Werbe- und Verkaufseinschränkungen
für Tabakwaren, höhere Zigarettenpreise und Rauchverbote: Einstellungen der Schweizer
Bevölkerung 2006/2007.
Krebsliga Schweiz, 2012. Lungenkrebs  Bronchialkarzinom. Eine Information der Krebsliga für
Betroffene und Angehörige. Krebsliga Schweiz, Bern.
Kulldorff, M, Nagarwalla, N, 1995. Spatial disease clusters: Detection and inference. Statistics in
medicine, 14(8):799810.
La Vecchia, C, Levi, F, Decarli, A, Wietlisbach, V, Negri, E, Gutzwiller, F, 1988. Trends in
smoking and lung cancer mortality in Switzerland. Preventive Medicine, 17(6):712724.
Law, J, Ping, WC, 2011. Monitoring residual spatial patterns using Bayesian hierarchical spatial
modelling for exploring unknown risk factors. Transactions in GIS, 15(4):521540.
Lee, C, Glantz, S, 2001. The tobacco industry's successful efforts to control tobacco policy making
in Switzerland. University of California, San Francisco.
Lee, PN, Fry, JS, Forey, BA, 1990. Trends in lung cancer, chronic obstructive lung disease, and
emphysema death rates for England and Wales 194185 and their relation to trends in cigarette
smoking. Thorax, 45(9):657665.
BIBLIOGRAPHY 125
Lee, TC, Dean, C, Semenciw, R, 2011. Short-term cancer mortality projections: A comparative
study of prediction methods. Statistics in Medicine, 30(29):33873402.
Lee, YC, Boffetta, P, Sturgis, EM, Wei, Q, Zhang, ZF, Muscat, J, Lazarus, P, Matos, E, Hayes,
RB, Winn, DM, Zaridze, D, Wünsch-Filho, V, Eluf-Neto, J, Koifman, S, Mates, D, Curado,
MP, Menezes, A, Fernandez, L, Daudt, AW, Szeszenia-Dabrowska, N, Fabianova, E, Rudnai,
P, Ferro, G, Berthiller, J, Brennan, P, Hashibe, M, 2008. Involuntary smoking and head and
neck cancer risk: Pooled analysis in the International Head and Neck Cancer Epidemiology
Consortium. Cancer Epidemiology, Biomarkers & Prevention, 17(8):19741981.
Levi, F, Lucchini, F, Negri, E, La Vecchia, C, 2004. Trends in mortality from major cancers in
the European Union, including acceding countries, in 2004. Cancer, 101(12):28432850.
Levi, F, Lucchini, F, La Vecchia, C, 2006. Trends in cancer mortality in Switzerland, 19802001.
European Journal of Cancer Prevention, 15(1):19.
Lienert, T, Serke, M, Schönfeld, N, Loddenkemper, R, 2000. Lung cancer in young females.
European Respiratory Journal, 16(5):986990.
Lopez, AD, Collishaw, NE, Piha, T, 1994. A descriptive model of the cigarette epidemic in
developed countries. Tobacco Control, 3(3):242247.
Luthi, JC, Clere-Berod, A, Favre, F, de Weck, D, 2005. Distribution géographique des cancers en
Valais, 19892000. Registre des Tumeurs. Observatoire valaisan de la santé 2005.
MacKay, J, Eriksen, M, 2004. The tobacco atlas. World Health Organisation.
Mallick, BK, Gelfand, AE, 1994. Generalized linear models with unknown link functions.
Biometrika, 81(2):pp. 237245.
Malvezzi, M, Bertuccio, P, Levi, F, La Vecchia, C, Negri, E, 2012. European cancer mortality
predictions for the year 2012. Annals of Oncology, 23(4):10441052.
Marques-Vidal, P, Cerveira, J, Paccaud, F, Cornuz, J, 2011. Smoking trends in Switzerland, 1992
2007: A time for optimism? Journal of Epidemiology & Community Health, 65(3):281286.
Marshall, RJ, 1991. A review of methods for the statistical analysis of spatial patterns of disease.
Journal of Royal Statistical Society, 154(3):421441.
Menzler, S, Piller, G, Gruson, M, Rosario, AS, Wichmann, HE, Kreienbrock, L, 2008. Population
attributable fraction for lung cancer due to residential radon in Switzerland and Germany.
Health Physics, 95(2):179189.
Mezzetti, M, Robertson, C, 1999. A hierarchical Bayesian approach to age-specific back-calculation
of cancer incidence rates. Statistics in Medicine, 18(8):919933.
Mitton, N, Colonna, M, Trombert, B, Olive, F, Gomez, F, Iwaz, J, Polazzi, S, Schott-Petelaz, A,
Uhry, Z, Bossard, N, Remontet, L, 2011. A suitable approach to estimate cancer incidence in
area without cancer registry. Journal of Cancer Epidemiology, 2011 (2011):418968.
126 BIBLIOGRAPHY
Møller, B, 2004. Prediction of cancer incidence  Methodological considerations and trends in the
Nordic countries 19582022. Faculty of Medicine, University of Oslo, Unipuc AS, Oslo.
Møller, B, Fekjaer, H, Hakulinen, T, Tryggvadóttir, L, Storm, HH, Talbäck, M, Haldorsen, T,
2002. Prediction of cancer incidence in the Nordic countries up to the year 2020. European
Journal of Cancer Prevention, 11 Suppl 1:S196.
Møller, B, Fekjaer, H, Hakulinen, T, Sigvaldason, H, Storm, HH, Talbäck, M, Haldorsen, T,
2003. Prediction of cancer incidence in the Nordic countries: Empirical comparison of different
approaches. Statistics in Medicine, 22(17):27512766.
Møller, B, Weedon-Fekjaer, H, Haldorsen, T, 2005. Empirical evaluation of prediction intervals
for cancer incidence. BMC Medical Research Methodology, 5 (21).
Nafstad, P, Håheim, LL, Oftedal, B, Gram, F, Holme, I, Hjermann, I, Leren, P, 2003. Lung cancer
and air pollution: A 27 year follow up of 16 209 Norwegian men. Thorax, 58(12):10711076.
National Institute for Cancer Epidemiology and Registration, 2011a. Fribourg Statistics of Cancer
Incidence 19852009.
National Institute for Cancer Epidemiology and Registration, 2011b. Graubünden Statistics of
Cancer Incidence 19842008.
National Institute for Cancer Epidemiology and Registration, 2011c. Ticino Statistics of Cancer
Incidence 19842008.
National Institute for Cancer Epidemiology and Registration, 2011d. Glarus Statistics of Cancer
Incidence 19842008.
National Institute for Cancer Epidemiology and Registration & Federal Statistical Office, 2012.
Switzerland Statistics of Cancer Incidence 19852009.
Negri, E, La Vecchia, C, Levi, F, Randriamiharisoa, A, Decarli, A, Boyle, P, 1990. The application
of age, period and cohort models to predict Swiss cancer mortality. Journal of Cancer Research
and Clinical Oncology, 116(2):207214.
Ntzoufras, I, 2009. Bayesian modeling using WinBUGS. John Wiley & Sons, Inc.
Oberaigner, W, Vittadello, F, 2010. Cancer mapping in Alpine regions 20012005.
Observatoire valaisan de la santé, 2005. Le cancer en Valais 19892000.
Ong, HC, Soo, KL, 2006. Backcalculation of HIV infection rates in Malaysia. Medical Journal of
Malaysia, 61(5):616620.
Osmond, C, 1985. Using age, period and cohort models to estimate future mortality rates. Inter-
national Journal of Epidemiology, 14(1):124129.
PAHO, 2002. Epidemiological Bulletin - Pan American Health Organization: Celebrating 100
years of health (September 2002), Standardization: A classic epidemiological method for the
comparison of rates. 23:3.
BIBLIOGRAPHY 127
Parkin, DM, 2011. Tobacco-attributable cancer burden in the UK in 2010. British Journal of
Cancer, 105:S6S13.
Parkin, DM, Hakulinen, T, 1991. Analysis of survival.
Peto, R, Lopez, AD, Boreham, J, Thun, M, Heath, C, 1992. Mortality from tobacco in developed
countries: Indirect estimation from national vital statistics. Lancet, 339(8804):12681278.
Pregibon, D, 1980. Goodness of link tests for Generalized Linear Models. Journal of the Royal
Statistical Society Series C (Applied Statistics), 29(1):pp. 1523, 14.
Pury, P, Lutz, J, Junker, C, Gantenbein, E, 2007a. Statistics of cancer mortality 19862005. Swiss
Association of cancer registries 2007.
Pury, P, Lutz, JM, Jundt, G, et al, 2007b. Statistics of cancer incidence 19862005. Swiss Asso-
ciation of cancer registries 2007.
Qiu, Z, Hatcher, J, Wang, M, Cancer Projection Analytical Network Working Team. Review can-
cer projections methods for Canadian Partnership Against Cancer Analytical Network. Alberta
Health Service.
Qiu, Z, Jiang, Z, Wang, M, Hatcher, J, 2010. Cancer Projections Network (C-Projections). Long-
term projection methods: Comparison of age-period-cohort model-based approaches. Alberta
Health Services.
Richardson, S, Abellan, JJ, Best, NG, 2006. Bayesian spatio-temporal analysis of joint patterns of
male and female lung cancer risks in Yorkshire (UK). Statistical Methods in Medical Research,
15(4):385407.
Samet, JM, Avila-Tang, E, Boffetta, P, Hannan, LM, Olivo-Marston, S, Thun, MJ, Rudin, CM,
2009. Lung cancer in never smokers: Clinical epidemiology and environmental risk factors.
Clinical Cancer Research, 15(18):56265645.
Sánchez, MJ, Payer, T, De Angelis, R, Larrañaga, N, Capocaccia, R, Martinez, C, 2010. Cancer
incidence and mortality in Spain: Estimates and projections for the period 19812012. Annals
of Oncology, 21 (suppl 3):iii3036.
Schüler, G, Bopp, M, 1997. Atlas der Krebsmortalität in der Schweiz, 19701990. Birkhäuser
Verlag.
Schopper, D, Obrist, R, 2005. Nationales Krebsprogramm für die Schweiz 20052010. Oncosuisse,
Bern.
Schrader, H, 1997. Entwicklungstendenzen ländlicher Räume in Deutschland und ihre Förderung
durch die EU-Strukturpolitik. In: Die ländlichen Räume in Deutschland und deren Besonderheit
in Mecklenburg Vorpommern. Universität Rostock.
Segi, M, 1960. Cancer mortality for selected sites in 24 countries (195057). Tohoku University
of Medicine, Sendai.
128 BIBLIOGRAPHY
Sitas, F, Douglas, AJ, Webster, EC, 1989. Respiratory disease mortality patterns among South
African iron moulders. British Journal of Industrial Medicine, 46(5):310315.
Sturtz, S, Ickstadt, K, 2007. A descriptive and model-based spatial comparison of the standardised
mortality ratio and the age-standardized mortality rate. Geospatial Health, 1(2):255266.
Subramanian, J, Govindan, R, 2007. Lung cancer in never smokers: A review. Journal of Clinical
Oncology, 25(5):561570.
Sue Bell, B, Broemeling, LD, 2000. A Bayesian analysis for spatial processes with application to
disease mapping. Statistics in Medicine, 19(7):957974.
Sun, DC, Tsutakawa, RK, Kim, H, He, ZQ, 2000. Spatio-temporal interaction with disease map-
ping. Statistics in Medicine, 19(15):20152035.
Taylor, R, Najafi, F, Dobson, A, 2007. Meta-analysis of studes of passive smoking and lung cancer:
Effects of study type and continent. International Journal of Epidemiology, 36(5):10481059.
Thun, MJ, Day-Lally, C, Myers, DG, Calle, EE, Flanders, WD, Zhu, BP, Namboodiri, MM,
Heath, CW, 1997. Trends in tobacco smoking and mortality from cigarette use in Cancer
Prevention Studies I (1959 through 1965) and II (1982 through 1988).
Thun, MJ, Henley, SJ, Burns, D, Jemal, A, Shanks, TG, Calle, EE, 2006. Lung cancer death
rates in lifelong nonsmokers. Journal of the National Cancer Institute, 98(10):691699.
Thun, MJ, Hannan, LM, Adams-Campbell, LL, Boffetta, P, Buring, JE, Feskanich, D, Flanders,
WD, Jee, SH, Katanoda, K, Kolonel, LN, Lee, IM, Marugame, T, Palmer, JR, Riboli, E, Sobue,
T, Avila-Tang, E, Wilkens, LR, Samet, JM, 2008. Lung cancer occurrence in never-smokers:
An analysis of 13 cohorts and 22 cancer registry studies. PLoS Med, 5(9):e185.
Torok, S, Hegedus, B, Laszlo, V, Hoda, MA, Ghanim, B, Berger, W, Klepetko, W, Dome, B,
Ostoros, G, 2011. Lung cancer in never smokers. Future Oncology, 7(10):11951211.
Trichopoulos, D, Kalandidi, A, Sparros, L, MacMahon, B, 1981. Lung cancer and passive smoking.
International Journal of Cancer, 27(1):14.
Tyczynski, JE, Bray, F, Parkin, DM, 2003. Lung cancer in Europe in 2000: Epidemiology,
prevention and early detection. Lancet Oncology, 4(1):4555.
United States Department of Health and Human Services, 2004. The health consequences of
smoking: A report of the Surgeon General. Department of Health and Human Services, Centers
for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health
Promotion, Office on Smoking and Health.
United States Department of Health and Human Services, 2010. How tobacco smoke causes
disease: The biology and behavioral basis for smoking-attributable disease: A report of the
Surgeon General. Centers for Disease Control and Prevention (US); National Center for Chronic
BIBLIOGRAPHY 129
Disease Prevention and Health Promotion (US); Office on Smoking and Health (US). Atlanta
(GA): Centers for Disease Control and Prevention (US).
United States Environmental Protection Agency, 1992. Respiratory Health Effects of Passive
Smoking: Lung Cancer and Other Disorders. Office of Health and Environmental Assessment,
Office of Research and Development, U.S. Environmental Protection Agency, Washington, D.C.
United States Public Health Service, 1964. Smoking and health. United States Public Health
Service. Office of the Surgeon General.
Ver Hoef, JM, Cressie, N, Fisher, RN, Case, TJ, 2001. Uncertainty and spatial linear models
for ecological data. In Spatial uncertainty in ecology: implications for remote sensing and GIS
applications, Chapter 10. Springer-Verlag, New York.
Waller, LA, Carlin, BP, Xia, H, Gelfand, AE, 1997. Hierarchical spatio-temporal mapping of
disease rates. Journal of the American Statistical Association, 92(438):607617.
Weinstein, ND, 2001. Public understanding of risk and reasons for smoking low-yield products, in
risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine.
u.s. dept. of health and human services, public health service, national institutes of health,
national cancer institute: Bethesda, md:193-197.
Whittle, P, 1954. On stationary processes in the plane. Biometrika, 41(3/4):434449.
WHO, 2008. WHO Report on the global tobacco epidemic, 2008: The MPOWER Package.
Geneva: World Health Organization.
WHO, 2009. WHO handbook on indoor radon: A public health perspective. Geneva. Geneva.
WHO, 2013a. WHO Framework Convention on Tobacco Control. http://www.who.int/fctc/
en/.
WHO, 2013b. Management of substance abuse. Tobacco. http://www.who.int/substance_
abuse/facts/tobacco/en/.
Willemsen, MC, Kiselinova, M, Nagelhout, GE, Joossens, L, Knibbe, RA, 2012. Concer about
passive smoking and tobacco control policies in European countries: An ecological study. BMC
Public Health, 12(1):876.
Wingo, PA, Landis, S, Parker, S, Bolden, S, Heath, CW, 1998. Using cancer registry and vital
statistics data to estimate the number of new cancer cases and deaths in the United States for
the upcoming year. Journal of Registry Management, 25(2):4351.
Xia, H, Carlin, BP, Waller, LA, 1997. Hierarchical models for mapping Ohio lung cancer rates.
Environmetrics, 8(2):107120.
